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To see a world in a grain of sand 
And a heaven in a wild flower,  
Hold infinity in the palm of your hand,  
And eternity in an hour. 
 
























Si le temps n’est qu’illusion, les illusions ne durent qu’un temps. 





In recent years, a novel technology took the world by storm. Stemming from puzzling repeats 
of DNA sequences found in bacteria thirty years ago, it was discovered to serve as a powerful 
defence mechanism against the constant threat of bacterial viruses. In this war of genetic 
information, bacteria integrated viruses’ genetic signatures and used them as targets, effectively 
turning their enemies’ weapons against them. The key element was encoded into the 
association of a target-finder (CRISPR-RNA) and its target-cleaver (Cas9 protein). Together, 
they formed CRISPR-Cas9. 
Twenty years later, its potential for gene editing came to light and transformed every field of 
biological sciences, thus empowered by its formidable capacity to rewrite genetic material. 
However, such power is not without risk. An edition at the wrong place and a whole organism 
could find itself altered, for the worse. Conversely, one could well protect the source of harm, 
thereby strengthen and not disarm, the intruder. Thus, questions arose about the reliability of 
this technology. ‘How frequently did CRISPR-Cas9 interact with a wrong target?’ ‘In fact, 
how, how much and with what did CRISPR-Cas9 interact, overall?’ 
To address those questions, we decided to use a direct approach and observe the main actor of 
this biological system; the Cas9 protein. Using a fluorescent marker, we were able to look at 
its movements within Escherichia coli cells and, with this information, detect when it would 
stop. Indeed, an arrest would indicate an interaction, and an interaction a potential DNA 
modification. Taking a step further, we compared the amount of interactions displayed by the 
protein in different conditions: with and without target-finder (gRNA); with and without target; 
even with and without DNA. Surprisingly, we found that the protein was predominantly 
moving away from interactions. Yet, our technique allowed us to detect much larger amounts 
of non-specific associations than previously reported, highlighting the presence of ‘silent’ 
DNA interactions and stressing the need for more extensive studies on their potential effect. 
In conclusion, my work not only enriches our comprehension of the CRISPR-Cas9 system, but 
also reveals the existence of strikingly vast non-specific protein-DNA interactions, whose 
influence remains to be determined. This technology shows huge promise for research and 





What do adaptive immunity, genetic engineering and antimicrobials have in common? 
CRISPR-Cas9, the popular enzymatic complex that produces DNA double-strand breaks when 
associated with a guide-RNA. Hundreds of labs routinely use this system to edit genomic DNA; 
however, some of the mechanisms by which it interacts with nucleic acid remain unclear.  
 
In my lab, we developed an expertise in the study of DNA recombination, DNA repair and 
DNA interactions in Escherichia coli. We use single-molecule fluorescent microscopy to 
collect images in real time, in vivo. During my PhD, I harnessed this expertise to follow the 
behaviour of the Cas9 protein under different conditions: various expression levels; various 
gRNAs; and various genomic targets. By observing the diffusion dynamics of the protein, I 
was able to quantify how different DNA interactions were impacting the motion of the protein 
in the cytoplasm and inferred that actual ON-target interactions were very rare throughout the 
lifetime of the protein. In contrast, the protein was mainly involved in non-specific OFF-target 
DNA interactions, in search of its actual target. Additionally, my results reveal the presence of 
a large fraction of non-specific interactions, hitherto not reported in the literature, owing to 
their absence of DNA modification. 
 
In total, this work offers a collection of highly quantitative measurements on the behaviour of 
a protein whose activity is central to many biologists, while shedding a new light on the 
importance of Cas9 searching and targeting mechanisms. Finally, it opens a discussion on the 
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Chapter I – Introduction  






This work revolves around CRISPR-Cas9, the technology originally designed by bacteria and 
re-programmed by mankind to target DNA, cleave it and use this open breach to rewrite any 
type of genetic material. 
In the following chapter (Chapter I), I will describe the system as it is used in bacteria, 
discussing its structures and mechanisms. Then I will highlight the various courses scientists 
have taken to re-direct this system, either for genetic editing purposes or for antimicrobial ones. 
The limitations of such endeavours will be discussed, and particularly the discovery of OFF-
target events, where the CRISPR system non-specifically interacts with DNA. On this basis, I 
will present the purpose of this thesis, which will bring us to the study itself; the quantification 
of CRISPR-Cas9 diffusion dynamics in Escherichia coli. 
After presenting the Materials and Methods used in this study (Chapter II), I will show how 
those methods were implemented, tested and employed to give a first overview of CRISPR-
Cas9 diffusion (Chapter III). This will be followed by a more comprehensive analysis, based 
on the multiplication of experimental conditions, allowing us to compare, infer and draw our 
own interpretations (Chapter IV). Finally, our findings will be more widely discussed in the 
context of the literature, leading us to our final conclusions (Chapter V). 














1.1 – CRISPR Origin: Structure and Mechanism 
To protect themselves against external DNA, every form of life has developed 
immunity mechanisms, such as RNA-guided systems which purposely target viruses1. In 
bacteria, such adaptive systems have been reported to provide resistance to bacteriophages2 
and even to prevent plasmid conjugation3. Indeed, about 40% of bacteria (and 90% of archaea) 
possess similar mechanisms2 which in 2002 were officially called CRISPR, for Clustered 
Regularly Interspaced Short Palindromic Repeats4. Many studies soon followed, revealing that 
relying on endonucleases associated to RNA-DNA homologies, those systems work in three 
phases. 
 
First, small fragments of external DNA called ‘spacers’ are captured and incorporated into long 
genomic sequences called ‘CRISPR arrays’, where they get interspersed with (up to several 
hundreds of) DNA repeats5 (Figure 1.1). Those arrays are, in a second phase, transcribed into 
long RNA molecules and processed into smaller transcripts (‘crRNAs’ or CRISPR-RNAs) 
consisting of single-spacer units, where they associate with Cas complexes; those complexes 
are formed of multiple subunits, usually transcribed in the vicinity of the CRISPR arrays, which 
have the ability to bind crRNAs to form Cas-crRNA complexes6. Third and final phase, those 
Cas-crRNA complexes recognise foreign DNA and degrade it through various endonuclease 
and exonuclease activities7. 






Figure 1.1. CRISPR general mechanism. The CRISPR system is composed of two main parts; the Cas 
genes (or effectors) and the CRISPR array with repeats (black triangles) and unique spacers (red boxes), 
resulting in a long transcript which will be further processed by the Cas proteins (or Cascade complex). 
Together, they will associate and target homologous sequences of external DNA which upon recognition 
will trigger degradation. Initially, the whole target and subsequent degradation mechanisms were still 
unknown. Extracted from Waters, et al. Regulatory RNAs in Bacteria. Cell 136, 615–628 (2009)8. 
 
Many different CRISPR types have been discovered, characterized by their Cas proteins (with 
more than 40 different genes)9. Those proteins present similarities with DNA-binding proteins 
including endonucleases (cas9), exonucleases (cas4), helicases (cas3) and even 
polymerases10,11.  
Another feature distinguishing CRISPR types from each other are PAM – or Proto Adjacent 
Motif – sequences, which beautifully ensure that CRISPR-containing cells do not damage their 
own DNA (Figure 1.2)12. Indeed, the first motifs recognised by CRISPR-Cas complexes are 
those PAM sequences (usually three-nucleotides long), subsequently facilitating direct 
Watson-Crick pairing between the crRNA and the targeted sequence. CRISPR arrays do not 
possess such motifs, preventing Cas complexes from cutting their very origin13. 
 




Due to its simplicity, ease to manipulate and DNA-processing efficiency, one particular type 
of the CRISPR family attracted most of the attention; the CRISPR type II, also called CRISPR-
Cas9. Originating from Streptococcus pyogenes, this CRISPR complex relies on three agents 
(Figure 1.2);  
(i) The Cas9 protein which possesses two endonuclease domains (HNH and RuvC, 
a Holliday junction resolvase),  
(ii) the crRNA which encodes the specificity of the CRISPR activity, with 20-
nucleotide homology with the target sequence, 
(iii) the tracrRNA (trans-activating crRNA), itself associated to the crRNA and 
forming, with it, a dual RNA14.  
Effectively acting as a DNA ‘handle’, the tracrRNA bridges Cas9 (effector protein) and the 
crRNA (target identifier) together15. Much like in other CRISPR families, the type II CRISPR 
array originates from the insertion of external DNA ‘spacers’ interspersed by DNA repeats 
which, after transcription in long RNA molecules, gets processed by the RNAseIII protein to 
eventually result in several individual Cas9-crRNA-tracrRNA (or CRISPR-Cas9) complexes, 













Figure 1.2. CRISPR-Cas9 immunization and immunity. (Top) Upon infection, the external (or viral) 
DNA gets degraded by the Cas complex which results in small sequences (coloured hexagons) inserted in 
the CRISPR array and interspersed with repeats (black rectangles). (Bottom) After downstream 
transcription, those long crRNAs associate with RNAseIII, tracrRNAs and the Cas9 protein to form 
individual CRISPR-Cas9 complexes. After PAM sequence recognition, such a complex can unwind the 
DNA to allow the crRNA to probe for homologies which, if found, triggers Cas9 endonuclease activity. 
Extracted from Mali, et al. Cas9 as a versatile tool for engineering biology. Nat Methods 10, 957–963 
(2013)16. 
 




In more details, the Cas9 protein has a molecular weight of 160kDa and is itself composed of 
two main lobes, themselves formed of several domains; the REC lobe (Helicase Recognition 
lobe) is constituted of three alpha-helical domains whose roles are to associate with the 
tracrRNA. The NUC lobe (nuclease lobe) contains the two endonuclease domains (RuvC and 
HNH), bound to each other by two linkers, and a CTD (C-terminal) domain which is involved 
in PAM sequence recognition. Finally, an arginine-rich domain links the two lobes together 
(Figure 1.3A, B). 
 
Figure 1.3. Cas9 domain organization and structure. (A) Cas9 domains organization. The two 
endonuclease domains RuvC-I (divided in three parts, in blue) and HNH (green) are associated with two 
linkers (L-I and L-II, both in yellow). The Helical domains (REC lobe, in grey) allow Cas9 to interact with 
the sgRNA (association of crRNA and tracrRNA) (orange). The arginine-rich bridge helix (Arg, in purple) 
is involved in protein conformational change to trigger DNA target (black) cleavage. Finally, C-terminal 
domain (CTD) relates to PAM recognition. (B) With the same previous colour code, this cartoon 
representation of Cas9 shows how every domain interacts with each other, with the sgRNA and with DNA. 
(C) With added transparency, it is possible to see the two endonuclease sites (yellow stars), and the too-large 
distance between the HNH active site and its target locus (dashed line), highlighting the necessary change 
of conformation to be effective. Adapted from Jiang, F. & Doudna, J. A. CRISPR–Cas9 Structures and 
Mechanisms. Annu. Rev. Biophys. 46, 505–529 (2017).17 






The dual-RNA formed by the association of the crRNA and the tracrRNA, commonly referred 
to as the guide-RNA (gRNA), strongly influences the conformation of the Cas9 protein. Indeed, 
observations of the crystallographic structure of the CRISPR-Cas9 complex showed that 
several conformational changes were necessary to (i) allow Cas9 to interact and recognise PAM 
sequences and (ii) to allow the restrictions sites to cleave the target site (Figure 1.3C).  
In the apo form (Cas9 without gRNA), the CTD domain (responsible for PAM recognition) is 
kept partly disorganized and therefore limits Cas9 ability to recognize PAM sequences. As can 
be seen on Figure 1.4, Cas9 interactions with PAM sequences are facilitated by the association 
of the protein with the gRNA, as its two recognition lobes (REC and NUC) open up to transition 
the protein domains from a largely disorganised state to a pre-organized one. After PAM 
recognition and through additional conformational change, the CRISPR-Cas9 complex 
unwinds both DNA strands and allow the crRNA to probe the DNA sequence by checking for 
homology. The specificity of the crRNA rests on its 20-nucleotide sequence, homologous to 
the target to find. However, a ‘seed region’ consisting of 10-12 nucleotides towards the PAM 
sequence (on the 3’ end of the spacer) contains most of the target specificity, as mismatches in 
this region dramatically decrease CRISPR-Cas9 activity18.  
After full recognition of the target sequence, the Cas9 protein uses its two endonuclease 
domains to produce a double-stranded break (DSB), blunt-ended, 3 nucleotides upstream of 










Figure 1.4. CRISPR mechanism for DNA-interaction and cleavage. The Cas9 protein is composed of 
two main lobes; the REC (Helicase Recognition) one which associates with the gRNA and the NUC 
(Nuclease) one which activates the endonuclease activity. Upon association with the sgRNA (crRNA-
tracrRNA), the PAM-interacting region of the Cas9 protein (dotted circle) opens up to allow for DNA 
recognition. Through its seed region (blue), the gRNA then probes the DNA sequence for homology (seed 
nucleation followed by near-active form). After full recognition, the endonuclease domains HNH and RuvC 
cleave the two strands of target DNA. Extracted from Jiang, F., Zhou, K., Ma, L., Gressel, S. & Doudna, J. 












1.2 – CRISPR Optimization: Genetic Engineering 
 
After a first characterization of the CRISPR complex, a set of additional features 
artificially designed to further simplify the use of CRISPR-Cas9 and, above all, to optimize its 
genetic engineering capabilities, were developed.  
For example, a chimeric single-guide RNA (sgRNA, or gRNA), made of the fusion of the 
crRNA (in 3’) and of the tracrRNA (in 5’) was produced; not only easier to build, this construct 
also presented the advantage of accelerating the formation of the CRISPR complex, due to its 
combined expression15 (Figure 1.5). 
Additionally, it was shown that elongating the tail of the tracrRNA (with up to 85 nucleotides) 
could increase the CRISPR efficiency (up to five times), due to higher RNA stability and 
stronger Cas9 affinity, thus leading to a new trend of gRNA designs20. 
 
Figure 1.5. Design of the single guide RNA, or sgRNA. Built from the fusion of the crRNA (in 3’) and of 
the tracrRNA (in 5’), associated to a linker loop, the sgRNA keeps the same features and the same affinity 
for both Cas9 and the DNA target, making it effectively easier and thus more efficient to use. Extracted from 
Jinek, M. et al. A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity. 
Science (80-. ). 337, 816–822 (2012)15. 
After CRISPR-Cas9 recognition of the PAM sequence, followed by complete homology with 
the crRNA, DNA cleavage is triggered and, as we previously mentioned, a DNA Double-
Stranded Break (DSB) is produced. In eukaryotes, this break can be faithfully repaired through 
Homology-Directed Repair (HDR)21 of which the most common form is Homologous 
Recombination (HR)22. Additionally, it can be repaired by a much less accurate mechanism 
called Non-Homologous End Joining (NHEJ)23. Left unrepaired, such DSB can be lethal. 




In Escherichia coli, the vast majority of DSBs are repaired through Homologous 
Recombination, which is triggered by the RecBCD enzyme (homolog of the MRX complex in 
budding yeast and of the MRN complex in mammals24) (Figure 1.6); it recognises DSB ends 
and processes the two DNA strands until it encounters a Chi site (8-nucleotide sequence), at 
which point the complex changes its conformation and limits its DNA digestion to a single 
strand, leaving the other available for the recruitment of a second protein; RecA (homolog of 
Rad51)25. Several RecA proteins then accumulate on the DNA strand and form a nucleoprotein 
filament, which will drive the homology search for an identical copy of the broken strand, able 
to act as a template for subsequent repair.  
 
 
Figure 1.6. Homologous Recombination in Escherichia coli. After DNA cleavage, (1 and 2) the RecBCD 
enzyme (triangle) recognises the DNA end and digests both DNA strands (at different speeds), consuming 
ATP. (3 and 4) Upon encountering a Chi site (black arrow), RecBCD changes its conformation and stops 
degrading one of the strands, leaving the other available for RecA recruitment. (5 and 6) A RecA 
nucleoprotein filament is progressively formed, which will trigger the homology search for an intact copy 
of the broken DNA. The copy will be used as a repair template to faithfully reconstitute the broken sequence. 
Extracted from Dillingham, M. S. & Kowalczykowski, S. C. RecBCD enzyme and the repair of double-








Importantly, RecA recruitment triggers an additional pathway called the ‘SOS response’26, 
which sees the overexpression of more than 40 genes in order to support repair mechanisms27. 
In normal conditions, a regulator called LexA specifically binds to those genes (on a SOS 
box28) and represses their expression. Upon DNA damage, the presence of the previously-
described RecA nucleoprotein filament interacts with LexA proteins and triggers its auto-
catalysis, effectively de-repressing the SOS genes within minutes29. 
Among those genes is the one expressing RecA, thus indirectly over-expressing itself, and 
many others including SfiA, a division inhibitor, as well as the mutagenic DNA repair 
polymerase (Pol V) which, as a result, inhibits cell division and facilitates repair while 
increasing genomic diversity25. Finally, as LexA is also repressing itself, the SOS response 
ensures that its main regulator remains expressed, so that when the damage is repaired, the 
signal disappears and all those genes go back to normal expression30. 
In contrast, the NHEJ pathway (absent in E. coli) uses the Ku protein to allow the recruitment 
of ligases, which will re-ligate the two DNA ends together31. This faster mechanism has the 
main disadvantage of being much more error-prone which can lead to ‘indels’ 
(insertion/deletion), themselves potentially deleterious due to gene loss of function (Figure 
1.7).  
Now, in the context of CRISPR-Cas9, both repair mechanisms can be harnessed for specific 
purposes. For instance, with the addition of an appropriate DNA template, HDR can lead to the 
effective rewriting of virtually any genomic DNA sequence32 (Figure 1.7). In contrast, NHEJ 
capacity to produce indels has been used to detect and measure Cas9 activity20. 
 
 





Figure 1.7. Double-Stranded break repair and gene editing. Following Cas9 cleavage, the DNA break is 
either repaired through non-homologous end joining (NHEJ), or through homology-directed repair (HDR). 
In the first scenario (NHEJ), the Ku protein triggers an error-prone ligation, which can lead to indel 
mutations, misalignment (frameshift mutations) and subsequent gene knock-out (represented here by the 
premature stop codon). In the other case (HDR), Rad51 (in eukaryotes) or RecA (in E.coli) uses a DNA 
template to faithfully repair the break. Consequently, a DNA repair template containing mutations 
(represented here by the dark rectangles) can be externally added to accurately edit any gene. Extracted from 
Hsu, P. D., Lander, E. S. & Zhang, F. Development and applications of CRISPR-Cas9 for genome 
engineering. Cell 157, 1262–1278 (2014). 
 
Note that one (or both) of the endonuclease domains can be voluntarily inactivated (by single-
point mutations) so as to prevent Cas9 from cutting the DNA33,34. Such catalytically-dead 
mutant, dubbed ‘dead-Cas9’ (dCas9) actually offers renewed opportunities such as gene 
regulation possibilities, illustrated by the CRISPR-interference (CRISPRi) mechanism, where 
dCas9 binds to promoter regions and prevents RNA polymerases from transcribing 
neighbouring genes, effectively inhibiting their expression35 (Figure 1.8).  
A similar approach used a dCas9 fusion to the omega subunit of the RNA polymerase (RNAP) 
to enhance transcription up to 23-fold, by stabilizing the binding of RNAP to the promoter of 
the nearby dCas9-bound target36. 





Figure 1.8 CRISPR-interference (CRISPRi) uses dCas9 for gene regulation. As opposed to the original 
wild-type Cas9 (on the left), dCas9 does not cleave the DNA (on the right). In consequence, it is possible to 
harness dCas9’s binding ability to prevent the RNA polymerase (RNAP) from transcribing any neighbouring 
gene, effectively interfering with the gene regulation. Extracted from Qi, L. S. et al. Repurposing CRISPR 
as an RNA-γuided platform for sequence-specific control of gene expression. Cell 152, 1173–1183 (2013). 
 
Finally, another notable function developed with CRISPR-Cas9 is based on its antimicrobial 
potential. Indeed, by targeting bacterial genome which, as we previously mentioned, 
extensively (if not exclusively, for some organisms) relies on Homologous Recombination to 
repair DNA breaks, it suffices to cleave all available repair templates (which in bacteria are 
rarely exceeding 10 copies), to irremediably kill the targeted organism37. Better still, the 
specificity embedded in the 20-nucleotides sequence of the crRNA would ensure to only hit 
designated targets (Figure 1.9). In the context of antimicrobial resistance, this technique would 
allow the directed targeting of resistant bacteria, leaving the rest to either outcompete the few 
survivors, or to be treated by usual antibiotic treatment. 
Considering that this mechanism was originally designed by bacteria to turn viruses’ genetic 
tools against them, let us appreciate the irony of having it now turned back against bacteria.  






Figure 1.9 CRISPR-Cas9 can be used to selectively kill resistant bacteria. (A) Two strains of 
Staphilococcus aureus cells were mixed 1:1 (one being both methicillin and oxacillin resistant) and 
transformed with a phagemid containing CRISPR-Cas9 targeting the methicillin resistance gene mecA. As a 
result, only the methicillin-resistant cells were killed, while the others were immunized to conjugative 
plasmids carrying the resistance gene. (B) Following transformation with phagemids, cells were either plated 
on a non-selective medium (ø), either on a medium containing chloramphenicol (Cm) to measure the number 
of cells carrying the phagemids (chloramphenicol resistant, as a control) or on a medium containing oxacillin 
(Oxa) to measure the number of resistant cells. In the presence of a spacer targeting the mecA gene, resistant 
cells die about 100-fold, compared to almost no effect on the population of non-resistant bacteria. Measures 
are in colony forming units (CFU) per microliter, with their respective standard deviations (error bars). 
Adapted from Bikard, D. et al. Development of sequence-specific antimicrobials based on programmable 
CRISPR-Cas nucleases. Nat. Biotechnol. 32, 1146–1150 (2014)37. 
In conclusion, from this time on, a simple RNA and a protein expressed together could easily 
recognise, cut and therefore edit any DNA sequence, effectively transforming (or killing) any 
organism of choice (Figure 1.10). Despite many remaining uncertainties, this discovery was a 
little revolution15…which unleashed a legal battle for its paternity38.  
 






Figure 1.10. A CRISPR revolution. CRISPR-Cas9 genome editing abilities can be harnessed to 
revolutionize various fields. In Molecular Biology, it can greatly facilitate the use of animal models and 
the development of different cell lines. In Biotechnology, it can increase fuel and food production. In 
Medicine, it can open the door to new personalized therapeutics, through gene therapy and new 
antimicrobials. Extracted from Hsu, P. D., Lander, E. S. & Zhang, F. Development and applications of 
















1.3 – CRISPR Limitations: ON and OFF-target 
 
After validation of the CRISPR-Cas9 potential, a new set of analyses started to 
highlight limitations in the way this system could be relied upon. For instance, Hsu and 
colleagues showed that the ‘seed’ region of the crRNA (spanning 10-12nt) could tolerate 
mismatches, thus revealing a complex recognition pattern20 (Figure 1.11). 
 
Figure 1.11. gRNA single-mismatches highlight ‘seed region’ and reveal base-dependent specificity. A 
set of gRNAs all targeting the human EMX1 gene and harbouring different single mismatches at different 
positions from the PAM sequence (starting at number 1) had their respective CRISPR efficiency measured, 
and normalized to the original target sequence. The heat map represents the CRISPR efficiency (increasing 
from white to dark blue), characterized by the presence of indel events originating from Cas9 cleavage and 
subsequent non-homologous end joining (NHEJ). We can observe that within the ‘seed’ region 
corresponding to the first 10-12 nucleotides, the CRISPR efficiency really varies from one base to another. 
Adapted from Hsu, P. D. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 
31, 827–832 (2013)20. 
 
These results shed new light on the interactions of the CRISPR complex with genomic DNA, 
and especially the secondary structures found at the target site. Indeed, such structures could 
sometimes improve, and other times entirely remove CRISPR-Cas9’s ability to cut the DNA, 
regardless of the accuracy of the match between the crRNA and its target33. Not to mention the 
additional impact of chromatin types (especially heterochromatin)39, methylation and other 
epigenetic DNA modifications40. 




More importantly – and more surprisingly – was the appearance of non-specific activity, where 
the CRISPR complex was observed interacting with DNA sequences which did not fully match 
its crRNA41,42. By targeting a single sequence with several crRNAs harbouring mismatches 
with the target, then by measuring gene expression which should be inhibited in the case of 
effective DSB, studies41 have noticed the phenomenon, but are yet to understand its cause or 
even predict its occurrence. Indeed, as opposed to ON-target activity where the CRISPR 
complex recognises the sequence matching its crRNA (i.e. its rightful target), OFF-target 
activity relies almost unpredictable on secondary structures which mimic the target sequence 
and can, potentially, also result in DNA double-stranded breaks43. In the context of genetic 
engineering, those particular effects are non-specific and therefore unwanted, for a reliable 
system not only requires efficiency, but also accuracy. 
As an example, Hsu and colleagues20 have shown that a single gRNA not only cleaved its target 
but also other loci across the genome (which happened to be human), going as far as 
recognising “wrong” PAM sequences (NAG instead of the usual NGG) (Figure 1.12), 
rendering the whole cleavage prediction process highly difficult and, worse, threatening any 
attempt at editing human DNA for therapeutic purposes44. Indeed, cutting DNA at the wrong 






















Figure 1.12. OFF-target events are difficult to predict. The activity of the CRISPR-Cas9 complex 
associated to a gRNA targeting the human EMX1 gene was measured and compared to its potential activity 
at 32 different sites harbouring sequence similarities but nucleotide mismatches, either with the target or 
with the PAM region. The activity was assessed as the frequency of indel events, produced by Cas9 cleavage 
and subsequent non-homologous end joining. We can observe that, surprisingly, the two putative targets 
displaying the highest activity (#26 and #31) also contain different PAM sequences (NAG, instead of NGG). 
In contrast, other sequences with the right PAM and the same nucleotides in the seed region (#29, #32) do 
not display any activity, making the whole prediction of OFF-target events rather difficult. Adapted from 









To adress this challenge, several directions were explored45, aiming to increase the specificity 
of the CRISPR recognition mechanisms (e.g. so-called ‘high-fidelity Cas9’ 46) or by adjusting 
gRNA sequences 47,48. Another saw the discovery of a protein preventing the CRISPR complex 
from binding DNA, so-called ‘anti-CRISPR’ protein49. Despite an elegant perspective, this 
technique would add the necessity of accurately controling both the ‘activation’ and 
‘deactivation’ of the CRISPR complex and the complexity of time dynamics. 
Another notable idea was double nickases (or ‘paired nickases’), as opposed to a single 
nuclease. Using two Cas9 mutants (Cas9-D10A, with an inactivated RuvC endonuclease and 
only the HNH domain active), Cho and colleagues47 reasoned that they could decrease the 
probability of having non-specific cleavage (due to the necessity of having two proteins present 
at the site during the same period of time). And indeed, with a single crRNA-target mismatch, 
not only did they observe as much as a 500-fold decrease in indel frequency (compared to the 
one without mismatch), but they also managed to keep an efficient ON-target activity. 
 
Figure 1.13. Paired nickases can improve Cas9 specificity. (A) In the presence of a gRNA, Cas9 wild-
type (WT) uses its two endonuclease domains to produce a DNA double-stranded break. (B) Two Cas9 
nickases (Cas9 mutants possessing only one endonuclease domain left, also written Cas9-D10A) can cleave 
one strand of the DNA at two close positions to effectively trigger Homology Directed Repair mechanisms 
and subsequent directed editing, without comprising on CRISPR-Cas9 specificity. Adapted from Cho, S. W. 
et al. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. 
Genome Res. 24, 132–141 (2014)47. 
That said, in order to keep a high level of ON-target events, this system requires a high 
expression of Cas9 nickases, which also presents its own limitations (in terms of inducible 
expression system, variability in copy number and, again, increased chances to produce OFF-
target interactions). 




Facing the necessity of predicting the level of OFF-target events across the genome, teams have 
developed techniques relying on genomic detection of indels, such as ChIP-seq experiments50 
and other deep sequencing protocols51,52. Based on those methods, evidence suggests that 
significantly low levels of OFF-target cleavage were observed with mismatches superior to one 
(105-time less than ON-target events in human cell lines)47. Nevertheless, single-mismatches 
could still yield levels of OFF-targets 10-time lower than their ON-target counterpart (which 
is very high)47.  
Moreover, a major hurdle pertains to the limited sensitivity of such detection techniques, which 
cannot pretend to detect extremely rare events (<0.12%)51 of the kind produced by an OFF-
target CRISPR-Cas9, where a single event could be significant.  
Finally, for the detection of OFF-target events, those techniques all rely on actual DNA 
mutations, thereby entirely ignoring the fraction of CRISPR-DNA interactions which does not 
result in DNA cleavage. This ‘silent’ fraction is likely to be vastly larger than what was 
quantified so far, and could emcompass several other behaviours, such as Cas9 probing non-
specific sequences and staying immobile, temporarily blocked on the DNA.  
It is indeed reasonable to believe that with near-complete target-gRNA homology, Cas9 would 
have unwound the two strands of DNA53 and engaged in a conformational change which, if not 
brought to completion, may trap the protein between two energetically-unfavorable stages 
(DNA-cleavage and DNA-release)54. Such eventuality may stand as an obstacle to the 
replication and transcription machineries, thus creating subsequent gene deregulation or 
replication fork colapse, leading to more unwanted consequences.  
An alternative to studying CRISPR OFF-target interactions is to directly observe the protein’s 
movement within the cell, and from its motion infer its interactions with DNA. Indeed, such 
interactions would slow the protein down, as shown by Elf and colleagues55 with the example 
of the LacI repressor. Similarly, as CRISPR-Cas9 specific interactions (ON-target events) 
would last longer, due to Cas9 breaking DNA, this technique should differentiate between ON 
and OFF-target events. Accordingly, various levels of protein diffusions would relate to various 
protein behaviours, some of which may have yet to be determined. 
The only way to reach such a detection level is through single-molecule microscopy, where 
every protein can be illuminated, observed and eventually tracked in time and space. 
 




1.4 – Protein diffusion: current techniques and Cas9 past studies 
First introduced in vitro, the development of single-molecule microscopy techniques 
was based on a collection of Nobel Prize discoveries (Green Fluorescence Protein56,57, awarded 
in 2008; super-resolution microscopy58,59, awarded in 2014; optical tweezers60,61, awarded in 
2018). It opened the door to many previously-unanswered questions, such as the dynamics of 
molecular motors62, of molecular rotors63 and of DNA replication64.  
However, despite their high temporal and spatial resolution coupled to exquisite experimental 
controls, those works failed to reproduce the complexity and the unexpected of actual living 
systems. Indeed, living organisms produce myriads of molecules in diverse quantities which 
constantly interact with each other, changing their environment and affecting their fate in ways 
that are impossible to entirely detect, nor predict.  
That is why efforts were made to push back the boundaries of both biology and microscopy, 
resulting in three main complementary approaches. 
• The search for bright, photostable and fast-maturing fluorescent proteins, 
leading to the discovery of the Yellow Fluorescent Protein65 (YFP), the 
mCherry protein66 and the more recent HaloTag protein67. 
• The development of microscopy techniques accommodating the required low 
number of particles to observe (Photo-activated Localization Microscopy or 
PALM59) and the limited illumination volume necessary to decrease the 
fluorescent background (Total Internal Reflection Fluorescence or TIRF 
microscopy68). 
• The design of fluorescent spot detection algorithms, which could not only 
accurately localize a protein but also track its trajectory over time69. 
 
Put together, those studies gradually improved spatial resolution from single cells to single-
molecules, eventually permitting the observation and quantification of protein diffusion in vivo 
and in real time70 (Figure 1.14). 





Figure 1.14. The evolution of fluorescent microscopy resolution. (1994) GFP was first used to look at 
cell population and averaged signal and then (1996) at single cells. (1998 and 2006) The improvement of 
spatial resolution allowed the detection of subcellular compartments, followed by actual single molecules of 
YFP, present in low copy numbers. (2008) Eventually, the development of photo-activation techniques freed 
scientists from the necessity of using low copy numbers proteins (P). Adapted from Kapanidis, A. N., 
Lepore, A. & El Karoui, M. Rediscovering Bacteria through Single-Molecule Imaging in Living Cells. 
Biophysical Journal 115, 190–202 (2018).71 
Consequently, it became possible to study the dynamics of proteins such as the lac repressor 
and extract its association constant (with its chromosomal operator), which Elf and colleagues72 
measured as one order of magnitude lower than what was previously measured in vitro. These 
results highlighted the limitation of membrane permeability to the repressor’s substrate, IPTG 
(thus decreasing the speed at which LacI would bind DNA), and the limitations of in vitro 
measurements. Moreover, this team observed that LacI spent on average 90% of its time non-
specifically interacting with DNA, and went as far as to estimate its time spent on the DNA to 
be inferior to 5 ms, thus revealing unprecedented insights into protein-DNA interactions.  
An additional interesting feature which pertains to the diffusion of a molecule and which can 
also be extracted from such techniques is the Mean Square Displacement73,74,75, a measure of 
the deviation of the position of a particle with respect to a reference position over time76; it was 
initially developed to study gas particles going through random collisions, propelled by 
stochastic fluctuations in temperatures77. In a relevant example applied to protein diffusion, 
Billaudeau and colleagues78 demonstrated that the actin-homologue MreB, involved in the 
elongation of the bacterial peptidoglycan (PG) was diversely regulated in E. coli and in Bacillus 
subtilis, which they accounted on their different cell walls. Furthermore, they observed in E.coli 




that following nutrient upshift, the fraction of MreB proteins rotating around the cell and 
following the membrane (and thus synthetizing PG) increased, suggesting that cells would 
adapt to growth rate upshift by increasing cell wall production, resulting in cell elongation 




Figure 1.15. Extraction of Mean Square Displacement (MSD) to quantify MreB diffusion behaviours. 
(A) Theoretical representation of the three main modes of protein diffusion and their respective MSD curves; 
directed motion in blue, random diffusion in orange and constrained diffusion in green. (B) Theoretical 
trajectories associated to their respective MSD, drawn in a rod-shaped bacteria. (C) Experimentally extracted 
MSD of the MreB protein (fused to the monomeric-superfolder-green GFP, msfGFP) observed in E. coli, 
either in LB-rich media (left) or  S-poor media (right). Heterogeneous diffusion behaviour can be observed, 
with the directed-motion fraction increasing when enriching the media, to the expense of the constrained 
fraction. Adapted from Billaudeau, C. et al. Contrasting mechanisms of growth in two model rod-shaped 
bacteria. Nat. Commun. 8, (2017).78 




In 2017, the Elf lab applied their single-molecule microscopy expertise to study the 
catalytically-dead dCas9 mutant79. They used an elegant method based on plasmids carrying 
repeated lacO targets to draw dCas9, associated with matching gRNAs. As illustrated in Figure 
1.16, upon addition of IPTG (and subsequent release of LacI from lacO, thus allowing the 
CRISPR complex to recognise the targets), they measured the time needed for the 
fluorescently-labelled protein to find its DNA target (thus yielding a fluorescent focus), 
eventually resulting in an averaged protein searching time of 6h. Interestingly, such a long 
search time indicated that the protein was most likely slowed down by other interactions, and 
the authors suggested that it was probably busy interacting with the numerous PAM sequences 




Figure 1.16. dCas9 recruitment after target site made accessible. (A) Schematics and associated 
microscopy images of dCas9-YPet, associated to a gRNA targeting lacO repeats present on a plasmid. Upon 
addition of IPTG, LacI proteins are released from the lacO targets, allowing dCas9 recruitment. (B) With on 
average 5 proteins and 40 target sites per cell, the fraction of cells with at least one detected fluorescent spot 
increases as a function of time, allowing the extraction of the CRISPR-lacO binding time of 0.65 min-1 
which, after renormalization, results in a search time of 6h. Extracted from Jones, D. L. et al. Kinetics of 










Despite its excellence, this study neither observed the original Cas9 protein, neither did it study 
the context of genomic DNA. Rather, it used a catalytically-dead mutant which does not behave 
as its original counterpart (dCas9 was reported to stay bound to its target for several dozens of 
minutes79, as opposed to the wild-type version which was observed for less than a minute80). 
This would indeed affect the interaction time of the protein with DNA, for instead of cleaving 
the target and leaving the site of the break, the protein stayed bound80. Thus limiting the 
interactions of other dCas9 proteins with the target, it also potentially affected interactions with 
other DNA-interacting proteins (e.g proteins involved in repair, transcription or replication).  
Additionally, targeting a plasmid is different from targeting the genome; the search may be 
facilitated, diffusion is surely higher and there may be less proteins in the vicinity. In 
conclusion, although this excellent work did improve our understanding of the CRISPR 
interactions with DNA, a number of uncertainties remains, particularly regarding OFF-target 
events which were neither detected, nor mentioned. 
In 2015, a team led by Jennifer Doudna81 was the first to investigate Cas9 diffusion in 
mammalian cells, also using the catalytically-dead dCas9 mutant, fused to the HaloTag protein. 
Targeting short interspersed nuclear elements (SINEs) of the B2 type present in the cells at 
about 350,000 copies, their results showed that the protein search was dominated by 3D 
diffusion and that OFF-target events where short-lived, with an average residence time inferior 
to 1s. Remarkably, quantifying the protein apparent diffusion coefficient (D, obtained from 
fitting MSD curves), they observed diffusion shifts towards slower values as a function of 
gRNA association. Indeed, increasing the gRNA homologies for the SINE target, they saw the 
fraction of dCas9 freely diffusing decrease (Figure 1.17). 





Figure 1.17. The diffusion of dCas9 decreases when associated to a gRNA. Apparent diffusion coefficient 
distributions of dCas9 either alone (no gRNA, orange), with a gRNA containing mismatches proximal to the 
PAM region (B2_0M, green), with a gRNA containing mismatches distal from PAM region (B2_13M, 
purple) and with a gRNA with the correct target sequence (SINE B2, blue). By increasing Cas9 chances to 
find a target, its diffusion decreases, indicating more interactions with DNA. Log scale. Extracted from 
Knight, S. C. et al. Dynamics of CRISPR-Cas9 genome interrogation in living cells. Science 350, 823–6 
(2015) 81. 
 
These interesting results seemed to stand in contradiction with the previous study (Elf and 
colleagues), where dCas9 was observed to predominantly interact with DNA, thus resulting in 
long searching times. In contrast, Doudna and colleagues suggested that dCas9 spent most of 
its searching time diffusing, with very few OFF-target events. It is notable that the present 
study occurred in mammalian cells, where the accessibility to DNA is different from what is 
found in bacteria; indeed, mammalian DNA is packed in chromatin structures, which can be 
difficult to access (heterochromatin). Additionally, mammalian cells are far bigger, and their 
number of targets as well, which makes uneasy the task of comparing one context with the 
other. Nevertheless, it shows how uncertain this topic remains. 




Another recent study harnessed the resolution of High-Speed Atomic Force Microscopy 
(ATM) to observe the CRISPR complex structure, in real time. Despite the limitations of in 
vitro experiments and the influence of the ATM probe interacting with the protein, Shibata and 
colleagues80 managed to uncover striking conformational differences between the Cas9 protein 
and its catalytically-dead mutant (dCas9). Additionally, they highlighted the importance of the 
HNH domain, its fluctuations and subsequent stabilization by the R-loop formed by the crRNA 
and its targeted sequence (‘dock-state’), allowing the nuclease to cleave DNA. Yet, they could 
not explain how the cleaved DNA fragments were released from the protein, itself bound to a 
mica surface. Regardless, they produced some of the best images ever taken of the Cas9 protein, 
which is seen in the presence of its gRNA, DNA and Mg2+ (which Cas9 needs for DNA 





Figure 1.18. QR-code redirecting to a movie showing Cas9 and its gRNA cutting DNA. Using High-
speed AFM, Cas9 is shown in the presence of its gRNA, DNA and Mg2+ successfully cleaving DNA, which 
fragment is then released. This beautiful movie is reproduced from Shibata, M. et al. Real-space and real-











1.5 – Goal of the thesis 
We have previously described the outstanding potential of the CRISPR-Cas9 technology, 
whether in regards to molecular genetics, gene editing or even as an alternative to antibiotics. 
However, despite the huge amount of already available studies, its main drawback has yet to 
be fully understood, nor solved. Indeed, OFF-target events remain largely unpredictable and 
under-studied, stemming from the technical challenges such investigations entail. 
So far, OFF-target effects have only been detected when resulting in DNA mutations (indels). 
However, this is ignoring the potentially vast majority of events where CRISPR-Cas9 does 
interact with DNA, yet does not cut it, which we could refer as ‘silent’ non-specific CRISPR-
DNA interactions. Those events may be significant, as an immobile DNA-bound Cas9 could 
represent a major hindrance to other DNA-related mechanisms (replication, transcription, 
regulation and repair). One way to study these ‘silent events’ is to use single-molecule 
microscopy, observing protein diffusion and detecting the different behaviours the protein can 
adopt; among them, the respective fractions of ON and OFF-targets events. 
As shown earlier, previous work found in the literature already used this approach, yet only 
focusing on the catalytically-dead mutant dCas9, for its easier manipulation, and easier 
observation79,81. However, the protein thus phenotypically different may diffuse significantly 
differently. Furthermore, its interactions with DNA have shown to be affected, due to the lack 
of activity of its nuclease domains, crucially impacting the protein conformation80. 
It is in this context that we aim to study the diffusion of the Cas9 wild-type protein, in order to 
quantify the set of behaviours it can adopt, so as to reveal the fractions of ON and OFF-target 
events, including the ´silent’ OFF-target ones that have not yet been detected. To do so, we 
want to use single-molecule tracking techniques, in vivo and in real time.  
For this purpose, we chose our favourite organism, Escherichia coli, as its smaller genome and 
unique chromosome – deprived of chromatin – make it particularly suited to build, study and 
quantify the CRISPR interactions driven by the various DNA constructs we built for this 
project. Additionally, being so exhaustively characterized, E. coli offers us unparalleled genetic 
and experimental control. 
 




In the following chapters, you will see described our attempts at harnessing the imaging 
capabilities of the HaloTag protein and of the HiLo microscopy technique, combined with our 
custom-made tracking algorithm. I will show how the displacement of the Cas9 protein was 
successfully tracked, in various conditions, and how it allowed us to infer its different diffusion 
behaviours, characterized by its range of interactions with the miraculous molecule of DNA.  











Chapter II – Materials and Methods  





2.1 – Constructs 
 
In this study, I used Escherichia coli strains DH5α, MG1655 and BW27783. These strains 
either came from the lab collection, either from other groups. They are all referenced in Table 




Our main protein of interest was Streptococcus pyogenes Cas9 expressed under the 
control of the araBAD promoter (also written pBAD)82. The pBAD-Cas9 construct was 
integrated into E.coli genome through clonetegration83, using the plasmid pOSIP-CT. More 
information on this construct is present further down and illustrated on Figure 2.3. 
Several single guide RNAs (sgRNAs) were used in association with Cas9. In every case, the 
20-nt target sequence (crRNA) was flanked by a Cas9-handle chimera (tracrRNA) under the 
control of the constitutive promoter J23119 (Figure 2.1). Those sgRNAs were on a kanamycin-
resistant, low-copy plasmid (sc101 origin of replication). Their target sequences are indicated 
on Table 6, in the Appendix. 





Figure 2.1. sgRNA expression and target. (A) Schematic of the plasmids carrying the sgRNAs, with the 
origin of replication and the kanamycin resistance gene. Zoomed-in, we see that the sgRNAs (combining the 
crRNA and the tracrRNA) are flanked by the J23119 promoter and a terminator region. (B) On this map of 
the E.coli genome are represented the various positions of the sgRNA targets and the integrated constructs 
with the origin of replication, the terminus and the lacZ location as references. 
 
The ptrA-sgRNA targets ptrA’s promoter (conserved gene within the recB operon whose 
function is unknown). The lacO-sgRNA targets E.coli's lacO wild-type sequence. Finally, the 
lacOA-sgRNA only targets the lacO repeats present on the lacO array. All three sequences are 
shown on Figure 2.2. Note that the lacOA-sgRNA is not expected to successfully cut the 
endogenous lacO sequence because of the misalignment between the crRNA and the lacO 
sequence; this was deliberately made this way to ensure the specificity of the lacOA-sgRNA 
for the array. Both sgRNAs have previously been used in the literature79, which encouraged us 
to use them as well. 
 









Figure 2.2. sgRNA target sequences. Our three sgRNAs target the ptrA, lacO and lacO-array sequences, 
the latter being artificially introduced on the chromosome. We see that (A) the ptrA-sgRNA displays a perfect 
match with its target sequence and the cut is happening. (B) Similarly, the sgRNA targeting the lacO array 
perfectly matches its targets and cuts. (C) However, the sgRNA targeting the endogenous lacO sequence, 
although displaying a perfect match, does not appear to successfully cut. See chapter 4 for more details. (D) 
Finally, the sgRNA targeting the lacO array was designed to mismatch the endogenous lacO sequence (18 
nucleotides match the sequence, but do not properly align with the PAM sequence), and therefore does not 
successfully cut. The black triangles show where the cuts are happening; in green are highlighted the sgRNA 
homologies with the target sequences; in red the PAM sequences are displayed and the black triangles show 












Directly upstream of the pBAD promoter is expressed the AraC protein; in the presence 
of arabinose, it enhances the recruitment of the RNA polymerase to the pBAD promoter. 
However, in its absence, it spontaneously prevents its recruitment due to the formation of a 
DNA loop84 (Figure 2.3).  Additionally, in the absence of glucose, the CAP protein (cAMP 
receptor Protein) binds to its CAP site, also helping with the recruitment of the RNA 
polymerase85. In E. coli, arabinose is transported inside the cell through two types of 
transporters, low affinity (AraF, G and H) and high affinity (AraE) which synthesis is inducible 
by arabinose. In the BW27783 strain, araF, G and H are deleted and araE is put under the 
control of a constitutive promoter to ensure that the pBAD promoter leads to a homogeneous 
induction.  
 
Figure 2.3. araBAD promoter regulation mechanism. In the absence of arabinose (top), the AraC protein 
forms a dimer that binds together the two operator regions O2 and I1, consequently forming a DNA loop 
which prevents the recruitment of RNA polymerase (RNAP), therefore repressing the expression of the 
protein (here, Cas9). In the presence of arabinose (bottom), the dimer changes its conformation, this time 
binding to the I1 and I2 operator regions, therefore removing the DNA loop and allowing the recruitment of 
the RNAP. Additionally, the absence of glucose permits the CAP protein to further increase the recruitment 
of the RNAP. Extracted from Schleif, R. AraC protein, regulation of the L-arabinose operon in Escherichia 
coli, and the light switch mechanism of AraC action. FEMS Microbiol. Rev. 34, 779–796 (2010) 82. 
Other promoters (pTet, leaky and tightly regulated) have also been tested but left aside in favour 
of the pBAD promoter, due to its more homogenous expression; they are not described here. 




SOS reporter gene 
 
Also integrated into our cells genome is the pSfiA-mGFP construct, acting as a 
fluorescent reporter of the SOS response. SfiA (also called SulA) inhibits cell elongation by 
preventing the formation of the division ring. Its expression is induced by SOS activation86. 
Here, we integrated this construct through clonetegration, using the pOSIP-KH plasmid83. 
 
HaloTag protein, fusion and labelling 
 
The HaloTag protein is a haloalkane dehalogenase87 which active site has been 
modified in order to irreversibly bind a chloroalkane linker, itself fused to a molecule called 
TMR ligand (for tetramethylrhodamine)88 or a variant called JF54989 (Figure 2.4). These 
ligands (also called HaloTag ligands) are highly photostable fluorophores particularly suited 
for single-molecule fluorescence microscopy. Excited at 555 nm, they emit at 585 nm. With a 
HaloTag protein fused to our protein of interest (here, Cas9), we make sure that we obtain one-
to-one labelling.  
Using Gibson Assembly, we fused the HaloTag protein and a 24-nt linker to Cas9, in 
C-ter. The fusion has been done on the pOSIP plasmid, prior to integration. More information 
on this construction can be found on Table 2 of the Appendix. 
 
 





Figure 2.4. HaloTag protein and its ligand. Fused to the protein of interest (here, in C-ter of the Cas9 
protein), the HaloTag protein possesses an active site where its HaloTag ligand (TMR or JF549) can 
covalently bind. The mutated phenylalanine residue (Phe272) which makes the interaction irreversible can 
be observed in blue. Taken from HaloTag® Technology, Promega™ website. 
 
During the expression of the HaloTag-fused protein of interest (usually for one hour), the 
HaloTag ligand is simultaneously added in excess (5μM final concentration for TMR and 1μM 
for JF549) for an hour, during which the HaloTag proteins get labelled by HaloTag ligand 
molecules. After this hour, the unbound ligands are washed out through 4 repeated washes, 
where cells are spun down, a pump is used to suck up the supernatant, and the cells are 
resuspended in a new tube with the media used for the experiment. Eventually, the cells are 




Several sets of lacO repeats were built in association with the Edinburgh Genome 
Foundry, of which two were successfully integrated into E.coli’s genome. They contain 6 and 
22 lacO repeats respectively. Each repeat is flanked by a PAM sequence, allowing for Cas9 
recognition (see Figure 2.5). The arrays were integrated into E.coli chromosome through 
clonetegration, using pOSIP-KO. Those arrays were inspired by work previously done in the 
Elf lab79. The repeats and associated sequences can be found on Table 6 in the Appendix. 





Figure 2.5. LacO arrays architecture. The lacO arrays we built and further integrated into E.coli 
chromosome are made of different number of repeats (22X or 6X) which all follow the same pattern; the 
sgRNA targets 20 nucleotides (in brown) that overlap part of the lacO sequence (13 nucleotides) and part of 
the array (7 nucleotides), flanked by the PAM sequence (TGG, in yellow). Each unit is separated from the 




Using PMGR (described below), the recA gene was knocked out. The ΔrecA phenotype 
was consequently confirmed by UV testing (see below  2.4 – Viability Tests). 
 
 




2.2 – Cloning techniques 
Gibson Assembly 
This technique was consistently used throughout this study to fuse DNA fragments and build 
plasmid constructs. Following the protocol published by Gibson and colleagues90, 40-60 
nucleotides of homology are needed between the fragments to ligate, either achieved using 
PCR and overhang primers (which carry the homology), and/or using restriction enzymes (if 
the homology is already present on the fragments). Briefly, a 5' exonuclease (T5) produces 
single-stranded DNA allowing homology sequences to anneal, while a polymerase also present 
in the buffer (Phusion®) fills the gaps, finally allowing a ligase (Taq) to bind the fragments 
together. After one hour at 50°C, the resulting product is transformed into competent cells, 
selected with the appropriate antibiotics (Figure 2.6). For more specific details about plasmid 
construction, please refer to the Table 2 of the Appendix. 
 
Figure 2.6. Gibson Assembly. The Gibson Assembly technique allows the fusion of several DNA fragments 
in a single step. In a tube placed at 50°C for an hour are added the fragments to fuse in addition to a 5’-
exonuclease, a polymerase and a ligase. The fragments need to possess ends homologous to each other in 
order to anneal when put in contact. First, the 5’-exonuclease produces single-stranded DNA ends that can 
be annealed with neighbouring complementary fragments. Second, the polymerase fills the gaps, allowing 
the ligase to bind the fragments together. Finally, the DNA product is transformed in the presence of the 
relevant antibiotic to select cells harbouring the resulting plasmid. Taken from NEB™ website. 







Developed by St-Pierre and colleagues83, this technique allows efficient integration of 
foreign DNA into E.coli’s chromosome at various predetermined genomic positions (Figure 
2.7B). Briefly, the integration relies on a pOSIP plasmid carrying the sequence to be integrated 
(flanked by FRT sites) and constitutively expressing a temperature-sensitive phage integrase 
only active above 30°C. Once the whole plasmid integrated at the genomic position of choice, 
a second plasmid carrying a flippase (pE-FLP) is transformed to remove the pOSIP backbone, 
effectively leaving only the sequence of interest in the genome (Figure 2.7A). The resulting 
pOSIP plasmids and strains are respectively displayed in Table 1 and Table 3 of the Appendix. 
 
Figure 2.7. Clonetegration. This technique allows the integration of external DNA in E.coli’s genome. (A) 
The pOSIP plasmid containing the sequence to integrate (in blue) is transformed into the recipient strain, 
previously made competent. Through its phage integrase, the whole plasmid is integrated at the attB locus 
of choice, with its FRT sites (green arrows) flanking the sequence of interest. Later on, the plasmid backbone 
(in orange) is removed using a helper plasmid pE-FLP containing a flippase. (B) This map of E.coli 
chromosome shows the different sites where clonetegration can be used. Each site requires a different 
plasmid. Adapted from St-Pierre, F. et al. One-step cloning and chromosomal integration of DNA. ACS 









To integrate the pBAD-Cas9 construct, the P21 site was chosen for historical reasons. 
Similarly, the SOS marker pSfiA-GFP was integrated at the HK022 site. Finally, the lacO 
arrays were all integrated at the 186 #1 site, due to its proximity to the terminus region as well 
as its high integration efficiency. Indeed, the proximity with the terminus ensured a low 
variability in terms of copy numbers. The choice of the highest integration efficiency was due 
to the challenging nature of the construct, with DNA repeats presenting risks of DNA 
recombination (Figure 2.8). 
 
Figure 2.8. Clonetegration efficiency. The efficiency of integration varies with the site used by the phage 
integrase. We see that 186 gives the best efficiency, while Phi80 gives the worst. Extracted from St-Pierre, 















Plasmid Mediated Gene Replacement 
 
Plasmid Mediated Gene Replacement (PMGR) also allows DNA integration into E.coli 
genome, but relies instead on homologous 
recombination and a helper plasmid91 (pTOF). 
The pTOF plasmid carries the sequence to be 
integrated, flanked by 100-nt homology arms 
making recombination possible. Through several 
selection stages, the first step sees the integration 
of the whole plasmid, while a second step selects 
cells that have gone through the recombination an 
additional time, consequently getting rid of the 
plasmid backbone (Figure 2.9). As opposed to 
clonetegration, PMGR is not restricted to a 
particular locus; however, its efficiency varies 
significantly from one locus to another. This 
method was used to build the strains containing 
the recB-Halo construct, as well as those lacking 
the recA gene. 
Figure 2.9. PMGR. (A) Plasmid Mediated Gene Replacement integrates external DNA into E.coli’s 
genome, using a pTOF helper plasmid where the DNA of interest (red triangle) is flanked by sequences 
homologous to the locus of integration (orange and blue). (B) A first round of homologous recombination 
integrates the whole plasmid at the locus of interest; the cells are selected at 42°C, where the plasmid cannot 
replicate (ensuring that only cells with the plasmid successfully integrated can grow on chloramphenicol 
plates, the associated resistance gene being present on the plasmid). In a second round of selection, the 
plasmid recombines with itself, thus removing its backbone from the genome and leaving only the sequence 
of interest; here, the cells are selected with sucrose, because of the presence of the toxic sacB gene on the 












Cell competency and Transformation 
 
Transformations were carried out following the Chung protocol92, relying on heat and 
osmotic shock to transfer DNA. Accordingly, cells were first made competent (grown until 
OD600 0.4, left on ice for an hour and spun down at 6.2k g to be resuspended in Transformation 
Buffer), then put in the presence of plasmid DNA for half-an-hour, still on ice, before being 
heat shocked. They were then allowed to recover for an hour at 37°C (or 30°C), and finally 




2.3 – Cell cultures 
 
E. coli cells were grown in Luria-Bertani (LB) broth supplemented, when appropriate, 
with the following antibiotics: kanamycin (50 μg/ml), chloramphenicol (30 μg/ml) and 
ampicillin (100 μg/ml). For microscopy experiment, Generic Media was used instead, 
containing M9 minimal media supplemented with 0.2% glucose, 2mM MgSO4, 0.1mM CaCl2, 
1X MEM Essential and 1X MEM non-essential Amino Acids (Gibco®). Please refer to Table 
7 and 8 of the Appendix for more details. 
For microscopy experiments, cells were grown overnight from a frozen stock, in Generic media 
(with appropriate antibiotics). The overnight cell culture was then diluted a thousand times and 
grown until OD600 0.1 (measured with a Perkin-Elmer™ Lambda 25 spectrophotometer). Cells 
were then pelleted (6.2k g), resuspended in clean media to reach OD600 0.2 and labelled with 
HaloTag ligand in excess for one hour; the ligand was either TMR (5μM final concentration) 
or JF54989 (1μM final concentration). If needed, protein expression was simultaneously 
induced, using arabinose (0.2% w/v). The excess of TMR was then washed 4 times with the 
same media by spinning them down (3 minutes, 6.2k g) and the cells finally mounted on agar-
pads (made of 2% agarose M9 minimal media, with or without 1mM IPTG). 
 
 




For counting experiments, the protocol is essentially the same, but in order to fix the proteins 
and count them, I added a step of chemical fixation right after the washes, consisting of the 
addition of formaldehyde (2.5% formaldehyde, Thermo Scientific, in 1X PBS) for an hour, at 
room temperature. The cells were washed twice with 1X PBS and finally mounted on agar-
pads. 
In parallel, microscope coverslips have been treated to remove any dirt or contaminant 
susceptible to affect our imaging conditions. To do so, coverslips have been put in a 400°C kiln 
for 12 hours, then kept in KOH (1M) overnight and finally washed in distilled water where 
they were kept until experiment, where they were used after being dried with nitrogen gas. 
2.4 – Viability Tests 
Spot tests were performed to assess cell survivability in the presence of a stressing 
agent. Cells grown overnight from a frozen stock, in LB media, were diluted 250 times in the 
morning in order to reach exponential growth. When reaching OD600 0.1, cells were washed in 
fresh media and left shaking for an hour at 37⁰C, under the presence of the stressing agent of 
choice. In the example of Cas9 activity, 0.2% w/v arabinose, or 0.2% w/v glucose were added. 
Consequently, cells were 10X-serial-diluted on a 96-microwell plate and plated on an agar petri 
dish supplemented with the relevant antibiotics. The plating was performed with a replica plater 
(Sigma®).  
UV tests were performed in a similar fashion, with the difference that instead of the 1h-
stress exposure, cells were directly serial diluted and plated. Afterwards, the plates were 
exposed to increasing amounts of UV radiation (with a different level of intensity per plate) 
using a UV Crosslinker94 (Scientz®). For instance, 0, 1000, 2000 and 3000 µJ/cm2. Finally, 
irradiated plates were wrapped in aluminium foil (to prevent a rare photo-induced alternative 
repair pathway to intrude) and left at 37⁰C over-night. 
DAPI staining assays have been used to assess the presence or absence of chromosomal 
DNA within cells, particularly in the context of ΔrecA genotype. Indeed, upon infliction of 
DNA damage (with cells exposed to 4ng/μl of ciprofloxacin for 2h), cells deprived of RecA 
proteins can neither repair the damage, nor prevent RecBCD from digesting the entire 
chromosome. After two hours and the addition of DAPI (1µl in 1mL of washed cells, left for 
15min and loaded on agar), it is possible to identify cells without chromosome, visualized by 
their absence of DAPI signal. 




2.5 – Microscopy 
Epifluorescence microscopy (conventional fluorescence microscopy) 
observations were conducted on a Nikon® Ti-E inverted microscope with a 100X Oil-
immersion objective lens (N.A = 1.45), a Lumencor® epi-fluorescent light source, a Perfect 
Focus system and an EMCCD camera (Andor®). Cube filters (Chroma®) were used in front 
of the camera to select the wavelengths according to the observed signal (GFP, HaloTag-TMR). 
Images were acquired using the software Metamorph®95. GFP proteins were imaged with an 
exposure time of 80 ms and a camera gain of 4. As for the HaloTag-TMR signal, we used 200 
ms exposure time and a camera gain of 10. 
Highly inclined and Laminated optical sheet (HiLo) microscopy is a 
derivative of TIRF microscopy that covers a bigger volume, allowing us to observe the whole 
bacterial cytoplasm (Figure 2.10A)96. Indeed, TIRF microscopy relies on the production of a 
so-called evanescent wave that is the result of the complete reflection of the incident laser light 
and subsequently excites the sample with a penetration of 100 nm. In contrast, HiLo 
microscopy (also called ‘dirty TIRF’) relies on laser refraction to excite a wider sample volume 
(up to 1000 nm penetration), in order to be able to capture the whole cell cytoplasm (Figure 
2.10B). This technique was performed on the same optical set up as the one used for 
epifluorescence, at a penetration depth of 1000 nm and in a temperature-controlled chamber, 
at 37⁰C. The TMR was excited using a 561 nm Coherent® laser, controlled through iLas2® 
system. We used a 0.2 mW/cm2 laser power and an exposure time of 12 ms. The recorded 
movies were taken with a Region-of-Interest (ROI) of 256x256 pixels, this in order to match 
our exposure time with the camera readout time (19 ms with 512x512, 10 ms with 256x256). 




Figure 2.10. HiLo microscopy. (A) On this schematic representation, the objective (in grey, below the 
sample) collects the fluorescent light emitted by the molecules in the sample (red) excited by the refracted 
laser (blue). (B) On this more detailed schematic, we can observe three different microscopy techniques; 
epifluorescence (Epi) relies on a source of light directly exciting the sample and passing right through it, 
perpendicular to the coverslip; TIRF microscopy (TIR) relies on complete reflection of the incident laser 
beam and produces an evanescent wave on a very short distance from the coverslip; finally, HILO uses a 
refracted laser beam that will excite only part of the sample, decreasing the fluorescent background (as 
opposed to epifluorescence) while still collecting light from a whole bacterium (unlike TIRF which would 
only excite part of it). Figure A was taken from ONI™ website and Figure B from Liu, C., Liu, Y. L., 
Perillo, E. P., Dunn, A. K. & Yeh, H. C. Single-Molecule Tracking and Its Application in Biomolecular 
Binding Detection. IEEE J. Sel. Top. Quantum Electron. 22, (2016)96. 
 
As an illustration, the following QR code redirects towards one of our movies displaying Ca9-
HaloTag proteins, labelled with TMR and observed through HiLo microscopy (Figure 2.11). 
 
Figure 2.11. QR code redirecting towards Cas9-HaloTag movie, done with HiLo microscopy.  
Cell border in green. 
 




2.6 – Image analysis 
 
Cell segmentation and SOS response quantification 
 
Every field of view was observed both within the fluorescent channel and within the 
Brightfield one, and to both, pictures were taken with Z-stacks (5 stacks separated by 0.4µm 
reaching a total of 2µm), so as to use the Brightfield images to identify cells edges, a process 
known as cell segmentation. This particular process was carried out with a custom-made 
algorithm (Matlab) designed by Sebastian Jaramillo-Riveri97, itself inspired from a Matlab 
segmentation routine98. Briefly, for each field of view, the algorithm is fed with the brightfield 
picture displaying the highest contrast (among the Z stacks), then each pixel is scored according 
to its neighbouring pixel intensity, in order to identify those at the cell edges where indeed, the 
intensity gradient is highest (because the cell content and the cell membrane are respectively 
darker and brighter than the image intensity average). A threshold is further applied to select 
only identified pixels linked to each other, resulting in a binary image (or mask) with each cell 
individualized with its position, length and fluorescent intensity (Figure 2.12).  
Downstream, a curation process manually confirms the quality of the segmentation, while 
discarding artefacts. For instance, cells in contact with the picture edges are systematically 
discarded, in order to avoid wrong length measurements. Once the cells properly identified, the 
program computes the average fluorescent intensity of every cell, normalized by pixel (in order 
to control for cell shape or length). We can therefore have an accurate measurement of a cell 
population’s SOS induction, with hundreds to thousands of cells per dataset. 




We must also note that the choice of segmenting using Brightfield images (and not fluorescent 
images, which display higher contrast and would therefore be easier to segment) stems from 
the fact that not all cells display fluorescence, for some do not induce the SOS response (as can 
be seen on the Figure 2.12). Therefore, segmenting using Brightfield ensures that we measure 
every cell, and not only those with high SOS induction. 
 
 
Figure 2.12. Cell segmentation. (Top) Brightfield and GFP images of cells expressing pBAD-Cas9-Halo, 
a sgRNA targeting the ptrA gene and the pSfiA-GFP SOS reporter gene. Three cells can be seen, albeit with 
varying GFP intensities; one is particularly not visible in the GFP channel (red triangle), presumably because 
it did not induce the SOS response. (Bottom) This image is fed into our segmentation algorithm which first 
identifies the pixels associated to the highest intensity gradients, yielding a score which is then applied to a 
series of filters (eg. maximum and minimum length) which yield a mask, where the cells are effectively 










Fluorescent spot detection and quantification 
 
After chemical fixation, the proteins labelled with TMR were counted in the following 
way. First, the cells were segmented with their Brightfield signal, as previously described, and 
then a spot detection algorithm (adapted from Alessia Lepore and colleagues99, itself inspired 
from previous protein counting work100) was used to identify the fluorescent spots. Briefly, for 
every field of view, a maximum projection of all Z-stacks images (6) was obtained before going 
through a band-pass filter101 supressing the pixel noise, allowing local intensity maxima to be 
fitted to a 2D Gaussian function so as to accurately identify the position of every fluorescent 
spot centre (see Figure 2.13). 
 
Figure 2.13. Fluorescent spot detection. HaloTag-containing cells can be observed in successive HaloTag 
and Brightfield channels, with the cell segmentation overlap and spot detection. A zoomed-in picture 












Our HiLo fluorescent movies were recorded at a rate of 83Hz (a frame every 12 ms), 
for a total of 600 frames. In order to detect fluorescent proteins moving from one frame to the 
next, I used a Matlab script written by Alessia Lepore, itself adapted from Crocker and 
colleagues102. Briefly, for every frame, a band-pass filter first supresses the pixel noise, 
allowing local intensity maxima to be fitted to a 2D Gaussian function so as to accurately 
identify the position of every fluorescent spot centre. Second, the algorithm links those 
identified spots between frames, in order to build a trajectory of each particle (Figure 2.14). To 
be identified as such, those trajectories need to be at least four consecutive frames long, with 
the maximum distance covered from one frame to the next constrained by the theoretical 
maximum displacement of the particle (which we empirically defined after analysis of the 
Cumulative Distributive Function of the particle displacement distribution). When two 
particles get close to each other, the program follows the particle yielding the lowest 
displacement. For every movie, we manually optimize the filters in order to maximize the 




Figure 2.14. Tracking illustration. Each movie is analysed through our custom-made Matlab algorithm 
where each frame goes through an intensity filter in order to identify the fluorescent spots corresponding to 
our protein of interest, which can then be followed from one frame to the next, until finally a whole trajectory 











When all the particles have been tracked, we can plot those tracks on the original fluorescent 
image of the cell and confirm that the tracks have been correctly identified, by checking that 
they stay within the edges of the cell. Unlike the GFP-SOS analysis, we do not use brightfield 
segmentation, but rather manually crop the cell using ImageJ and then use the maximum 
projection (in Z) of its fluorescent intensity to segment it, based on the idea that the particles 
should move homogeneously within the cell and, coupled to the initial autofluorescence, should 
make the whole cell area fluorescent when projected over several frames. This successfully 





Figure 2.15. Tracking analysis. (Top) Each cell is manually cropped on the ImageJ software, as can be 
seen on the Brightfield picture, while its maximum fluorescent intensity is projected in Z to allow our Matlab 
software to identify the cell(s) present on the image (segmentation). (Bottom) Subsequently, every frame is 
analysed in order to identify and track the fluorescent spots, built trajectories which can eventually be plotted 
back on the original fluorescent picture. Our tracking resolution is good enough to differentiate the tracks 
coming from one cell from its neighbouring sister cell (see zoomed-in subset, in red). 
 
 




As an example of the tracking process in action, please refer to the QR code below, which 
redirects to a movie showing Cas9-HaloTag proteins, labelled with TMR and tracked by our 




Figure 2.16. QR code redirecting towards Cas9-HaloTag tracking movie. Labelled with TMR, Cas9-
HaloTag proteins cam be seen freely diffusing in the cell (in the absence of gRNA). Overlaid on the original 
movie, we can observe the tracks detected by our tracking algorithm, following Cas9 over time. 
For additional details, a more exhaustive description of the successive steps of the algorithm 
with associated function names can be found on Table 9, in the Appendix of this document. 
 
Mean Square Displacement (MSD) and apparent Diffusion Coefficient (Dapp) 
 
Using diffusion theories developed to study gas particles randomly moving103, and 
considering that freely diffusing proteins adopt a similar random motion (also called Brownian 
motion), trajectories can be quantitatively analysed. To do so, we applied the same 
mathematical principles and therefore attributed a Mean Square Displacement (MSD) to every 
identified particle, which can intuitively refer as a measure of the averaged area explored by a 
particle during a number of time-intervals. A time-interval represents the time separating one 
frame to the next; here, one such time interval is equal to our exposure time (12 ms). Two time-
intervals therefore represent 24 ms, or the time separating the frame 1 from the frame 3, and so 
on (Figure 2.17).  
 




The MSD is eventually calculated in the following way: 
 
with n being the number of time-intervals, N being the total number of frames for which the 
particle has been tracked, and ri the position of the molecule at the frame i.  
 
Figure 2.17. Example of MSD calculation. This plot represents a particle (in red) moving in 2D 
(coordinates X and Y) with its position recorded at every one of the 13 frames within which it has been 
identified. Its trajectory is highlighted in blue. We can observe that in order to calculate the MSD of this 
particle for two time-intervals (2Δt), one has to compute the average of all the squared distances highlighted 
in dotted red lines, following the written equation. 
 
When the MSD has been computed for every time-interval Δt, it is possible to plot it against 
the values of those time-intervals and observe the evolution of the particle diffusion over 
increasing periods of ‘time’. When a particle randomly diffuses, its MSD should linearly 
increase as a function of time-intervals, illustrating that the more time you give a particle to 
diffuse, the more space it explores (Figure 2.18). 





Figure 2.18. MSD plot and extraction of Dapp. This plot represents the MSD of a particle against 6 time-
intervals (up to 72 ms). The experimental data (in red) can be linearly fitted (in blue), illustrating the expected 
free diffusion of the protein. The equations recall the MSD and Dapp calculations, the latter being proportional 
to the MSD gradient. 
From this, we deduce the apparent Diffusion Coefficient (Dapp) of each particle, which is 
effectively a measure of the diffusion capacity of the particle in its environment, proportionally 
to the MSD gradient. We can therefore compute it from the first MSD point (being the 
statistically strongest) and the lag time Δt (here 12 ms), as followed: 
 
 
The MSD is measured in squared microns (µm2) whereas the apparent Diffusion Coefficient is 
measured in squared microns per second (µm2/s). Following a purely free diffusive behaviour 
(Brownian motion), a particle MSD should linearly increase as a function of the lag time, 
however, there are instances where the particle movement is not strictly freely diffusing and 
that translates into different MSD trends. For instance, a purely one-directional movement 
(such as a motor protein sliding along a proteofilament) would yield a “super diffusive” 
behaviour.  




On the other hand, a freely diffusing particle constrained in a closed environment would show 
signs of containment, with its MSD reaching a plateau over longer time intervals Δt (Figure 
2.19). The latter case is particularly relevant when one looks at proteins moving inside a cell, 
for the cell membrane constitutes a barrier through which most proteins can no longer 
diffuse104.  
Finally, we talk of apparent Diffusion Coefficient in reference to the raw value of the 
parameter, being uncorrected for other features such as the localization error or the dynamic 
error. The localization error stems from the difficulty of accurately identifying the centre of a 
particle, given the resolution limit of our microscope setup. In contrast, the dynamic error is a 
consequence of a particle’s motion and the blurriness of the fluorescent signal that is 
associated; indeed, as a particle moves, its signal gets diluted across the space it has covered, 
hence the apparent blur. 
 
Figure 2.19. Examples of various diffusions. Different diffusion behaviour display different MSD; free 
diffusion (in blue) yields a linear MSD; super diffusion (eg. directed motion, in red) yields an exponential-
like MSD; finally, a contained diffusion (yellow) yields a MSD which ends up with a plateau. All three MSD 










Radius of Gyration (Rg) and Centre of Mass (R) 
 
 An alternative to the computation of the MSD is to calculate the Radius of Gyration 
(Rg), which only relies on a particle’s trajectory, that is, without making any assumption on the 
type of diffusion the particle adopts (Figure 2.20). First, the Centre of Mass (R) is obtained by 
calculating the average position of the particle across its trajectory, following this equation: 
 
where ri is the position of the particle at the frame i and N is the total number of positions. 
Then, Rg
2 is obtained by calculating the average squared distance between the particle and the 
Centre of Mass (R), as can be seen on the following equation: 
 
 
Figure 2.20. Centre of Mass (R) and Radius of Gyration (Rg). Following the trajectory of a particle (blue 
lines interspersed with black dots), it is possible to compute the particle’s centre of mass (R, in red) and its 













Chapter III – Results I 
 
CRISPR-Cas9 diffusion: Establishing the Method 
  




3.1 – Introduction 
 
Let us remind the reader of the motivation behind this project; to quantify the diffusion 
dynamics of the Cas9 protein, so as to unravel how the CRISPR system interacts with DNA. 
This objective relies on a set of conditions; 
• the presence of a strong and stable fluorophore, to observe Cas9 in real time 
• the use of a regulated expression system, to express the protein in sufficiently low 
amounts to perform Single-Particle Tracking 
• the use of a suitable microscopy technique, to observe the protein at the single-molecule 
level 
• the use of a reliable image analysis pipeline, to extract quantitative information 
 
All four conditions were met with different techniques which, in the same order, can be 
summarized as the following;  
• the HaloTag protein67 which, fused to our protein of interest, can covalently bind an 
external fluorophore, known to be both stable and bright; 
• the araBAD promoter105, which can be induced with arabinose and repressed with 
glucose, producing a homogeneous expression across the population; 
• the HiLo microscopy technique96, which decreases the fluorescent background due to 
its narrow illumination, while using a laser for strong excitation; 
• custom-made algorithms103 to detect fluorescent spots with high throughput, build 
particle trajectories and compute diffusion parameters. 
 
The following chapter is a description of their implementation, development and verification. 
In parallel to the results obtained through these techniques were also listed the reasons behind 
their choice, their challenges as well as their limitations. 
 
The first aim of this chapter is to confirm the technical possibility of following the Cas9 protein 
over time, in vivo, through Single-Particle Tracking.  The second aim of the chapter is to further 
quantify the diffusion dynamics of the protein so as to identify the set of behaviours the protein 
can adopt. Our hypothesis is that quantifying the diffusion behaviour of Cas9 with and without 
gRNA should highlight the interactions the CRISPR complex has with DNA. 




3.2 – Cas9-HaloTag viability and signal specificity 
3.2.1 – Cas9-HaloTag looks as active as Cas9 (qualitatively) 
 
The very first thing we needed to control was the ability of our system to be successfully 
activated and, above all, reliably repressed. Indeed, our main motivation behind a tightly 
controlled expression system was to avoid the constitutive expression of Cas9 which, in the 
presence of a gRNA targeting the genome, could very quickly become lethal for the cells. 
Additionally, single-molecule microscopy requires very small numbers of particles, in order to 
count them or to track them in time, again highlighting the need for a tightly-controlled 
expression system. 
 
The araBAD (also called pBAD) promoter is induced by arabinose and repressed by glucose. 
As a quick reminder, the dimerization of the AraC protein, expressed alongside the promoter 
and constitutively expressed, encapsulates the regulation by either bending the DNA (and thus 
inhibiting RNA polymerase recruitment) or either enhancing the recruitment of RNA 
polymerase. Please refer to Materials and Methods for more details (Figure 2.7). 
 
The second motivation behind the use of this particular system was its ability to yield a 
homogenous expression across the population. Indeed, such protein expression offers the 
benefit of decreasing cell-to-cell variability and therefore increasing statistical relevance. 
Consequently, the pBAD promoter sounded particularly appropriate for our purpose, both 
because of its regulated induction/repression and its homogeneous expression105. 
 
We checked the promoter’s activity through the expression of the Cas9 gene, placed under its 
control. For that purpose, cells containing a gRNA targeting the ptrA gene (written ptrA-
gRNA), constitutively expressed from a plasmid (Kanamycin resistant) and pBAD-Cas9, 
integrated into the genome were exposed to a 1h-pulse of either glucose, arabinose or none of 
those, then serially diluted and transferred on kanamycin plates (please refer to the 2.4 Viability 
Test section of the Material And Methods). Cas9’s activity being to produce double-strand 
breaks (DSBs), and those DSBs being hard to repair and thus lethal for the cells, we used spot 
tests to detect cell survivability, related to Cas9 activity and therefore to pBAD activation. The 
pulse of protein expression guaranteed the apparition of CRISPR-Cas9 activity at the last stage 
of the experiment, thus shielding the cells from unwanted DSBs. 




In Figure 3.1A, we can observe that cells exposed to increasing concentrations of arabinose 
increasingly die, which we can compare to the normal growth of cells exposed to glucose. Also, 
we can observe that cells neither exposed to glucose nor to arabinose seem to grow just as well 
as those put in the presence of glucose. Indeed, our system presents two levels of repression; 
an active one in the presence of glucose and a passive one in the absence of arabinose. It seems 
that the passive repression is enough to prevent cell death. 
 
In other words, there may be several explanations to the lack of cell death in the absence of 
arabinose; it may indeed be that some Cas9 proteins were still expressed, but not in sufficient 
numbers to produce DSBs and subsequent cell death. To go further, it was unclear whether a 
large amount of cells were exposed to repairable DSBs, or whether only a very small numbers 
of cell did suffer unrepairable breaks. Additionally, when the arabinose concentration reached 
10-2 %, it was possible to observe some change in colony colour and/or turbidity which we can 
interpret as the appearance of cell suppressors. Indeed, the high toxicity of the CRISPR-Cas9 
system is likely to trigger the appearance of cells harbouring mutations protecting them from 
the lethality of our system, either by mutating the Cas9 protein, the promoter, the gRNA (on a 
plasmid) or, most likely, the PAM sequence flanking the target ptrA gene. 
 
After confirming the activity of our inducible CRISPR system, we aimed to do the same with 
our CRISPR-HaloTag system. We thus repeated the previous experiment, this time comparing 
Cas9-HaloTag to Cas9 wild-type. As can be seen in Figure 3.1B, the system is well repressed, 
but the HaloTag fusion seems to slightly impair Cas9 activity, since the cells die slightly less 
than when the wild-type protein is used. Although mostly qualitative, we can make two 
hypotheses; either the fusion may result in less protein expression (and thus less cell death), 
either Cas9-HaloTag may be slightly less active than the wild-type protein. If proven to be 
qualitatively true, those results may affect our future observations of Cas9 diffusion and Cas9 
interactions with DNA. Indeed, if the HaloTag fusion were to either affect protein folding, 
protein conformation with the gRNA or with the DNA, we would consequently underestimate 
the actual activity of the Cas9 protein. Those observations will be further confronted with 
single-cell measurements. 
 
But for now, those results confirm that our CRISPR systems are active and their expression 
successfully controlled. 





Figure 3.1. pBAD-Cas9 and pBAD-Cas9-HaloTag are operational. Cells containing (A) pBAD-Cas9 or 
(B) pBAD-Cas9-HaloTag associated to the ptrA-gRNA (kanamycin-resistant plasmid) have been grown 
over-night in LB supplemented with kanamycin and glucose, diluted then grown until OD600nm 0.1 where 
they were exposed to either 0.2% w/v arabinose, 0.2% w/v glucose, or nothing (-) for 1h, at 37°C. Finally, 
they were serially diluted (10X), plated on kanamycin petri dishes and left at 37°C over-night. Those results 
confirm that in our construct, Cas9 cuts DNA and can be reliably repressed or expressed with varying levels 
of induction.  
 
In parallel, we also studied the activity of the pTet promoter (inducible with tetracycline or, in 
our case, anhydrotetracycline). This promoter has previously been reported to yield high 
induction, but without the possibility of varying expression levels (instead following an 
ON/OFF or ‘bistable’ expression). We nonetheless decided to build the constructs and 
characterize them. Observing the induction of the pTet promoter (Figure 3.2), the activity of 
Cas9 is maintained but at a lower scale than with the pBAD promoter. Indeed, as quantified on 
Figure 3.3, the pTet systems yield less cell death than the pBAD systems, which can be 
attributed to either a lower induction (which could have potentially been solved by increasing 
the dosage of anhydrotetracycline), or either a heterogenous expression (with only a small 
proportion of the cells actually expressing Cas9). However, being already satisfied with our 
pBAD system, we decided to leave the pTet system aside. 





Figure 3.2. pTet promoter is also active, but with a lower range of expression. Cells grown in the 
presence of the ptrA-gRNA and expressing either Cas9 (pTet) or Cas9-HaloTag (pTet-H) under the control 
of the pTet promoter have been exposed to either 1µM of anhydrotetracycline (+) or nothing (-) for 1h. We 
see that with this construct, Cas9 is active and can be effectively induced or repressed. However, the pTet 




Figure 3.3. pBAD promoter expression is more suitable than pTet’s. The results of the previous spot 
tests are displayed here with their averaged survival rates (expressed as a percentage of cells surviving the 
fully-induced CRISPR construct, normalized by the amount of cells growing when the system is not induced, 











3.2.2 – Cas9-HaloTag is as active as Cas9 (quantitatively) 
 
After we successfully confirmed the activities of both our Cas9 and Cas9-HaloTag 
constructs, as well as the reliable control we could achieve on their respective expression and 
activity, we decided to further characterize them by pursuing a more quantitative approach, 
using single-cell measurements. To do so, we used our SOS-response reporter gene, namely, a 
GFP under the control of the pSfiA promoter, itself activated by the SOS response. Cells 
containing the pBAD-Cas9 construct supplemented with the ptrA-gRNA on a plasmid were 
therefore exposed to pulses of either arabinose, glucose or nothing and their fluorescent signal 
was monitored on the microscope. 
 
In the first experiment we performed, we observed a significant shift in GFP signal (ie, SOS 
response) intensity between the repressed (and leaky) expression conditions and the arabinose-
induced one (see Figure 3.4, low dilution). Confirming our previous observations, our CRISPR 
system did trigger DSBs and subsequent SOS response. However, it was also noted that in the 
induced condition, a remaining proportion of cells was still displaying very low GFP intensity. 
 
This observation could be interpreted in two ways; either those cells had fail to express Cas9 
(for a variety of reasons, ranging from a mutation in the CRISPR system to a lack of access to 
the arabinose input) or they were either expressing Cas9, but too late in regard to the 
microscopy acquisition, again for a variety of reasons. This second hypothesis stems from the 
fact that Cas9 may have taken too much time between its expression, its target recognition and 
its cutting activity, or perhaps more simply that cells may have started their metabolic activity 
later than other neighbouring cells. 
 
Indeed, the state of balanced growth is obtained when all the cells in a population have reached 
an identical metabolic rate. Before this state, the metabolic rates are heterogeneous and 
therefore lead to some exponentially-growing cells (expressing proteins) and others, still in a 
state of dormancy (metabolically inactive). As a result, the first would display high SOS 








To test this last hypothesis, we decided to increase the initial dilution of the overnight inoculum 
from 1/250 to 1/1000, as we reasoned that allowing more cell generations to reach the final 
OD600nm would allow more time for the cells to reach balanced growth. And indeed, we 
observed a disappearance of those previously ‘not-induced’ cells and managed to reach a more 
homogeneous distribution of GFP signal, direct measurement of Cas9 activity (see Figure 3.4, 
high dilution). 
 
Figure 3.4. In balanced growth, our CRISPR system can be successfully expressed or repressed. SOS 
response distributions of cells containing pBAD-Cas9 and the ptrA-gRNA, exposed for 1h to either 0.2% 
glucose (repressed), 0.2% arabinose (induced) or nothing (leaky). On the top row, the initial overnight 
dilution was of 1 in 250 (low dilution), whereas on the bottom row, the dilution was of 1 in 1000 (high 
dilution, closer to balanced growth). The SOS response is plotted as the average GFP fluorescence intensity 
per cell, per pixel. The total numbers of cells are indicated. 
 
 
At this point, we repeated this experiment with our CRISPR-HaloTag system. Figure 3.5 shows 
how Cas9-HaloTag cells reproducibly displayed significant SOS activity difference depending 
on the presence or absence of gRNA, following the wild-type Cas9 phenotype.  
 







A longer tail of low SOS-activity cells with the Cas9-HaloTag construct could be observed, 
which was attributed to a particularly heterogeneous replicate (see Figure 3.6). Following the 
same previous reasoning, we concluded that this particular dataset was brought to the 
microscope a little too early, depriving Cas9 from enough time to reach its target, cut and 
trigger the SOS response.  
 
Nevertheless, we can confidently conclude that the HaloTag fusion does not hinder Cas9 




Figure 3.5. Our CRISPR constructs induce SOS. Following the same protocol used for spot tests, cells 
over-expressing either Cas9 (left) or Cas9-HaloTag (right) were grown either in the presence (red) or absence 
(blue) of the ptrA-gRNA. Their SOS response was monitored through our GFP reporter gene. Here are shown 
distributions of average GFP intensity per cell, per pixel. Total numbers of cells (n) and standard errors (from 










Figure 3.6. One of Cas9-HaloTag triplicates shows a second population. s (A) Three replicate datasets 
are shown monitoring Cas9-HaloTag SOS response, after Cas9 induction, in the presence of the ptrA-gRNA. 
(B) Here is displayed the averaged distributions of all three previous datasets, with associated standard errors. 
We can observe that the third dataset displays an additional peak of cells with low SOS response. Total 
















3.2.3 – Cas9-HaloTag signal is specific 
 
After confirmation of the cutting activity of our CRISPR-HaloTag system, we 
proceeded to look at the fluorescent signal we could obtain from the HaloTag-TMR complex. 
As a brief reminder, the TMR molecule is a bright and stable fluorophore that has the capacity 
to covalently bind the HaloTag protein. However, it needs to be added externally, usually in 
excess, which requires further washing steps in order to remove the unbound TMR molecules. 
 
As opposed to the previous SOS measurements, based on several thousands of GFP per cell, 
we were interested in expressing Cas9-HaloTag in relatively low copy numbers; barely 10 
molecules per cell, in order to be as close as possible to the single-particle tracking conditions. 
This fact is worth noting, as cells tend to display autofluorescence, which despite its lower level 
in the red wavelength (TMR) than in the green wavelength (GFP), can still affect our ability to 
confidently record HaloTag-TMR signal. 
To confirm the specificity of the TMR fluorescent signal to our Cas9-HaloTag protein as well 
as our ability to detect it, we compared the fluorescence displayed by cells expressing the 
HaloTag fusion to that of wild-type cells, both following induction with arabinose, TMR 
labelling and chemical fixation. Using the analysis pipeline previously described to quantify 
the SOS response (with Brightfield segmentation and quantification of average GFP 
fluorescence intensity per pixel, per cell), we quantified the fluorescent signal obtained in the 
TMR emission wavelength. 
 
Our first attempts revealed that HaloTag cells indeed displayed higher TMR signal than wild-
type ones, albeit with a rather low signal-to-noise ratio, as can be seen on the example shown 
in Figure 3.7. This could be explained by a variety of factors, including the accuracy of the 
focus, the level of cleanliness of the coverslip and the quality of the TMR batch. That said, 
after optimization of our imaging conditions (use of a 400°C kiln followed by overnight wash 
in KOH 1M to clean the coverslips; use of a pump to wash the excess of TMR, instead of a 
pipette) and scrupulous validation of our successive TMR samples (consistently using negative 
controls without HaloTag fusion to check the level of unbound TMR molecules), we managed 
to reach levels of signal-to-noise ratios high enough to both confirm the specificity of our 
HaloTag-TMR construct as well as our ability to confidently record it, as illustrated in Figure 
3.8. 




Finally, despite this successful qualitative confirmation, this analysis does not permit to 
quantitatively discuss the expression of our Cas9 protein. We will therefore rely on actual 






Figure 3.7. In poor imaging conditions, the HaloTag-TMR signal is not specific enough. Cells 
containing the Cas9-HaloTag fusion (HaloTag, in red) and cells only expressing Cas9 (WT, in blue) were 
exposed to 0.2% arabinose for 1h, then labelled with excess of TMR, washed and fixed with formaldehyde, 
before being mounted on agarose-pads to be observed on the microscope. Top. The average TMR fluorescent 
intensity per pixel per cell is displayed. Bottom. Associated are images taken in the TMR channel (maximum 
Z projection, with the same contrast) and in the Brightfield channel. Total numbers of cells (n) are indicated. 


















Figure 3.8. After optimization, HaloTag-TMR gives specific signal. Here is a different dataset showing 
cells expressing the same constructs and exposed to the same conditions as presented in the precedent figure. 
Top. The average TMR fluorescent intensity per pixel per cell is displayed (log scale). Bottom. Associated 
images taken in the TMR channel (maximum Z projection, with the same contrast) and in the Brightfield 












3.2.4 – Cas9-HaloTag expression 
 
Now that the specificity of our fluorescent signal was confirmed and in order to get a 
better characterization of the expression level of our araBAD constructs, I further analysed the 
previously mentioned datasets (Cas9 with and without HaloTag fusion, and with and without 
gRNA) and proceeded to count the number of Cas9-HaloTag proteins per cell. Importantly, my 
lab previously reported99 that this technique yielded a detection efficiency of labelled proteins 
superior to 80%, thus adding confidence to our protein quantification.  
 
To count the number of fluorescent proteins per cell, I used a custom-made algorithm which 
first relied on Brightfield images for cell segmentation, and which then produced Z-maximum-
projections (for every field of view, images were taken with varying heights, so called ‘Z-
stacks’, which maximum intensity per pixel were projected onto one resulting image called 
‘maximum projection’). Those maximum projections were essential to cover the entirety of the 
cellular content and thus ensure that we would detect fluorescent particles present on different 
focal planes. The resulting images were filtered to remove much of the fluorescent background 
noise and then run through another algorithm aimed at identifying fluorescent spots (more 
details are in Materials and Methods, Chapter II). 
 
We therefore observed that in those conditions (0.2% glucose media, 1h exposure to 0.2% 
arabinose), cells displayed an average of 2.93 Cas9-HaloTag proteins, which conveniently 
matched the low number of proteins necessary for Single-Particle Tracking (Figure 3.9). We 
also observed a homogeneous protein expression, with only a few cells (~15%) exhibiting 
higher amounts of proteins.  
In addition, I looked at the same construct, but in the absence of arabinose and therefore in the 
absence of araBAD induction, resulting in only twice less Cas9-HaloTag proteins per cell (1.52 
spots/cell, Figure 3.10). This surprisingly small discrepancy can be explained by the constant 
presence of glucose in the media which applied its inhibitory activity and therefore limited the 
arabinose induction. Interestingly, we could observe that in repressed conditions, 80% of the 











Figure 3.9. In our expression conditions, Cas9-HaloTag is expressed at a suitable amount for single-
particle tracking. Cells containing the Cas9-HaloTag construct (under the control of the araBAD promoter) 
were grown in the presence of 0.2% glucose and then exposed to 0.2% arabinose for 1h (during the TMR 
labelling), chemically-fixed, washed and finally mounted on agar-pads to be observed on the microscope. 
Both Brightfield and TMR signals were recorded, the first for cell segmentation and the second to count 
protein numbers. Total numbers of cells and standard errors (from duplicate experiments) are indicated. The 
average number of fluorescent foci per cell amounts to 2.93, which is appropriate for single-particle tracking. 







Figure 3.10. Without arabinose, Cas9-HaloTag expression is even lower. Cells containing the Cas9-
HaloTag construct were grown in a media containing 0.2% glucose but without addition of any arabinose. 
They were then labelled, chemically-fixed, washed and finally mounted on agar-pads to be observed on the 
microscope. Both Brightfield and TMR signals were recorded. Total numbers of cells and standard errors 
(from duplicate experiments) are indicated. As expected, we observe a diminution of the number of 
fluorescent foci per cell, compared to cells exposed to arabinose induction. 
 
 




We repeated this experiment in the presence of a gRNA (targeting ptrA) and observed an 
increase in the number of fluorescent foci per cell (4.01 spots/cell, Figure 3.11). However, this 
increase does not appear to originate from a change in protein expression, but rather from the 
elongation of the cells exposed to CRISPR-Cas9 activity which produces DNA double-strand 
breaks, induces SOS response and subsequent cell elongation, as can be seen on Figure 3.12.  
 
Indeed, elongated cells do not divide and thus do not dilute their labelled proteins by 
transferring them to daughter cells, effectively displaying more of them. Consistent with that 
hypothesis, after normalizing the number of fluorescent foci per cell with the cell length, we 
observe no significant difference between the samples with and without gRNA (Figure 3.13).  
 





Figure 3.11. In the presence of a gRNA, the number of detected Cas9-HaloTag per cell increases. Cells 
containing the Cas9-HaloTag construct and the ptrA-gRNA were exposed to the same conditions stated 
above (Figure 3.9). Total numbers of cells and standard errors (from duplicate experiments) are indicated. 
The average number of fluorescent foci per cell amounts to 4.01, which is higher than what has been observed 
in cells containing Cas9-HaloTag but without gRNA (2.93 foci/cell). 
 
  





Figure 3.12. In the presence of a gRNA, cells elongate due to the activation of the SOS response. Cells 
containing the Cas9-HaloTag construct with (right) or without (left) the ptrA-gRNA were exposed to the 
same conditions stated above (Figure 3.9). Total numbers of cells and standard errors (from duplicate 
experiments) are indicated. With the gRNA, cells experience DNA damage and subsequent SOS response 




Figure 3.13. Normalized by cell length, the presence of a gRNA does not seem to affect the number of 
detected proteins per cell. Cells containing the Cas9-HaloTag construct with (right) or without (left) the 
ptrA-gRNA were exposed to the same conditions stated above (Figure 3.9). Total numbers of cells and 
standard errors (from duplicate experiments) are indicated. With the gRNA, cells display slightly less 










In order to quantify the specificity of our signal, I performed the same experiment with cells 
lacking the HaloTag fusion and counted an average of 0.69 fluorescent spots/cell, which is 
fairly high (see Figure 3.14). When comparing with cells not exposed to TMR at all, I only 
detected 0.08 fluorescent spots/cell (Figure 3.15), indicating that (i) the autofluorescent 
background was very low and that (ii) our coverslips were very clean. Put together, these results 
indicate that after TMR labelling and subsequent washes, a non-negligible proportion of 
unbound – or free – TMR molecules most likely stays within the cells. This could be addressed 
by increasing the number of washes, which would however decrease the number of cells 
available for microscopy.  
 
In the context of absolute protein quantification, this issue would be slightly inconvenient, but 
our aim is different; it is to characterize the optimal expression regime for Single-Particle 
Tracking, which fits our present conditions. Furthermore, if those unbound TMR molecules 
can be observed with chemical fixation, they would presumably disappear in live cell imaging, 
due to their very small size, very high diffusion and subsequent lack of concentrated signal. 
 





Figure 3.14. Without the HaloTag fusion, very little fluorescent foci are visible. Cells containing the 
Cas9 (WT) construct were exposed to the same conditions stated above (Figure 3.9). Total numbers of cells 
and standard errors (from duplicate experiments) are indicated. In the absence of HaloTag fusion, we detect 
much less fluorescent foci, indicating that our signal is specific and our analysis reliable. 
 





Figure 3.15. Without TMR, no fluorescence is observed. Cells containing the Cas9 (WT) construct were 
exposed to the same conditions stated above (Figure 3.9). Total numbers of cells and standard errors (from 
duplicate experiments) are indicated. In the absence of TMR (fluorophore), there is no  









Finally, comparing the maximum fluorescent intensity of detected spots, with and without 
HaloTag, we observe much brighter spots with the protein fusion (Figure 3.16), indicating that 
the spots detected without it are actually dim artefacts. Consequently, an appropriate intensity 
threshold would easily differentiate between the two; technique that we will apply to the 
following tracking analyses. 
 
Overall, we were satisfied with our expression conditions and ready to proceed with the main 
experiment of this chapter; Single-Particle Tracking. 
 
 
Figure 3.16. With HaloTag, detected spots have a higher fluorescent intensity. Cells containing the Cas9 
(WT) or Cas9-HaloTag (HaloTag) construct were exposed to the same conditions stated above (Figure 3.9). 
Distributions of maximum spot intensities. Mean and standard errors (from duplicate experiments) are 
indicated. In the presence of HaloTag proteins, the detected spots display higher intensity than without, 










3.3 – Cas9-HaloTag tracking with one genomic target 
 
3.3.1 – HiLo quality for tracking 
 
In the previous parts of this chapter, we confirmed the activity of our CRISPR-Cas9 
constructs as well as the specificity of our HaloTag fluorescent signal. We now wish to 
determine whether Single-Particle Tracking is applicable to our system.  
 
As opposed to our previous microscopy experiments which either dealt with very high numbers 
of fluorescent proteins (pSOS-GFP) or either chemically-fixed molecules (fixed Cas9-
HaloTag), Single-Particle Tracking aims to observe very small numbers of proteins in living 
cells (so without fixation), in real time (with a resolution of dozens of milliseconds, compared 
to previous 200 ms), therefore relying on much less photons to detect. This creates two 
technical challenges; the first is to produce a high enough and stable enough fluorescent signal 
which can be detected with such short exposure times, and which will not photobleach 
throughout the acquisition. The second is to sufficiently decrease the fluorescent background 
of the sample in order to highlight the signal of interest.  
 
The HaloTag-TMR complex does provide a strong and photostable signal. However, in those 
conditions it needs to be even stronger, and above all, without fluorescent background. Those 
two challenges can be addressed with one technique; HiLo microscopy. 
 
As a reminder, HiLo stands for Highly Inclined Laminated Optical sheets, a technique derived 
from TIRF microscopy which also relies on laser illumination96. A laser triggers much stronger 
fluorescent excitation than traditional light sources, thus strongly uplifting the number of 
emitted photons.  
Additionally, both techniques dramatically decrease fluorescent background. TIRF microscopy 
relies on total reflection of the laser at the interface with the sample, in turn producing a so-
called ‘evanescent’ wave which illuminates the sample on a scale of several nanometres. In 
contrast, the HiLo technique uses a laser beam which is not reflected but refracted throughout 
the sample and illuminates only part of it, therefore limiting the fluorescent background to the 
area of interest (with a depth of 1 µm), while ensuring that the whole content of an E.coli cell 
can be illuminated. For more details, please refer to the Materials and Methods. 




Finally, a more photostable version of the HaloTag ligand (TMR) was used; JF549 (see 
Material and Methods for more details). Throughout our experiments, a partner laboratory 
worked with us to provide the new ligand, allowing us to improve the quality of our movies. 
Added in the same concentration and for the same time period as TMR, our tracking 
experiments remained identical. From this point on, every experiment was carried on with 
JF549 instead of TMR, but to facilitate the reading, we chose to keep the same “TMR” label. 
 
Therefore, following the same concentration and time periods as in the previous “protein 
counting” experiments (to ensure the results between the two types of experiments would 
remain consistent), I collected movies (100 frames, 20 ms exposure time) capturing the 
HaloTag signal emitted from our cells. 
 
As can be observed in Figure 3.17, the resulting images we obtained with the HaloTag construct 
clearly displayed fluorescent signal. With maximum projections executed on all the frames of 
the movies (here, 100), even some foci can be seen, and the background looks sufficiently dark 
to indicate a good signal-to-noise ratio. Moreover, we can compare this result to the wild-type 
dataset which further confirms that the signal is specific to the HaloTag-TMR complex, for 
without it, there is no fluorescent signal to be seen. 
 





Figure 3.17. With HiLo microscopy, the HaloTag-TMR signal is visible and specific. (Top) Wild-type 
cells and (Bottom) cells containing the pBAD-Cas9-HaloTag construct were grown in the presence of 0.2% 
glucose, labelled and simultaneously exposed to 0.2% arabinose for 1h, washed and finally mounted on agar-
pads to be observed through HiLo microscopy. In the TMR channel (laser excitation at 561 nm), images 
were taken with an exposure time of 20 ms. Both Brightfield and TMR signals were recorded. The TMR 
pictures are time-projections (all the frames’ maximum intensity pixels were projected on those resulting 
images). Both datasets TMR images are using the same contrast. The scale bars indicate 5µm. We can detect 
fluorescent signal from the HaloTag samples, with a good signal-to-noise ratio. In the absence of HaloTag 
fusion, we do not detect any fluorescent signal in those conditions. 
 
However, an artefact’s low signal is not a guarantee of not being captured by a spot-detection 
algorithm, as was previously shown in Figure 3.14, were even wild-type cells displayed a few 
detected spots. Consequently, to shield our tracking analysis from false positives, we used 
intensity threshold parameters to analyse both WT and HaloTag datasets, resulting in not even 
one track detected among wild-type cells (Figure 3.18). In contrast, the HaloTag-fusion-
containing cells did yield an average of 53 detected tracks per cell.  




Furthermore, about 87% of those cells did emit enough signal to be detected by our tracking 
algorithm, compared to 0% without the HaloTag fusion (Figure 3.19). Together, those results 
indicate that our microscopy setup coupled to our genetic constructs yield enough specific 
fluorescent signal to perform Single-Particle Tracking experiments. 
 
 
Figure 3.18. Without HaloTag fusion, our algorithm does not detect any track. (A) Example of tracks 
detected from two cells in a HaloTag dataset. Cell borders are highlighted in white. On the right, a zoomed-
in image shows that with our tracking parameters, tracks are not detected outside of the cells, illustrating our 
good tracking resolution. (B) Cells containing the wild-type (WT) or the HaloTag construct were grown and 
prepared in the same conditions as described in Figure 3.17. Both Brightfield and TMR signals were recorded 
and run through our tracking algorithm. Plotted here is the number of detected tracks per cell. Total numbers 
of cells, of tracks and standard errors (from duplicate experiments) are indicated. In the absence of HaloTag 
fusion, the tracking algorithm detects no track. With the HaloTag fusion, we observe an average of 53.4 
tracks/cell. 





Figure 3.19. With HaloTag fusion, most of the cells display detected tracks. Same cells as in Figure 3.17. 
Standard errors (from duplicate experiments) and averages are indicated. In the presence of HaloTag fusion, 



























3.3.2 – Tracking of HaloTag protein 
 
We have shown that we can reliably detect the fluorescent signal emitted by our 
HaloTag-TMR constructs and follow their trajectory through Single-Molecule Tracking. Now, 
in order to acquire a more quantitative understanding of the diffusion of our protein of interest 
(Cas9-HaloTag), we decided to start by analysing the diffusion of a simpler protein; HaloTag. 
Indeed, the HaloTag protein expressed on its own is free to diffuse in the cell without any 
interaction, thus limiting our observations to a single diffusive behaviour. 
 
Therefore, from the trajectories of our HaloTag proteins identified through our tracking 
algorithm, we computed the respective Mean Square Displacements (MSDs), which have been 
extensively used in the literature to characterize the diffusion of proteins. Indeed, following the 
theory developed to study freely-diffusing gas particles, it is possible to apply similar principles 
to freely-diffusing cytoplasmic proteins, such as our current HaloTag protein, which should 
not interact with any cellular component. 
 
In theory, freely diffusing particles display a MSD which, as a function of ‘lag time’ (here 
proportional to the exposure time, 10 ms), should follow a linear trend. However, we also know 
that due to spatial constraints generated by the enclosed cellular compartment, the MSD should 
also display a so-called ‘containment’ effect and therefore follow a plateau, direct consequence 
of the protein’s incapacity to diffuse more largely in its environment. As an illustration, please 
refer to Figure 2.19, in the Materials and Methods section of this work. 
 
However, when plotting the averaged MSD of the tracked HaloTag proteins, we observed no 
such trends (Figure 3.20). In fact, a closer look indicates that if most of the curve does not 
follow a linear trend, the first part actually does (Figure 3.21). Interestingly, the computation 
of the MSD reveals a statistical bias that increases as a function of time; for every lag-time, the 
associated MSD corresponds to the (squared) displacement of a particle, averaged on all the 
displacements sharing the same duration throughout the track. It soon became apparent that for 
longer lag-times, much less displacements emerged, thus decreasing the averaging statistical 
strength and eventually making noise and variability more apparent. As an illustration, please 
refer to Figure 2.17 found in the Materials and Methods. 





Figure 3.20. Mean Square Displacement (MSD) of the HaloTag protein. Cells containing the HaloTag 
protein (on a plasmid) were observed through HiLo microscopy. In the TMR channel (laser excitation at 561 
nm), images were recorded with an exposure time of 10 ms. Those images were run through our tracking 
algorithm which computed their respective MSD, which average (over 25 cells) is shown here. Time (in ms) 
refers to the lag-time Δt. Total numbers of cells and tracks are indicated.  
 
 
Figure 3.21. Linear trend of the HaloTag protein MSD. Only the first five timepoints of the previous plot 
are shown here, highlighting the linear trend of the MSD as a function of lag times. Time (in ms) refers to 
the lag-time Δt. Total numbers of cells and tracks are indicated. The black shade represents the standard 
deviation over the 25 datasets. 







Looking at the MSD in this way, we can therefore confirm the freely diffusive nature of our 
HaloTag protein, associated to an initial linear trend followed by the emergence of a plateau, 
matching our expectations. We can now go one step further and compute the apparent Diffusion 
Coefficient (Dapp) of our protein.  
 
There are two ways to do this. The first one relies on the MSD curve’s gradient and is therefore 
obtained from linear fitting. However, this technique has several disadvantages; (i) it is strongly 
dependent on the accuracy of the fit and therefore leads to large parts of the data being 
discarded (around 50%) for not sufficiently matching our accuracy threshold (r2 > 0.8). 
Additionally, (ii) variability was further introduced in the analysis due to the wide range of 
track lengths (Figure 3.22), amplifying the statistical bias previously mentioned. 
In contrast, the second technique is more straightforward; it consists in computing Dapp from 
the first MSD timepoint. We still filter the tracks by selecting those longer than four frames (to 
discard fluorescent artefacts) but we are no longer dependent on additional fitting thresholds, 
thus preventing significant loss of (precious) data. Moreover, the use of a single timepoint 
limits the impact of the statistical dilution affecting the MSD over longer timepoints. 
 
 
Figure 3.22. HaloTag track length. Distribution of the duration of tracks (in ms) identified from the 
analysis of the datasets introduced in Figure 3.21. Total numbers of cells, of tracks and median of the 
distribution are indicated. 





The quantification of Dapp, seen on Figure 3.23, displays a log-normal distribution centred on 
4.1 µm2/s, which does fit our expectations. Indeed, such a fast diffusion constant corresponds 
to proteins of similar sizes106.  
 
In addition, we did expect a single diffusive behaviour – freely diffusing – for HaloTag should 
neither interact with DNA, nor with other proteins. We can also observe that our observations 
are consistent across datasets (according to the standard deviation), thus confirming the 
robustness of our microscopy setup, the accuracy of our image analysis and the relevance of 
our diffusion computation. 
 
In conclusion, we are now sufficiently confident in our materials and methods, both from the 




Figure 3.23. Apparent Diffusion Coefficient of the HaloTag protein. Cells containing the HaloTag 
protein (on a plasmid) were observed through HiLo microscopy. In the TMR channel (laser excitation at 561 
nm), images were recorded with an exposure time of 10 ms. The Apparent Diffusion Coefficient of each 
track was computed from the first timepoint of their associated MSD. Total numbers of cells and mean of 
the distribution are indicated. The black shade represents the standard deviation over 25 datasets. 




3.3.3 – With gRNA, Cas9 diffusion slows down 
After confirmation of the robustness of our analysis, we could proceed with the analysis 
of our protein of interest, Cas9-HaloTag. On a first approach, we quantified the diffusion of 
the protein in the absence of gRNA, and then compared it to its behaviour in its presence. 
 
As shown previously with freely-diffusing HaloTag, we extracted the Mean Square 
Displacement (MSD) of Cas9-HaloTag across 28 datasets (each one being a different cell, see 
Figure 3.24 and remarked a much slower MSD trend than with the previous HaloTag protein. 
Example movies can be found in the Materials and Methods chapter (Figure 2.11 and 2.16). 
Again, those observations match our expectations, and for two reasons. First, because of the 
size difference between the two proteins (34kDa compared to 194kDa); a longer protein should 
indeed diffuse slower. The second reason lies in their respective interactions; where HaloTag 
alone should not interact with anything, Cas9-HaloTag should interact with the genome, even 
in the absence of gRNA. Consequently, not only Cas9-HaloTag tracks should be slower than 
HaloTag’s, but some of them should be even more so. 
 
 
Figure 3.24. MSD of Cas9-HaloTag (first timepoints). Cells containing the Cas9-HaloTag protein were 
grown in the presence of 0.2% glucose, labelled and simultaneously exposed to 0.2% arabinose for 1h, 
washed and finally mounted on agar-pads to be observed through HiLo microscopy. Here, we can observe 
the MSD of the proteins, averaged over 28 datasets, with the blue shade representing the standard deviation, 
compared to previous HaloTag measurements (black). Time (in ms) refers to the lag-time Δt. Total numbers 
of cells and of tracks are indicated.  





A further quantification reveals that Cas9-HaloTag apparent Diffusion Coefficient (Dapp) is 
also lower than HaloTag’s, which naturally follows our previous interpretations (Figure 3.25). 
More importantly, it appears impossible at this stage to be able to differentiate more than one 
diffusive behaviour, despite our previous hypothesis that the protein should either be freely 
diffusing, either interacting with the genomic DNA. 
 
Already, we can assume various explanations for this phenomenon; (i) Cas9 may either spend 
most of its time interacting with DNA, or either none of it, therefore resulting in a single 
diffusive behaviour. Or (ii), our present setup may not be able to detect such differences, again 
for several potential reasons. However, we shall leave those considerations aside for the time 





Figure 3.25. Apparent Diffusion Coefficient (Dapp) of the Cas9-HaloTag protein. Cells containing the 
Cas9-HaloTag protein were prepared as described in Figure 3.24 and observed through HiLo microscopy. 
Here is the distribution of Dapp, averaged over 28 datasets, with the blue shade representing the standard 
deviation, compared to previous HaloTag measurements (black). Total numbers of cells and mean of the 
distributions are indicated. 
 




After addition of a gRNA targeting the ptrA gene, also written ptrA-gRNA or more simply 
gRNA, we did observe a difference in terms of MSD, but rather small (Figure 3.26). These 
results suggest that most of the CRISPR complex (Cas9 with its gRNA) diffusive behaviours 
are in common with Cas9’s, diffusing on its own. 
 
Another observation relates to the weight of the construct. Indeed, as opposed to our previous 
comparison (Cas9-HaloTag and free-HaloTag, with a 5.7-fold weight difference), the CRISPR 
complex is only 1.9% (or 1.01-fold) heavier than the Cas9 protein. This would also explain 





Figure 3.26. The MSD of Cas9-HaloTag is slower with a gRNA.  Cells containing the Cas9-HaloTag 
protein with the ptrA-gRNA were prepared as described in Figure 3.24 and observed through HiLo 
microscopy. Here, we can observe the MSD of the protein, averaged over 12 datasets, with the red shade 
representing the standard deviation. Time (in ms) refers to the lag-time Δt. We can compare to previous 
measurements without gRNA (blue dotted line). With the gRNA, Cas9-HaloTag MSD slows down and 








Looking at their respective Dapp, additional observations can be made. The two distributions 
overlap (Figure 3.27). However, with the gRNA, there seems to be an additional mode, slower, 
which could very well represent the new diffusion behaviour adopted by Cas9. Indeed, the 
presence of a gRNA may be characterized by increasing interactions with genomic DNA, 




Figure 3.27. With a gRNA, Cas9-HaloTag displays two Dapp populations. Cells containing the Cas9-
HaloTag protein and the ptrA-gRNA were prepared as described in Figure 3.24 and observed through HiLo 
microscopy. Here is the distribution of Dapp, averaged over 12 datasets, with the red shade representing the 
standard deviation. We can compare to previous measurements without gRNA (blue dotted line). Mean of 
the distributions are indicated. Two populations seem to appear, one that overlaps with the no-gRNA 
distribution and a slower one. 
 
 
Finally, we can confirm that the presence of a gRNA does decrease Cas9-HaloTag diffusion, 
but it remains unclear whether this slow-down stems from a simple weight increase, or actual 
interactions with DNA. It is also worth noting that in those conditions, the gRNA only targets 
one particular target, ptrA, which can reach a maximum of two copies per cell (according to 
our cellular growth rate), thus limiting the chances of the CRISPR complex to find it and with 
that, our chances of observing the protein bound to its target. 
 




3.4 – Summary and Future Work 
In this chapter, we have shown that Cas9-HaloTag can be reliably expressed without 
impairing the original endonuclease activity of the protein, and at levels both suitable for 
phenotypic observation (high expression) and Single-Particle Tracking (SPT) (low expression). 
 
We took advantage of our tightly-controlled expression system to count the number of proteins 
per cell, after fluorescent labelling and chemical fixation. Using our glucose-containing media 
and a 1h-exposure to arabinose, we observed an average of 2.93 Cas9-HaloTag per cell, very 
suitable number of proteins for SPT (<5 proteins/cell). In parallel, in the absence of arabinose 
and therefore in complete inhibitory conditions, we could still observe an average of 1.52 
proteins/cell, illustrating the extent of the repression and of the leakiness of our promoter. 
Finally, in the presence of a gRNA (and after addition of arabinose), we could count on average 
4.01 proteins/cell, highlighting the cell elongation provoked by CRISPR DNA double-strand 
breaks and subsequent SOS response activation, preventing cell division and corresponding 
labelled-protein dilution. 
 
I then proceeded to actual SPT using HiLo microscopy, confirmed the validity of the technique 
(in my hands), both in terms of hardware (microscopy images quality) and software 
(downstream image analysis), first with the freely-diffusing HaloTag protein and then with our 
protein of interest, Cas9-HaloTag. 
 
By comparing the diffusion of the protein both in the presence and absence of a gRNA, I 
showed that our setup could reliably distinguish two diffusion behaviours, albeit with a set of 
limitations. Indeed, despite the emergence of a new diffusion behaviour corresponding to the 
addition of the gRNA, we were unable to identify whether this new behaviour appeared in 
response to a heavier protein weight (that we could call ‘passive’ diffusion shift) or rather in 
response to different protein-DNA interactions (or ‘active’ diffusion shift), or even both. 
 
To address these limitations, it is possible to either increase or decrease those interactions and 
observe the associated protein diffusion, therefore validating one hypothesis over the other. 
Indeed, if such variations do affect the resulting protein diffusion, it will prove that our previous 
observations did originate from protein-DNA interactions rather than from simple molecular 
weight variations. 




One way to decrease those interactions can be to remove the target of the gRNA (either directly 
from the genome or by using a different gRNA without an associated genomic target). Another 
way, more drastic, is to completely remove the DNA content of the cell, for example by 
triggering RecB digestion (with DNA damage) in a ΔrecA cellular background107. 
 
Conversely, it is possible to increase the amount of protein-DNA interactions, either by 
increasing the amounts of targets recognised by a gRNA (for instance by introducing repeated 
targets in the genome) or by increasing the time during which the protein stays bound to the 
genome (for example, by using the catalytically-dead mutant dCas9, shown to stay immobile 
on DNA for several tens of minutes). 
 
Those examples will precisely be explored in the next chapter, which will see the introduction 
of different gRNAs of which targets will or will not be present in the cells.  
 
In conclusion, this third chapter has presented the elaboration, the development and the 
confirmation of our method, of our techniques and of our constructs which can now be extended 
to further characterize the diffusion behaviour of the CRISPR-Cas9 complex.









Chapter IV – Results II 
 
Quantification of CRISPR-Cas9 diffusion behaviours 
 
  




4.1 – Introduction 
The previous chapter confirmed our ability to qualitatively and quantitatively study Cas9 
diffusion through Single-Particle Tracking (SPT). I showed how the technique was developed, 
implemented and how our CRISPR constructs activity was controlled. 
Our first study dealt with Cas9 diffusion differences with and without a gRNA targeting the 
ptrA gene. We showed that the addition of the gRNA slowed down Cas9 diffusion, albeit 
mildly, for the apparent Diffusion Coefficient (Dapp) decreased by a mere 1.6%.  
However, this decrease looking particularly small, it limited our ability to identify further 
diffusion behaviours of the CRISPR-Cas9 complex. We thus decided to improve our sensitivity 
by increasing the number of targets recognised by the CRISPR complex. Doing so, we 
reasoned, should push Cas9’s Dapp towards lower values and highlight additional diffusion 
behaviours. 
Additionally, one remaining uncertainty was tied to the complex molecular weight increase 
when associated to a gRNA. Surely, adding more targets should address this question in the 
following way; if the aforementioned Dapp decrease observed with the addition of the gRNA 
was solely the result of a weight increase, then adding more targets should not affect Dapp any 
further. Conversely, observing Dapp decreasing as a function of a target number increase would 
irremediably prove that Cas9 slowing down originates from actual protein-DNA interaction. 
To achieve this task, we chose to use two arrays of lacO repeats; one with 6 repeats and a 
second with 22. Every repeat would be flanked by PAM sequences (to be recognised by Cas9) 
and integrated into E.coli’s chromosome, at the same locus (see Materials and Methods). In 
addition to this, two gRNAs were designed; one targeting the array, called lacOA-gRNA, and 
a second targeting the lacO endogenous sequence, labelled lacO-gRNA. Please refer to Figure 
2.9 in the Materials and Methods, Chapter II.  
The choice of lacO sequences as CRISPR targets was not arbitrary. Importantly, lacO 
sequences are usually bound by LacI proteins, which in our case offers the benefit of having 
LacI effectively protecting the DNA from Cas9 recruitment, until addition of IPTG (which 
binds to LacI and releases it from its lacO binding). Additionally, the lacO-LacI interaction is 
already well characterized and can be used in several ways (e.g. LacI fused to a fluorescent 
protein to localize the site of the array), as was demonstrated by Johann Elf who used similar 
repeats as dCas9 plasmid targets79. 




In this chapter, I will show how those newly-built CRISPR-lacO constructs successfully work, 
I will examine the diffusion results obtained through SPT and finally discuss their implications 
in the light of Cas9 interactions with DNA reported in the literature. 
 
4.2 – lacO arrays: viability and target recognition 
4.2.1 – CRISPR activity with lacO arrays 
 
After integration of the lacO repeats into cells containing the pBAD-Cas9-HaloTag 
construct, our first objective was to test the efficiency of our new sgRNAs. Indeed, having a 
perfect homology between a gRNA and its target is not a guarantee that the CRISPR complex 
will cut the DNA. As an illustration, the secondary structure of the target sequence may prevent 
the correct recruitment of the Cas9 protein, its activity or even the recognition of the gRNA. 
Conversely, some gRNAs are so effective that targeting the genome becomes too lethal for the 
cells and it is impossible to express both Cas9 and the gRNA without mutating and losing the 
CRISPR activity altogether. For example, in our hands, the crRNA-lacZ1108 would not damage 
the cells whereas the crRNA-lacZ2108 would be so damaging that mutants having lost the 
construct were systematically selected (data not shown). 
 
An appropriate way to test the activity of the CRISPR complex in the presence of our new 
gRNAs is to perform a transformation assay108; namely, to transform cells already containing 
the Cas9 construct, overexpressed with arabinose, with plasmids containing different gRNAs 
targeting the genome. Successful CRISPR complexes would prevent the survival of cells that 
managed to receive the gRNA-plasmids. Comparing those transformations to the same ones 
performed in the absence of Cas9 overexpression, it is possible to identify which gRNAs 
effectively drive Cas9 to cut the DNA. 
 
We performed this assay and observed that our two new gRNAs were behaving very differently 
(see Figure 4.1). First, after normalizing our results to the negative control (deprived of any 
gRNA), we observed that the ptrA-gRNA successfully prevented the transformation, as 
expected. Similarly, the lacOA-gRNA (targeting the lacO-array sequences) prevented the 
survival of any transformants, validating the efficiency of both our constructs: the gRNA’s for 
driving Cas9 breakage and the lacO array’s for being recognised by the CRISPR system.  





In contrast, the lacO-gRNA (targeting the endogenous lacO sequence) did not seem to affect 
the transformation efficiency of Cas9-overexpressed cells, showing a defect in CRISPR 





Figure 4.1. With CRISPR induction, cells containing the lacO array cannot be transformed with the 
lacOA-gRNA. Cells containing pBAD-Cas9-HaloTag and the lacO6-array have been grown in LB 
supplemented with either 0.2% glucose (repressed, blue) or 0.2% arabinose and 1mM IPTG (active, orange), 
and transformed with a plasmid containing either of the following; ptrA-sgRNA, lacOA-sgRNA, lacO-
sgRNA or empty (pUA). Transformed colonies were then counted and normalized by the number of colonies 
obtained with the pUA transformation performed in the same condition (repressed or active). Samples were 
duplicated (except for lacO-sgRNA). Mean values and standard errors are displayed. With CRISPR active, 
both the ptrA-sgRNA and the lacOA-sgRNA fail to give transformants. However, the lacO-sgRNA does not 










4.2.2 – lacO-array-gRNA viability and specificity  
 
As mentioned earlier, an effective CRISPR system may prove too effective and 
therefore present too much of a burden for the cells. This may in turn trigger selection to get 
rid of the construct altogether, which would prove particularly detrimental to our experiments; 
first because it would make our construct highly unstable (and thus unreliable) and second 
because of the technical difficulty of working with cells constantly on the brink of death. 
Therefore, to confirm our ability to work with the CRISPR-lacOA construct, I performed a spot 
test with cells previously transformed with the plasmids carrying the gRNAs (in Cas9-
repressed conditions). The cells were exposed for 1h to either 0.2% of glucose (to keep 
repressing Cas9, as a negative control), either 0.2% arabinose (to overexpress Cas9), with or 
without 1mM of IPTG (which releases LacI from the lacO sequences and therefore leaves the 
target free for Cas9 recognition). If the phenotypes previously observed during the 
transformation assay could be repeated with the spot test, that would validate our ability to 
conserve the constructs and with them, the CRISPR activity. 
 
Our results indicate that for both the lacO6 and lacO22 constructs, we do conserve CRISPR-
lacOA activity across several generations (in Cas9-repressed conditions). Indeed, Figure 4.2 
shows that the cells transformed with the lacOA-gRNA and grown for 16-hours (in glucose) 
displayed successful CRISPR activity in the form of cell death. After an hour of exposure to 
0.2% arabinose, we start to observe cell death. In the presence of additional IPTG (1mM), the 
cell death increases to an additional log. In contrast, kept with glucose, the cells fail to show 
signs of CRISPR activity. 
 
Put together, those results indicate that our CRISPR-lacOA system can be submitted to three 
levels of regulation; full repression (i) with glucose, where Cas9 is not expressed and therefore 
does not cut. Half-repression (ii) where Cas9 is expressed but where LacI protects the lacO 
targets by staying on the DNA. And full induction (iii), where Cas9 is expressed and where the 
lacO targets are free for CRISPR recognition, due to IPTG releasing LacI from DNA.  Also, 
we confirm that even in the presence of arabinose and IPTG, the gRNA targeting the 
endogenous lacO sequence (lacO-gRNA) does not lead to any observable CRISPR activity 
(see Figure 4.2A). 
 







Figure 4.2. Cells containing the lacO array and the lacOA-gRNA conserve the CRISPR phenotype. 
Cells containing pBAD-Cas9-HaloTag and the lacO6-array (A) or the lacO22-array (B) have been grown in 
LB supplemented with 0.2% glucose and kanamycin (to keep the plasmids carrying the different gRNAs, or 
the empty plasmid pUA), then exposed for 1h to either 0.2% arabinose (with or without 1mM IPTG) or 
nothing, then serially plated on kanamycin petri dishes. ptrA-gRNA and lacOA-gRNA contain cells with the 
eponymous gRNAs. In those cells, CRISPR is normally activated (and repressed) with the ptrA-gRNA as 
well as with the lacOA-gRNA (targets the lacO array). However, there is no sign of CRISPR activity with 
the lacO-gRNA (targets the lacO endogenous sequence). pUA rows correspond to the same cells containing 
the gRNA-containing plasmids, but without the gRNA. 
 
In addition to the previous confirmation of the successful activity of our CRISPR-lacOA 
system, we tested whether it displayed any non-specific activity. To do so, we performed the 
same transformation assay, but in cells lacking the lacO repeats. As a result, there should not 
be any CRISPR recognition nor DNA break, unless another genomic locus were non-
specifically cut. We observed that in the absence of the proper targets (lacO array), the 
transformation was just as efficient as in the absence of gRNA (empty plasmid) and therefore 
confirmed the strong specificity of our system for its rightful target (see Figure 4.3). This was 
very important as this further confirmed our ability to reliably express our system and observe 
















Figure 4.3. Without lacO array, the lacOA-sgRNA does not produce any damage. Cells containing 
pBAD-Cas9-HaloTag and no integrated lacO-array have been grown in LB supplemented with either 0.2% 
glucose (repressed, blue) or 0.2% arabinose and 1mM IPTG (active, orange), and transformed with a plasmid 
containing either of the following; ptrA-sgRNA, lacOA-sgRNA, or empty (pUA). Transformed colonies 
were then counted and normalized by the number of colonies obtained with the pUA transformation 
performed in the same condition (repressed or active). With CRISPR active, the ptrA-sgRNA fails to give 
transformants, confirming Cas9 cutting. However, the lacO-sgRNA does not affect transformation, 












4.2.3 – SOS dynamics with CRISPR-lacO 
 
Despite our confirmation, at the population level, of the successful activity of our 
lacOA-CRISPR constructs (i.e. the association of pBAD-Cas9-HaloTag, the lacOA-gRNA and 
the lacO-repeats), we still lacked the insight provided by single-cell measurements; the level 
of CRISPR activity’s heterogeneity among the population, the dynamics of the activity and 
more simply, the differences between the three levels of regulation; full repression, full 
activation and intermediary state. 
 
To address these questions, I measured the SOS activity of single cells exposed to the three 
aforementioned levels of regulation (through our pSfiA-GFP construct, see the Materials and 
Methods chapter). Fully-repressed cells were constantly exposed to glucose. Fully-activated 
cells were grown in glucose but exposed to both arabinose (0.2% w/v) and IPTG (1mM) for an 
hour. Finally, the intermediary state of regulation was triggered by a pulse of arabinose, but 
without IPTG, the idea being to have Cas9-HaloTag expressed (in the presence of the lacOA-
gRNA), but with LacI still sitting on the lacO sequences, thus protecting them from Cas9 
recruitment. 
 
Figure 4.4 clearly shows those three states of regulation, with three populations that 
progressively shift towards higher SOS activity following increasing CRISPR activation. 
Interestingly, we reproduce the results previously obtained through the spot test experiment, 
but this time with the additional insight of the shape of each distribution. When fully repressed, 
the great majority of the cells show no sign of SOS induction. When fully activated (arabinose 
and IPTG), most of the cells switch to a high-SOS condition. Finally, the intermediary state 
(with arabinose but without IPTG) does show an intermediary result, with a heterogeneous 









Figure 4.4. araBAD and LacI give two layers of CRISPR/lacO repression. Cells containing pBAD-Cas9-
HaloTag, the lacO22-array and the lacOA-sgRNA have been grown in Generic media (supplemented with 
0.2% glucose) and then exposed for 1h to either 0.2% arabinose with 1mM IPTG (+ IPTG, red), only 
arabinose (no IPTG, blue) or nothing (glucose, black). Then the cells were mounted on agar-pads for 
microscopy. Their respective distributions of GFP signal (fluorescence intensity/pixel/cell) are shown here. 
Number of cells (n) are indicated. We can see three populations, displaying three levels of regulation; fully 
repressed with glucose, half-repressed with only arabinose and fully induced with both arabinose and IPTG. 
 
However at this point, it was impossible to say whether the intermediary state originated from 
a combination of cells – those with CRISPR fully working, and the others with LacI completely 
preventing Cas9 recruitment – or whether this state was just a snapshot of a more dynamic 
picture, with an equilibrium between Cas9 and LacI recruitment at the lacO sites not yet 
reached.   
 
To answer this question, I imaged the same sample (intermediary dataset, with arabinose but 
no IPTG) 105 minutes after the first acquisition (from which the previous results have been 
extracted). After such a period of time (corresponding to roughly 4 generations), we could 
observe a clear shift of the SOS expression towards very high SOS activity (Figure 4.5), 
indicating that during the previous acquisition, the cells were simply waiting for Cas9 to bind 
the target sites. This further shows that the main difference presented by the absence of IPTG 
is a delay in CRISPR-Cas9 recruitment, due to LacI protecting the lacO targets, but not a 
complete repression.  
 





Figure 4.5. LacI repression deceases over time. The GFP signal of the same cells described in Figure 4.4 
are displayed here. In addition, cells exposed to arabinose but without IPTG have been observed 105 minutes 
after the first acquisition (no IPTG + 105min, blue). In comparison, the first acquisition is shown in dashed 
blue line. Numbers of cells are indicated (n). After 105 minutes, cells display much more GFP signal (SOS 
induction). 
 
This interpretation is confirmed by the fact that after 105 minutes, the amount of cells highly 
inducing SOS is actually higher than what could be observed in the sample exposed to IPTG 
in the first place. Indeed, in order to obtain additional quantification, I counted the number of 
cells displaying SOS activity above a certain threshold, which has been chosen with the glucose 
dataset as a reference (in normal conditions, about 10% of the cells in a population should 
spontaneously induce SOS109). Figure 4.6 clearly shows the three levels of regulation (full 
repression, intermediary and full activation), with respective 10%, 57% and 83% of cells 
displaying SOS activity higher than the chosen threshold. Interestingly, after 105 minutes, the 
intermediary state displayed 91% of its cells expressing very high SOS, confirming that over 
time, the vast majority of the cells temporarily protected by LacI did suffer a Cas9 break. 





Figure 4.6. Quantification of CRISPR/lacO repression with araBAD and LacI. An intensity threshold 
has been applied to the GFP signal distributions shown on the previous figure (4.5), and the resulting 
proportions of cells displaying GFP fluorescent above this threshold are shown here. Compared to CRISPR 
full repression (glucose, black, 10%), we see an increasing CRISPR activation with arabinose (blue, 57%) 
and arabinose with IPTG (red, 83%). Finally, after 105 minutes, even in the absence of IPTG, the cells show 
a high SOS induction (blue stripes, 91%). 
 
In conclusion, we have shown that we can successfully use our lacOA-sgRNA to drive Cas9-
HaloTag, itself under the control of the araBAD promoter, to the lacO array we integrated into 
the chromosome. Furthermore, we have also shown that this system offers three levels of 
regulation which allow us to obtain different shades of CRISPR activity, which, as we will see 












4.3 – Cas9-HaloTag tracking with several genomic targets 
 
4.3.1 – Tracking with lacO6 
 
Of the two lacO arrays that we have at our disposal, respectively containing 6 and 22 
repeats, let us have a look at the first one, which we simply write lacO6.  
 
Harbouring six-times more targets than our previous construct targeting the ptrA gene, we were 
expecting to increase the chances of Cas9-HaloTag to be recruited on the DNA and thus 
observe a slower protein diffusion. And indeed, Figure 4.7 shows exactly that, with the Mean 
Square Displacement (MSD) curve clearly below its ptrA counterpart, indicating a much 
smaller diffusion area, on average. A closer look at the shape of the curves, however, indicate 
similar slopes and therefore points at similar behaviours, which again fits our expectations, as 
the protein should still behave similarly (with the same cellular containment), yet slower. 
 
Quantifying the duration of the tracks detected in our Cas9-HaloTag movies, we observe that 
our lacO6 construct does yield longer tracks, on average (116 ms as opposed to 80 ms with the 
ptrA-gRNA, Figure 4.8). Indeed, due to a more concentrated signal, slower molecules are easier 
to track and therefore yield longer trajectories. This is yet another indication that the protein 























Figure 4.7. With the lacO6 array and the lacOA-gRNA, Cas9-HaloTag displays a lower Mean Square 
Displacement (MSD). Cells containing the Cas9-HaloTag construct, the lacO6 array and the lacOA-gRNA 
were grown in the presence of 0.2% glucose, labelled (with TMR) and simultaneously exposed to 0.2% 
arabinose for 1h, washed and finally mounted on agar-pads to be observed through HiLo microscopy. In the 
TMR channel (laser excitation at 561 nm), images were recorded with an exposure time of 12 ms. The MSD 
is plotted as a function of lag-times (or time, in ms), compared to previous HaloTag measurements (ptrA-
gRNA in red and no-gRNA in blue). Total numbers of cells are indicated. The yellow shading represents the 
standard deviation of the lacO6 dataset (over 34 cells) and the blue one recalls the pUA dataset standard 
deviation (over 28 cells). In the presence of the lacO6 array and of the lacOA-gRNA (targeting the array), 
Cas9-HaloTag appears slower. 
 





Figure 4.8. With the lacO6 array and the lacOA-gRNA, Cas9-HaloTag displays longer tracks. Cells 
containing the Cas9-HaloTag construct, the lacO6 array and the lacOA-gRNA were prepared as described 
in Figure 4.7. Here, we can observe the distribution of track duration of the aforementioned cells (in yellow), 
compared to previous datasets (ptrA-gRNA in red and no-gRNA in blue). Mean of the distributions are 
indicated. In the presence of the lacO6 array and of the lacOA-gRNA (targeting the array), Cas9-HaloTag 
tracks appear longer. 
 
The distribution of apparent Diffusion Coefficient (Dapp) of the CRISPR-lacO6 construct 
reproduces a clear shift from the no-gRNA form, and goes much further left than the CRISPR-
ptrA did (Figure 4.9). Indeed, where the CRISPR-ptrA shows two modes, one overlapping the 
no-gRNA and one shifting away towards slower values, the CRISPR-lacO6 only shows one 
mode, leftwards, displaying higher homogeneity and slower diffusion.  
The distributions’ mean follow the same trend; where CRISPR-ptrA only displayed an overall 
1% decrease from the no-gRNA construct’s Dapp, CRISPR-lacO6 shows a 27% decrease. 
Interestingly, this 27-times difference is much higher than the expected 6-times one (for 6-
times more targets). At this point, we could even hypothesize the presence of a form of 
facilitated recruitment, where several targets located at short distance from each other may in 
fact increase the recruitment of the Cas9 protein. Indeed, after a first recruitment, the protein 
may stay in the vicinity of the array and therefore find it easier to run into another neighbouring 
target. 




Another round of quantification was produced by counting the proportion of tracks in each 
dataset displaying an apparent Diffusion Coefficient (Dapp) inferior to 1 µm
2/s (chosen as an 
indicator of slow molecules). This threshold was chosen in accordance with previous 
measurements found in the literature81, where the Dapp of the catalytically-dead Cas9 mutant 
(dCas9) was observed to vary between 10 µm2/s (for very fast molecules) and 0.1 µm2/s (for 
immobile molecules); therefore, they observed that slow molecules would appear so below 1 
µm2/s. Additionally, another study106 studying Dapp as a function of molecular weight allows 
us to estimate that Cas9 should freely diffuse above 1 µm2/s, reinforcing our choice of 
threshold. 
Consequently, this additional quantification resulted in a similar trend, yet not as dramatic 
(Figure 4.10); without any gRNA, 18% of the detected tracks displayed ‘slow’ diffusion, as 
opposed to 26% and 31%, respectively for CRISPR-ptrA and CRISPR-lacO6. This time, the 
increase difference between the two CRISPR constructs is only of 1.6-times. 
 
Figure 4.9. With the lacO6 array and the lacOA-gRNA, Cas9-HaloTag appears slower than previously 
observed. Cells containing the Cas9-HaloTag construct, the lacO6 array and the lacOA-gRNA were 
prepared as described in Figure 4.7. Here, we can observe the distribution of apparent Diffusion Coefficient 
(Dapp) of the aforementioned cells (in yellow), compared to previous datasets (ptrA-gRNA in red and no-
gRNA in blue). Mean of the distributions are indicated. In the presence of the lacO6 array and of the lacOA-
gRNA (targeting the array), Cas9-HaloTag detected molecules appear slower than the protein diffusing in 
the absence of a gRNA, and the protein diffusing with the ptrA-gRNA. 






Figure 4.10. With the lacO6 array and the lacOA-gRNA, Cas9-HaloTag displays very slow tracks. 
Cells containing the Cas9-HaloTag construct, the lacO6 array and the lacOA-gRNA were prepared as 
described in Figure 4.7. Here, we quantified the proportion of detected tracks with Dapp < 1 µm2/s. The lacO6 
dataset is in yellow (31%), the ptrA-gRNA is in red (26%) and the one without a gRNA is in blue (18%). In 
the presence of the lacO6 array and of the lacOA-gRNA, Cas9-HaloTag displays more slow tracks than in 
the absence of a gRNA, and with the ptrA-gRNA. Error bars indicate the standard deviation calculated on 
their respective number of cells (34, 12, 28). 
 
 
In conclusion, our CRISPR-lacO6 construct did significantly slow down Cas9-HaloTag, and 
its comparison with our previous ptrA construct seems to indicate that this Dapp decrease stems 
from an increased number of targets. Repeating these experiments with our second array 
containing 22 lacO targets, we will investigate whether this assumption is further confirmed, 










4.3.2 – Tracking with lacO22 
 
After studying the protein diffusion observed with the lacO6 construct, let us examine 
the behaviour displayed with the CRISPR-lacO22 construct, and see if another increase in 
CRISPR targets does yield a similar slow-down in protein diffusion. A first glance at the MSD 
of the CRISPR-lacO22 construct shows a very similar behaviour to the lacO6’s, albeit slightly 
slower (3%) (Figure 4.11A).  
This trend is conserved with the apparent Diffusion Coefficient (Figure 4.11B), although in 
both cases, the area representing the standard deviation of the lacO22 dataset covers both 
construct averages, therefore making it hard to assess the significance of such a difference. 
That said, this difference hardly reaches the expected 3.6-times increase due to the higher 
number of targets (from 6 to 22).  
The additional quantification of the proportion of slow tracks in each dataset showed a 20% 
increase in slow tracks with the lacO22 construct (compared to the lacO6 one) (Figure 4.12A). 
This indicates that a wider look at the population does not show much behaviour change, while 
a closer look to the slow part of it does highlight such a difference, pointing at the particularly 











Figure 4.11. With the lacO22 array and the lacOA-gRNA, Cas9-HaloTag appears slower than with 
lacO6 array. Cells containing the Cas9-HaloTag construct, the lacO22 array and the lacOA-gRNA were 
prepared as described in Figure 4.7. (A) The MSD is plotted as a function of lag-times (or time, in ms) (in 
purple), compared to previous HaloTag measurements (lacOA6-gRNA in yellow, ptrA-gRNA in red and no-
gRNA in blue). (B) The distribution of apparent Diffusion Coefficient (Dapp) of the aforementioned cells 
shows a similar trend. Mean of the distribution and total numbers of cells are indicated. The purple shadings 
represent the standard deviation (over 24 cells). In the presence of the lacOA-gRNA and the lacO22 array, 
Cas9-HaloTag appears slightly slower than with 6 lacO targets, making it the slowest condition. 





Figure 4.12. With the lacO22 array and the lacOA-gRNA, Cas9-HaloTag displays slower and longer 
tracks than with the lacO6 array. Cells containing the Cas9-HaloTag construct, the lacO6 array and the 
lacOA-gRNA were prepared as described in Figure 4.7. (A) Here, we quantified the proportion of detected 
tracks with Dapp < 1 µm2/s. The lacO22 dataset is in purple (37%), the lacO6 dataset is in yellow (31%), the 
ptrA-gRNA is in red (26%) and the one without a gRNA is in blue (18%). In the presence of the lacO22 
array and of the lacOA-gRNA, Cas9-HaloTag displays more slow tracks than in the absence of a gRNA, and 
with the ptrA-gRNA. Error bars indicate the standard deviation calculated on their respective number of cells 
(24, 34, 12, 28). (B) The distribution of track duration of the aforementioned cells follows a similar trend, 
with increasing longer tracks across datasets. The means of the distributions are indicated and plotted (inlet) 
with their respective standard deviation (error bars). 




Now, CRISPR-Cas9 interactions with DNA can be described in two ways; ON-target 
interactions which are characterized by the CRISPR complex finding the target encoded in the 
gRNA; and OFF-target ones where the CRISPR complex does interact with DNA, but not at 
its right target. Both processes slow down Cas9, which must momentarily stop its course to 
unwind the DNA. That is the reason why our measure of slow tracks (with Dapp < 1 µm
2/s) can 
effectively be a first approach to describe the fraction of the population combining both ON-
target and OFF-target events. 
A reasonable assumption is that within this combination of ON and OFF-target events, only 
the proportion of ON-target ones varies as a function of the number of targets present in the 
cell, because it originates from specific interactions with targets. In contrast, OFF-target events 
originate from non-specific interactions throughout the genome, which should not be affected 
by the number of targets.  
Bearing those hypotheses in mind, and assuming that the fraction of ON-target events linearly 
increases as a function of the number of targets (as was also hypothesised in the literature79), 
then we can build an easy set of equations, with ai and the bi the respective fractions of OFF 
and ON-target events with the lacOi construct: 
a6 + b6 = 31%      a6  = 28.75%  
a22 + b22 = 37%         resulting in:  a22  = 28.75%  
a22 = a6      b6  = 2.25%  
b22 = b6 x 22/6 = b6 x 3.66    b22  = 8.25% 
 
The result of these equations shows that only 2.25% of all the tracks with the lacO6 construct 
would actually be ON-target, which would increase to 8.25% with the lacO22 construct (Figure 
4.13). Even more interesting, in this model, about 29% of the tracks would come from non-
specific (OFF-target) DNA interactions, so respectively 13 and 3.5-times more than the specific 
(ON-target) interactions. 
 





Figure 4.13. We hypothesize the respective proportions of ON and OFF-target tracks with the lacO6 
and lacO22 CRISPR constructs. Cells containing the Cas9-HaloTag construct, the lacOA-gRNA and either 
the lacO6 (yellow) or lacO22 (purple) arrays were prepared as described in Figure 4.12. After quantification 
of the proportion of detected tracks with Dapp < 1 µm2/s, we show that respectively 31% and 37% of lacO6 
and lacO22 tracks are slow. Making the assumption (i) that in both cases, the proportion of OFF-target 
interactions is the same, and the assumption (ii) that with 22 targets, there should be (22/6 = ) 3.6-times more 
ON-target interactions than with 6 targets, we find that with lacO6, only about 2% of the overall tracks 
actually come from ON-target interactions, compared to about 7% with lacO22 (and opposed to 29% of 
OFF-target interactions). 
Despite those promising results, the coarse simplicity of our model should be further supported 
by a more thorough analysis, where quantitative data would be directly extracted from Dapp 
distributions. Nevertheless, we can still observe a diffusion shift from 6 targets to 22, thus 
confirming that the consecutive diffusion contractions we have observed so far are indeed the 
result of protein-DNA interactions, and not of the gRNA’s putative weight increase (see 
Chapter 3, Discussion). 
Finally, after studying the effect of increased amounts of targets recognised by the CRISPR 
complex and confirming an increase in protein-DNA interactions, it would be particularly 
useful to compare those previously-showed results to the opposite situation; a CRISPR-Cas9 
complex deprived of a genomic target. This time, we should expect a decrease of slow tracks 
and an acceleration of the protein. 




4.3.3 – Tracking without gRNA target 
 
We have just shown that increasing the number of targets recognised by the CRISPR 
complex increases the amount of slow trajectories, and with it the amount of protein-DNA 
interactions. However, would the opposite be true? Could we remove any form of target and 
observe faster protein diffusion? We decided to test this hypothesis by observing cells 
containing our usual pBAD-Cas9-HaloTag construct, in association with the lacOA-gRNA 
(recognising the lacO arrays), but without any integrated array, hence without any proper 
target. 
As mentioned, we expected to see Cas9-HaloTag diffusing faster, freed from all its ON-target 
interactions (specific target recognition) and only subjected to OFF-target (non-specific) ones. 
And indeed, Figure 4.14 matches our expectations. Without target, the protein looks slightly 
faster than with 22 targets, both with MSD and Dapp.  
Further quantifications confirm these observations (Figure 4.15), with the proportion of 
CRISPR-lacOA slow tracks falling to 30% (as opposed to 36%, with 22 targets, as can be seen 
on Figure 4.15A). This result loosely fits our previous model of ON/OFF-targets, which indeed 
estimated the proportion of OFF-target activity to be of 29% (Figure 4.13).  
 
 






Figure 4.14. Without a target, the CRISPR complex diffuses faster than with a target. Cells containing 
the Cas9-HaloTag construct and the lacOA-gRNA - but without a target (lacO array) - were prepared as 
described in Figure 4.7. (A) The MSD is plotted as a function of lag-times (or time, in ms) (in green), 
compared to previous HaloTag measurements (lacOA22-gRNA in purple and no-gRNA in blue). (B) 
Distribution of apparent Diffusion Coefficient (Dapp) of the aforementioned cells. Mean of the distributions 
and total numbers of cells (n) are indicated. The green shadings represent the standard deviation (over 18 
cells). In the absence of a target (lacO array), Cas9-HaloTag and its gRNA appear faster than with the 22 
lacO targets, and slower than Cas9-HaloTag on its own (without gRNA). 





Figure 4.15. Without a target, the CRISPR complex displays an intermediate diffusive behaviour. 
Cells containing the Cas9-HaloTag construct and the lacOA-gRNA - but without a target (lacO array) - were 
prepared as described in Figure 4.7. (A) Here, we quantified the proportion of detected tracks with Dapp < 1 
µm2/s. The aforementioned dataset (no-target) is in green, the lacO22 dataset is in purple and the one without 
a gRNA is in blue. In the absence of a target, the CRISPR complex displays more slow tracks than in the 
absence of a gRNA, but less than in the presence of a target (lacO22), which fits our expectations. Error bars 
indicate the standard deviation calculated on their respective number of cells (18, 24, 28). (B) The 
distribution of track duration of the aforementioned cells follows a similar trend. The mean of the 
distributions are indicated and plotted (inlet) with their respective standard deviation (error bars). 
 
However, the comparison with other constructs (lacO6 and ptrA) offers a more complex 
picture. Figures 4.16, 4.17 and 4.18 all indicate that without target, the CRISPR-lacOA 
complex diffuses slower than the CRISPR-ptrA complex, despite the clear phenotypic evidence 
that no DNA double-strand break (DSB) happens in the first case, but does happen in the 
second (Figure 4.3). This is rather counter-intuitive, as we would expect DSBs to significantly 
slow down the CRISPR complex, and yet, we seem to see just the opposite. 
















Figure 4.16. Cas9-HaloTag seems to diffuse as a function of its gRNA type, regardless of the presence 
of a target. Cells containing the Cas9-HaloTag protein were observed as described in Figure 4.7, with either 
of those constructs; the lacO22 array and lacOA-gRNA (purple), the lacO6 array and lacOA-gRNA (yellow), 
the ptrA-gRNA (red), the lacOA-gRNA without target (green) and finally no gRNA at all (blue). The 
distributions of apparent Diffusion Coefficient (Dapp) show that Cas9-HaloTag diffusions with the lacOA-
gRNA cluster together, regardless of the presence of a target, as opposed to the diffusions with ptrA-gRNA 



















Figure 4.17. Cas9-HaloTag MSD confirms that the protein seems to diffuse as a function of its gRNA 
type, regardless of the presence of a target. Cells containing the Cas9-HaloTag protein were observed as 
described in Figure 4.7, with either of those constructs; the lacO22 array and lacOA-gRNA (purple), the 
lacO6 array and lacOA-gRNA (yellow), the ptrA-gRNA (red), the lacOA-gRNA without target (green) and 
finally no gRNA at all (blue). (A) The MSD is plotted as a function of lag-times (in ms). (B) Track duration 
means with standard deviations (error bars). CRISPR-lacOA constructs similarly diffusive (with or without 











Figure 4.18. With the ptrA-gRNA, Cas9-HaloTag displays less slow tracks than the lacOA-gRNA and 
no target. Cells containing the Cas9-HaloTag protein were observed as described in Figure 4.7, with either 
of those constructs; the lacO22 array and lacOA-gRNA (37%, purple), the lacO6 array and lacOA-gRNA 
(31%, yellow), the ptrA-gRNA (26%, red), the lacOA-gRNA without target (30%, green) and finally no 
gRNA at all (18%, blue). After quantification of the proportion of detected tracks with Dapp < 1 µm2/s, we 
can observe that Cas9-HaloTag associated to its lacOA-gRNA displays as much slow tracks with and without 
lacO targets. The CRISPR-ptrA construct looks faster than all CRISPR-lacOA ones. Error bars represent 
standard deviations. 
So, why does the CRISPR-lacOA complex diffuse slower than the CRISPR-ptrA complex? 
Could the level of CRISPR-ptrA’s OFF-target interactions be lower than that of CRISPR-
lacOA’s? A first explanation could stem from a different GC content, which may facilitate the 
interactions of one gRNA with genomic DNA over the other. Unfortunately, the ptrA target 
sequence shows 45% GC content, compared to 50% with the lacOA sequence, thus showing 
easier DNA interactions with ptrA, in opposition to the faster diffusion we observed with this 
construct. We can therefore refute this hypothesis. 
A second explanation relates to the level of nucleic acid similarities found across the genome, 
which change from one gRNA to another, due to their different target sequences. Indeed, more 








BLASTing the two target sequences against E.coli’s genome, we first found no significant 
differences (Figure 4.19). However, restricting our observation to long mismatches (longer 
than 15bp), the lacOA sequence displayed twice more hits than its ptrA counterpart (Figure 
4.20). Indeed, long mismatches are more likely to stabilize the CRISPR complex on the DNA, 
in accordance with the gRNA ‘seed region’ (of 12 nucleotides19). Potentially, such interactions 
may even block Cas9 on the DNA as it neither gets the signal to cut (without full recognition, 
Cas9 does not rearrange itself to DNA-cleavage conformation19), neither the signal to move 
out (because of crRNA-DNA base-pairing).  
Therefore, we can now confirm that the lacOA-gRNA most likely triggers significantly more 
CRISPR OFF-target (non-specific) interactions than its ptrA counterpart.  
Additionally, as we estimated the level of ON-target interactions stemming from the lacOA-
complex to reach a mere 2% of the total amounts of tracks, with 6 targets (Figure 4.13), it is 
reasonable to assume that the level of ON-target interactions reached with the unique target of 
the ptrA-complex would certainly not exceed this amount.  
Put together, those observations show that the CRISPR-ptrA construct displays both small 
amounts of  OFF-target interactions (indicated by its few long genomic mismatches), and small 
amounts of ON-target interactions (due to its unique target sequence) which explain that despite 
the presence of a target, the CRISPR-ptrA construct still appears faster than the CRISPR-
lacOA’s lack of one. 
 
 





Figure 4.19. Genomic mismatches of the ptrA- and lacOA-gRNA target sequences. The 20-nucleotides 
target sequences of the ptrA-gRNA (red) and of the lacOA-gRNA (yellow) were BLASTed against E.coli’s 
genome. (A) Distribution of numbers of matching nucleotides, normalized to 1. (B) Distribution of numbers 




Figure 4.20. The lacOA-gRNA displays more long mismatches than the ptrA-gRNA. The 20-nucleotides 
target sequences of the ptrA-gRNA (red) and of the lacOA-gRNA (yellow) were BLASTed against E.coli’s 
genome. Here are displayed the numbers of hits with at least 15-base-pair (15bp) homology, for each gRNA. 
The ptrA target sequence displays 12 hits and the lacOA one displays twice more (24 hits). 
 
 




In conclusion, we have shown that increasing the number of targets that a gRNA can recognise 
increases the CRISPR construct’s chances to (specifically) interact with DNA. However, 
surprisingly, we have also shown that non-specific DNA interactions, based on the gRNA target 
sequence itself, are actually more relevant when it comes to protein diffusion.  
Now that we have identified this discrepancy, we aim to further quantify the ON/OFF balance 
of CRISPR interactions by dramatically increasing the numbers of targets, no longer by a factor 





























4.3.4 – Tracking with large amounts of plasmid targets 
 
In the previous parts of this chapter, we have shown that Cas9-HaloTag can adopt 
several diffusion behaviours which are affected by the gRNAs with which the protein 
associates. We have also shown that in those conditions, the strongest feature of the CRISPR 
complex’s diffusion was not its specific interactions with DNA, but rather its non-specific ones. 
However, these observations have been made with small numbers of targets; in the case of our 
lacOA-gRNA, we have built up to 22 actual targets, as opposed to 24 long non-specific 
interactions, and almost 3,000 short non-specific ones (Figure 4.19B). Therefore, our question 
is the following; can we tilt the balance of CRISPR ON/OFF interactions by adding much 
higher numbers of targets? To address this question, we built a plasmid containing the lacO22 
array, sitting on a high-copy origin of replication (pUC) reaching hundreds of copies per cell. 
In effect, this new system should produce, on average, around 2,000 lacO targets per cell, thus 
reaching a level similar to the amount of short genomic sequences non-specifically recognised 
by the lacOA-CRISPR complex. 
A first observation shows that despite much larger numbers of lacO targets, both MSD (Figure 
4.21) and Dapp (Figure 4.22) seem rather unperturbed. The MSD curve almost entirely overlaps 
with lacO22’s, as if no new targets had been added. Similarly, the apparent Diffusion 
Coefficient only recorded a meagre 1.7% decrease from the previous one obtained with solely 
22 genomic targets. 
Considering the very small effect of the addition of the plasmid, I decided to assess the 
recognition of the targets present on the plasmid by the lacOA-CRISPR complex. To do so, I 
tracked Cas9-HaloTag in cells containing the lacOA-gRNA, with targets only present on the 
plasmid (and not on the genome).  
Figure 4.21 shows that despite the absence of genomic targets, Cas9-HaloTag diffusion is still 
very slow, and even slower than its non-specific diffusion behaviour (where there is no target 
at all). These results indicate that our CRISPR complex recognises targets from plasmid DNA 
(as it was originally meant to), albeit not as strongly as we expected, given the considerable 
amount of targets coming from the plasmids. Indeed, this last experiment confirms that specific 
targets are, even in great number, surprisingly not the driving force of the CRISPR complex 
diffusion.  





Additionally, in the absence of genomic targets and in the presence of plasmid ones, no SOS 
response was triggered (data not shown), despite Cas9-HaloTag diffusion slowing down, 
confirming that previous effects observed on protein diffusion did not stem from SOS 
activation (whether we talk of protein regulation, division arrest or even crowding effects), but 
really from protein-DNA interactions. 
Another thing to consider is the actual presence of the plasmids, for indeed, due to homologies 
with either the endogenous lacO sequence, or with the integrated lacO arrays, recombination 
events may have provoked significant variations in target numbers, or even their complete 
removal. Such eventualities could be investigated by plasmid extraction and further 
verification. 
Figure 4.21. The lacO targets on the plasmid are recognised by Cas9-HaloTag. Cells containing the 
Cas9-HaloTag protein and the lacOA-sgRNA were observed as described in Figure 4.7, with either of the 
following constructs; the lacO22 array on a (high-copy) plasmid (pLacO22, grey), the lacO22 array both on 
a plasmid and on the genome (pLacO22-lacO22, brown), the lacO22 array only on the genome (lacO22, 
purple) and finally, no lacO array on the genome (green). As a comparison, diffusion from cells with the 
ptrA-gRNA (red) and without any gRNA (blue) are also displayed. (A) The MSD is plotted as a function of 
lag-times (or time, in ms). The grey shading represents the standard deviation of the pLacO22 dataset (over 
16 cells).  (B) Quantification of the proportion of detected tracks with Dapp < 1 µm2/s (individual numbers 
are indicated in the inlet). We can observe that when the CRISPR complex only targets plasmid DNA, Cas9-
HaloTag diffusion slows down to a similar level as when the complex only targets genomic DNA, which is 
slower than its OFF-target behaviour (no-lacO, highlighted by the green dashed line). Error bars represent 
standard deviations. 
 




Moreover, we will remember that in those conditions, Cas9-HaloTag is expressed in very low 
amounts (barely more than 5 proteins/cell, as showed in Chapter 3, Figure 3.12 and 3.14), 
which could in turn produce a saturation effect, where not enough proteins would be available 
to bind additional targets. This hypothesis would explain why above 22 lacO targets, Cas9 
diffusion barely changes.  
Initially, the reason behind this very low expression level was precisely to perform Single-
Particle Tracking (SPT, see Materials and Methods), but in the light of those last observations, 
we could increase the expression level of our protein and adapt our imaging conditions by 
labelling less proteins (under-labelling). That way, we would aim to obtain a similar number 
of labelled proteins per cell (as required by SPT), while providing suitable conditions for the 
detection of differences between varying numbers of targets. 
That said, in those conditions where the number of targets is maximal, Cas9 diffusion reached 
its slowest point (with, on average, Dapp = 1.76 µm
2/s and the fraction of slow tracks reaching 
39%). Conversely, the fastest point was reached with Cas9 diffusing without gRNA (averaged 
Dapp = 2.48 µm
2/s with slow tracks = 18%). Put together, those results indicate that the range 
of diffusion variations we can detect barely covers a 2-fold difference. This is not great 
sensitivity. 
Now, as highlighted on Figure 4.22, our protein diffusion behaviour is very much affected by 
the target sequence of the gRNA involved in the CRISPR complex; we clearly see the lacOA-
CRISPR constructs clustering together, away from the ptrA-CRISPR one. As discussed before, 
this feature originates from the gRNAs’ respective OFF-target interactions, with lacOA-gRNA 
interacting much more with genomic DNA than its ptrA counterpart. 
 





Figure 4.22. Cas9-HaloTag diffusion in various conditions. Cells containing the Cas9-HaloTag protein 
and the lacOA-sgRNA were observed as described in Figure 4.7, with either of the following constructs, in 
order of increasing apparent Diffusion Coefficient (Dapp); the lacO22 array both on a plasmid and on the 
genome (pLacO22-lacO22, brown), the lacO22 array only on the genome (lacO22, purple), the lacO22 array 
only on a plasmid (pLacO22, grey) and finally, no lacO array at all (green). As a comparison, diffusion from 
cells with the ptrA-gRNA (dotted red) and without any gRNA (dotted blue) are also displayed. Here, we can 
see the distributions of Dapp with their respective means (indicated in the legend and plotted in bottom inlet). 
The dotted green line indicates the separation of the lacO constructs with the two other constructs. 
 
Therefore, an additional direction to explore to further quantify CRISPR-Cas9 diffusion 
behaviours may be to look for a gRNA which triggers less OFF-target (non-specific) 
interactions, to start with a faster profile which would then get progressively slowed down by 
the addition of increasing numbers of targets. In other words, the slowest Dapp would remain 
the same (corresponding to the maximal amount of targets, and its maximal amount of ON-
target interactions), but CRISPR-Cas9 non-specific diffusion (OFF-target) would be faster, 
allowing a gradual increase in target numbers and a correspondingly gradual decrease in 
diffusion measure. 




Another possibility could be to increase the range of diffusion behaviours by suppressing OFF-
target interactions entirely, either using anti-CRISPR proteins (preventing DNA interactions)49, 
or by removing all genomic content. Such goal can be achieved in a ΔrecA background, where 
cells put in the presence of DNA Double-Strand Breaks (DSBs) cannot stop the RecBCD 
enzyme from digesting their entire chromosome. Deprived of genomic DNA to interact with, 
Cas9 is left entirely free to diffuse in the cell104. In that scenario, one could also study ON-
target interactions, using plasmid targets; indeed, the comparatively short plasmid sequences 
would deprive the gRNA from any unwanted homology with its target, leaving only a few 
available PAM sequences for Cas9 to interact with (which again would be far less numerous 
than in the genome). 
As a matter of fact, we tested this last hypothesis by observing Cas9-HaloTag in such ΔrecA 
background and induced DSBs using ciprofloxacin (4ng/µl), thus removing the chromosome 
through the aforementioned mechanism. I checked the absence of DNA content with DAPI 
staining and analysed the tracks detected from such cells. In Figure 4.23A, we can observe that 
such tracks are indeed 24% faster than those displayed by Cas9-HaloTag with intact genomic 
DNA (and without gRNA).  
Additionally, Figure 4.23B shows that the Mean Square Displacement of the protein without 
genomic DNA reaches a stronger plateau much sooner (containment effect), again matching 
our expectation of a freely diffusion protein, reaching the edges of the cell much faster. 
Finally, some 8% of total tracks can be considered “slow”, characterized by an apparent 
Diffusion Coefficient (Dapp) slower than 1 µm
2/s. That is interesting, considering that those 
proteins should not have any genomic DNA to interact with anymore. We can assume that 
those remaining slow tracks emerge from some proteins diffusing closer to the cell membrane, 
or perhaps trapped in inclusion bodies (due to potential misfolding). However, we can also note 
that 92% of the tracks are actually faster than 1 µm2/s, confirming the chosen threshold as a 










Figure 4.23. Cas9-HaloTag diffusion without genomic DNA is faster. Cells containing the Cas9-HaloTag 
protein in ΔrecA background were exposed to ciprofloxacin (4ng/µl) for one hour so as to get rid of their 
genomic DNA. Consequently, Cas9-HaloTag expression was induced and the protein labelled. Finally, the 
cells were observed as described in Figure 4.7, while a DAPI staining allowed the identification of cells 
deprived of DNA content. Those cells are here represented in black, while as a comparison, are also displayed 
cells containing the lacO22 array with the associated lacOA-sgRNA (in purple) and those not containing any 
gRNA at all (in blue). (A) The distributions of Dapp with their respective means (indicated in the legend) and 
their respective proportions of slow tracks (with Dapp < 1 µm2/s) (inlet, with indicated frequencies) show 
that without genomic DNA (ΔrecA), Cas9-HaloTag diffuses faster. (B) Likewise, this construct displays the 
fastest MSD. 




4.4 – Discussion and Future Work 
A model of Cas9 diffusion behaviours 
 
We can now associate the data we have collected and quantified from Cas9-HaloTag diffusion 
in different conditions and explore whether our previous model can be further improved. 
Putting side-by-side the proportions of slow tracks we detected from Cas9-HaloTag with-or-
without gRNA, with-or-without target and with-or-without genomic DNA, it is possible to infer 
the respective fractions of protein behaviours eventually contained in a tracking dataset. 
Indeed, when associated to a gRNA and expressed in the presence of a genomic target, Cas9-
HaloTag can adopt four diffusion behaviours. The first and simplest behaviour is ‘free 
diffusion’, where the protein can randomly diffuse in the cell and does not interact with DNA, 
which we can attribute to our ΔrecA dataset. The second behaviour describes the interaction 
Cas9 has on its own with DNA, through PAM recognition, but without gRNA. The third 
behaviour relates to so-called ‘OFF-target’ interactions, when Cas9-HaloTag is in a complex 
with a gRNA, interacts with DNA but not at its rightful target; these interactions can be 
observed in the ‘no-target’ dataset, when Cas9-HaloTag is associated with the lacOA-gRNA, 
but when no lacO target is present in the cell. Finally, the last behaviour appears when Cas9 
does find its target or ‘ON-target’ interaction; here, we can use any such dataset which has both 
a gRNA and the target. 
As mentioned earlier, we speculated on a simple model of ON/OFF-target quantification, 
assuming that among CRISPR-lacO datasets with varying number of targets, the proportion of 
OFF-target interactions should not vary (Figure 4.13). As a reminder, we reasoned that the 
OFF-target interactions being a result of genomic homologies, and not of actual targets, the 
number of targets should not impact the OFF-target fraction of total detected tracks. 
Based on this assumption, we decided to compare our CRISPR-lacO datasets, making the 
additional hypothesis that all four diffusion behaviours were independent from each other, thus 
mutually exclusive. In other words, taking the example of the lacO22 dataset, we reasoned that 
its proportion of slow tracks (36%) included four smaller fractions; (a) one of proteins diffusing 
in the cytoplasm but confined to a small area (e.g. the vicinity of the membrane), (b) another 
of proteins merely interacting with PAM sequences, (c) one characterized by OFF-target 
interactions and (d) a last one with ON-target events.  




Applying the same reasoning to the no-target, the no-gRNA and the no-genomic-DNA datasets, 
respectively containing three (a, b & c), two (a & b) and one (a) of the four previous behaviours, 
it is possible to identify their respective fractions of slow tracks. 
Of course, this model only constitutes a first approach towards the proper quantification of 
Cas9 diffusion behaviours and should be supported by a statistical analysis of our Dapp 
distributions, much like Kapanidis and colleagues110 did.  
Nevertheless, this approach still offers a first quantitative glance, as illustrated on Figure 4.24, 
where our model infers that those four behaviours respectively occupy 8% (confined diffusion), 
10% (Cas9-PAM interactions), 11% (OFF-target) and 7% (ON-target) of the total amounts of 
tracks detected by Single-Particle Tracking.  
 
Figure 4.24. A quantification of Cas9 various diffusion behaviours. Here displayed are the proportions 
of slow tracks (with Dapp < 1 µm2/s) detected from cells containing the Cas9-HaloTag protein with either of 
the following constructs; no gRNA and no genomic DNA (ΔrecA dataset, black), no gRNA (blue), the 
lacOA-gRNA without lacO target (green) and the lacOA-gRNA with the lacO22 array (purple). On the 
lacO22 dataset (purple) are displayed the different diffusion behaviours the protein can adopt (see legend), 
deduced from the three other datasets, with their respective quantifications. The plot is not to scale. 
 
 




Cas9 diffuses in the cytoplasm, searching for DNA before searching for a target 
 
Another observation pertains to the ‘non-visible’ part of our previous plot, the 64% of lacO22 
tracks appearing to be faster than our 1 µm2/s threshold, thus displaying freely-diffusing 
behaviour.  
This observation seems to stand in contradiction with our previous hypothesis of Cas9-HaloTag 
reaching target saturation, due to insufficient protein expression. Our previous hypothesis 
stated that because of a lack of Cas9 proteins in the cell, increasing the number of targets would 
not affect Cas9 apparent diffusion, as most of the proteins would already be interacting with 
their targets. And yet, even with thousands of targets (on plasmids), we still observed a 
significant portion of freely-diffusing Cas9 proteins, confirming that our initial hypothesis of 
Cas9 saturating was incorrect. 
Nevertheless, this still does not explain why more than half of Cas9 proteins freely diffusive in 
the cytoplasm, when plenty of targets are available. 
As a matter of fact, before searching for a target on the genome, Cas9 proteins first need to find 
the genome…! We can imagine Cas9, in complex with its gRNA, diffusing in the cytoplasm 
and eventually encountering genomic DNA. However, we ignore how long this simple process 
takes. Previous studies79 have measured Cas9 searching time to be of about 6 hours; and yet of 
those 6 hours, we do not know what actual time Cas9 spent diffusing in the cytoplasm, and 
how much time it spent on the DNA. Our results suggest that of those 6 hours, a lot of time is 
spent in the cytoplasm, where Cas9 most likely enters in cycles of quick DNA-interactions 
followed by free-diffusion steps.  
Our measurements do not differentiate between ON and OFF-target events 
 
We have just shown that the first reason why we do not observe a dramatic diffusion difference 
when increasing target numbers is probably due to Cas9’s predominant genomic-searching 
time, where the protein freely diffuses in the cytoplasm, unaffected by DNA and thus 
unaffected by target numbers. However, every time Cas9 encounters the genome, it probes for 
targets, and this type of interaction should be affected by target number. So then again, should 
we not expect a larger diffusion difference with larger target numbers? 
 




A second answer to this question relates to one of our previous assumptions, the ‘independence 
of OFF-target interactions from varying target numbers’, due to OFF-target events originating 
from non-specific DNA interactions across the genome (thus unrelated to specific ones). We 
also initially considered the respective fractions of OFF-target and ON-target events to be 
independent from each other, but are they really? 
In fact, we can imagine that if the number of targets increases, then every time Cas9 interacts 
with DNA, it has more chances to encounter a target – or ‘specifically’ interact – and thus less 
to ‘non-specifically’ do so. Practically speaking, this means that increasing the fraction of ON-
target should decrease the fraction of OFF-target.  
Moreover, our method of choice to identify slow tracks (with a Dapp threshold) cannot 
differentiate between specific and non-specific interactions, which put in relation with our 
previous reasoning, would mean that increasing target numbers may very well increase the 
amount of ON-target interactions, but would correspondingly decrease the amount of OFF-
target ones,  which would result in an apparently unaffected fraction of slow tracks, effectively 









Figure 4.25. ‘ON+OFF’-target quantification. Here displayed are the proportions of ‘ON+OFF’ target 
tracks, identified as the proportions of slow tracks (with Dapp < 1 µm2/s) with gRNA, thus above the ‘no-
gRNA’ fraction quantified in Figure 4.24 (>18%). The datasets come from Cas9-HaloTag cells with lacOA-
gRNA and the following constructs; the lacO6 array (yellow), the lacO22 array (purple) and the plasmid 
carrying the lacO22 array (black). Plain rectangles represent the estimated proportions of ON-target tracks, 
whereas the striped rectangles represent the OFF-target tracks. If we consider the proportion of OFF-target 
tracks identical in all datasets, we do observe an increase in ON-target tracks as the number of targets 
increases. However, the right-hand panel shows how an increase in the fraction of ON-target events may 
actually decrease the proportion of OFF-target ones, without affecting the overall proportion of slow tracks. 
 
Put together, these two reasons can explain why in the present conditions, we do not observe 
striking diffusion differences between samples with varying target numbers. One is that Cas9 
appears to spend most of its searching time away from DNA, freely diffusing. The second is 
that when Cas9 does find DNA, our current method cannot detect the difference between 
specific and non-specific interactions; we thus remain oblivious to changes in ON/OFF-target 
variations, actual key of specific diffusion change. 
 
 




In order to single out ON and OFF-target behaviours, one potential method relies on the 
assumption that the fraction of ON-target tracks linearly increases as a function of target 
number, before reaching a plateau, due to actual saturation. This hypothesis, already described 
in the literature79, assumes that the interactions of the CRISPR-complex with different targets 
are independent from each other and constrained by both the number of proteins and the 
number of targets. Following this putative behaviour, we mathematically derived (data not 
shown) that an additional array with a different number of targets would prove essential to truly 
extract the respective fractions of ON and OFF-target tracks from our current quantifications.  
Our measurements can still quantify Cas9 behaviours 
 
Despite our inability to quantify absolute fractions of “ON and OFF”-target interactions, we 
can still quantify the fractions of “ON or OFF” interactions, which indeed show differences 
between samples with various amounts of targets, and notably between 6 and 22 targets (Figure 
4.25). We observe that lacO6 “ON or OFF” fraction is of 12%, and the lacO22 one of 18%, 
resulting in a 50% increase, showing that Cas9 did increase its proportion of CRISPR-DNA 
interactions as a result of a higher target number. 
Also, we still have the ability to identify other fractions of diffusion behaviour. For instance, 
in the lacO22 dataset, we identify 64% of freely-diffusing protein, 8% of confined proteins, 
10% of Cas9 interacting with PAM sequences and 18% of CRISPR-Cas9-gRNA interactions 
(“ON or OFF” interactions, Figure 4.26). Put together, those results indicate that more than 
half of Cas9’s lifetime is spent freely diffusing in the cytoplasm. Then when Cas9 interacts 
with DNA, at least half of those interactions relate to the CRISPR complex inserting the gRNA 
to check for targets, while a third relates to the protein simply recognizing PAM sequences111. 
Regarding diffusion absolute quantification, I have also shown how freely diffusing Cas9-
HaloTag displays an averaged Dapp of 3.15 µm
2/s, first ever measure of Cas9-HaloTag diffusion 
coefficient in vivo. Another experiment would consist in observing Cas9-HaloTag in a ΔrecA 
background, this time with the addition of a plasmid containing the targets, so as to ensure that 
the majority of Cas9 interactions with DNA would be the result of ON-target interactions. Such 
an experiment would have the advantage of quantifying the diffusion of the protein bound to 
its DNA target which, as of now, has never been accurately quantified.  




Finally, further fitting and statistical work should refine the parameters (fraction and Dapp) of 
its additional DNA-interacting behaviours, following previous work done on other proteins, 
found in the literature71,112. 
 
Figure 4.26. Fractions of Cas9 diffusion behaviours. Here displayed are the proportions of tracks 
quantified from the lacO22 dataset, detected from Cas9-HaloTag cells with lacOA-gRNA and the lacO22 
array, with their respective diffusion behaviours (described in the legend). 
 
In conclusion, this chapter shows how one can successfully use different arrays of targets to 
draw the CRISPR complex to cutting DNA, while offering a range of different conditions to 
study protein diffusion. Indeed, this setup allowed me to quantify Cas9 diffusion with-and-
without gRNA, with-and-without target and, eventually, with-and-without genomic DNA, so 
as to as identify, study and quantify its four main diffusion behaviours.









Chapter V – Discussion  






The aim of this project was to study the interactions of CRISPR-Cas9 with DNA, both 
specific (ON-target) and non-specific (OFF-target). For this purpose, we used single-molecule 
microscopy and single-particle tracking to follow Cas9 displacement over time, within E. coli 
cells. 
Using a range of genetic constructs integrated into the chromosome (and on plasmids), we 
managed to detect, identify and quantify the various diffusion behaviours the protein can adopt, 
themselves associated to determined types of protein interactions with DNA. 
Those behaviours can be summarized in five main types: 
• Free diffusion, where the protein randomly diffuses in the cytoplasm. 
• Constrained diffusion, where the protein diffuses in a limited area, such as the vicinity 
of the cell membrane. 
• Cas9-PAM interactions, where apo-Cas9 (without gRNA) interacts with DNA, only 
recognising PAM sequences. 
• OFF-target interactions, where the Cas9-gRNA complex recognises PAM sequences, 
unwinds the DNA but not at the right target site encoded in the gRNA sequence. 
• ON-target interactions, where the Cas9-gRNA complex interacts with its rightful 

















Throughout this work, we managed to measure absolute values of apparent diffusion 
coefficients (Dapp) of the Cas9-HaloTag protein, in different conditions. The first one 
corresponds to Cas9-HaloTag freely diffusing, which we measured by observing the protein 
on its own, in the absence of genomic DNA (ΔrecA background), to be of 3.15 µm2/s, on 
average. Interestingly, a comparison with the freely diffusion HaloTag protein (4.10 µm2/s) 
shows that Cas9-HaloTag was still slower even in the absence of DNA and gRNA, which 




Figure 5.1. HaloTag diffuses faster than freely-diffusing Cas9-HaloTag. Apparent Diffusion Coefficient 
distributions of HaloTag (dotted line) and Cas9-HaloTag (in ΔrecA background, thus without genomic 









HaloTag is indeed 30% faster, despite being 82% smaller. This observation corresponds to 
previously reported non-linear relationship between molecular mass and diffusion106. Notably, 
whereas HaloTag very well matched the model described in those studies, Cas9-HaloTag 
appeared faster (Figure 5.2), which we can account on (i) the protein’s conformation potentially 
facilitating diffusion across the cytoplasm and (ii) the fact that those studies were performed in 
the presence of genomic DNA. Consistent with that second hypothesis, our HaloTag 
measurements were also performed in the presence of genomic DNA, whereas our Cas9-
HaloTag ones were not (as free diffusing Cas9-HaloTag corresponds to our ΔrecA sample, 
with genomic DNA digested). Indeed, genomic DNA may preferentially interfere with large 
proteins, due to increased surface interactions. 
 
Figure 5.2. The relationship between protein weight and diffusion does not appear linear. 
Experimentally, the diffusion coefficients of proteins of different molecular masses were measured and 
plotted against each other, highlighting a non-linear relationship between the two. As reference, the blue 
arrows indicate the relative positions of both HaloTag (34kDa, 4.10 µm2/s) and Cas9-HaloTag (194kDa, 
3.15 µm2/s) on the plot. Adapted from Kumar, M., Mommer, M. S. & Sourjik, V. Mobility of cytoplasmic, 
membrane, and DNA-binding proteins in Escherichia coli. Biophys. J. 98, 552–559 (2010) 106. 
Another important observation relates to the difference between tracks and proteins. Indeed, 
all our tracking data originate from tracks, not proteins. The reason for this discrepancy is that 
a single protein may be detected several times by our tracking algorithm and thus produce 
several tracks. Furthermore, fast proteins are more difficult to track and therefore lead to more 
tracks/protein, as the algorithm loses sight of the protein and, once found back, simply starts a 
new trajectory. In contrast, slow molecules are easier to follow and produce less and longer 
trajectories, as can be observed in Figure 4.15B (Chapter 4).  




Indeed, in the presence of the lacO6 array and the lacOA-gRNA (which we previously showed 
to significantly slow down Cas9 diffusion), Cas9-HaloTag displays longer tracks.  
With proteins displaying single diffusion behaviours, this observation bears little consequence. 
However, with proteins displaying several diffusion behaviours, as is the case with Cas9-
HaloTag, this observation would over-estimate the fraction of fast molecules (freely diffusing) 
and conversely under-estimate the fraction of slow molecules (despite a correct absolute 
number of slow tracks). One way to circumvent this phenomenon and thus re-normalize our 
measurements would be to limit the number of labelled Cas9-HaloTag proteins to one per cell. 
However, this would prove challenging and technically difficult to achieve, due to protein 
expression variability. Moreover, it would then require significantly more images to reach 
statistically comparable sample sizes. With this in mind, we can now turn our attention to our 




With the exception of Cas9-HaloTag freely diffusing in the absence of genomic DNA, 
absolute quantifications of Cas9-HaloTag Dapp are not straightforward, for protein diffusion 
behaviours are not separate from each other. Rather, they form a mixture of DNA-interacting 
Cas9 proteins and freely diffusing ones. Real Dapp quantification of each Cas9 behaviour would 
require fitting each distribution, with additional constraints: large sample sizes; presence of 
less than three different behaviours; which would need to be really different from each other. 
As an illustration, Rocha and colleagues113 observed that with 5,000 tracks, conventional fitting 
methods could differentiate two behaviours, provided that their respective Dapp were more than 
2-fold different; fitting of more similar diffusions would completely miss their respective 
fractions (Figure 5.3). With three different behaviours, the task gets even more challenging. 
Never mind four behaviours. 





Figure 5.3. In a mixture of two diffusion behaviours, the quantification of Dapp and their respective 
fractions is difficult. 3D simulations of confined Brownian motion generated 5,000 tracks with a mixture 
of two diffusion behaviours respectively characterizing 20% and 80% of their total amount, with Dapp values 
varying between 1 µm2/s and 15 µm2/s. The comparison between the input (fixed) and the output (fitting) is 
plotted on a heat map, with levels of error going from blue to yellow. We see that regardless of Dapp values, 
the fitting is accurate. However, the quantification of their respective fractions is very inaccurate, particularly 
with the smaller fraction (20%). Extracted from Rocha, J., Corbitt, J., Yan, T., Richardson, C. & Gahlmann, 
A. Resolving Cytosolic Diffusive States in Bacteria by Single-Molecule Tracking. Biophys. J. 116, 1970–
1983 (2019)113. 
Nevertheless, we suggested a simple model based on the measurement of slow tracks across 
all datasets, which gave us a first approximation of the quantification of the following diffusion 
fractions of the Cas9-HaloTag protein (Figure 4.26, Chapter 4); 
o 64% freely diffusing,  
o 8% with confined diffusion, 
o 10% of Cas9-PAM interactions, 
o 18% of ON-and-OFF-target interactions. 
The most striking observation pertains to the freely-diffusing fraction of Cas9-HaloTag 
molecules which appears to account for more than half of the total. Accordingly, we 
hypothesized that Cas9 spent most of its time searching for its target, away from DNA. How 
does that compare with previous studies found in the literature? 
 




Doudna and colleagues81 made similar observations, stating that in mammalian cells, Cas9 
searches predominantly through 3D diffusion. As a reminder, they used the catalytically-dead 
dCas9 mutant to target short interspersed nuclear elements (SINEs) of the B2 type present in 
the cells at about 350,000 copies. Their results showed that the protein search was dominated 
by 3D diffusion and that OFF-target events where short-lived, with an average residence time 
inferior to 1s. Quantifying the protein apparent diffusion coefficient, they observed diffusion 
shifts towards slower values as a function of gRNA association (Figure 5.4B). 
Additionally, in the absence of gRNA, they measured a diffusion coefficient of the same order 
of magnitude as ours (between 1 and 10 µm2/s). However, in the presence of a gRNA, they 
observed two distinct diffusion behaviours, separate from each other by as much as two orders 
of magnitude (10 and 0.1 µm2/s). In contrast, not only did we not observe such a difference, 
but also in all conditions, our freely diffusing fraction was always predominant (Figure 5.4A).  
Two reasons can explain those discrepancies. First, we used 22 targets, as opposed to their 
300,000 SINEs targets. Normalizing by the size of the genome, their CRISPR complex still 
had 10-times more chances to find a target, thus accounting for an increased fraction of DNA-
bound molecules. Second, they used the catalytically-dead version of the Cas9 protein (dCas9), 
which has been shown to stay bound to its target for several dozens of minutes79, as opposed 
to the wild-type version which, even in vitro, was observed to stay bound to DNA for less than 
a minute80. Therefore, not only their dCas9-HaloTag proteins could find their targets quicker 
(10x), but they would also stay bound to them for much longer (10x), resulting in much larger 












Figure 5.4. Comparison of our observation of Cas9-HaloTag diffusion with Doudna’s dCas9-Halotag. 
(A) From this work are shown apparent diffusion coefficient distributions (Dapp) of Cas9-HaloTag, without 
genomic content (black), with genomic content but without gRNA (blue) and with gRNA targeting 22 
genomic targets (purple). Mean of distributions are indicated. (B) Extracted from Doudna’s publication81, 
distributions of dCas9-HaloTag diffusion coefficient, either alone (nonsense, orange), with a gRNA 
containing mismatches proximal to the PAM region (B2_0M, green), with a gRNA containing mismatches 
distal from PAM region (B2_13M, purple) and with a gRNA with the correct target sequence (SINE B2, 
blue). 
 
In conclusion, we can hypothesize that at equal proportion of targets, we should have been able 
to observe a 1-log difference between the fast and slow diffusion behaviours. Regardless, we 












This naturally brings us to a second study; that of Elf and colleagues79 who measured a 
searching time (for dCas9) of about six hours, in E.coli. This measure is in agreement with our 
previous hypothesis of Cas9 spending most of its time searching for a target. However, our 
interpretations differ. We suggest that Cas9 does so freely diffusing, away from DNA, whereas 
they proposed that Cas9 is all this time interacting with DNA PAM sequences.  
They based their interpretation on the fact that by taking images of dCas9-YPet with various 
exposure times, detecting a fluorescent spot would indicate that a protein stayed immobile for 
at least the length of the exposure. Without gRNA, this resulted in an averaged exposure time 
of 30 ms, which they interpreted as the time dCas9 takes to interrogate a PAM sequence. They 
went further by calculating that if Cas9 were to spend all its 6h-searching-time interacting with 
PAM sequences (which amount to 106 in the genome), it would indeed result in around 20 ms 
spent per PAM sequence, which was of the same order of magnitude as their previous 
measurement of 30 ms probing time. They hence concluded that Cas9 does spend all its 
searching time probing PAM sequences. 
In response to this, we have two comments to make. First, despite the discrepancy of their 30 
ms-probing time with what was previously found in the literature (750 ms in eukaryotic cells81 
and 1s in vitro114), they assumed that a similar order of magnitude between their measurement 
and their searching time estimation was sufficient to justify their interpretation. Yet, it is not 
because dCas9 spends as little as 30 ms to probe a PAM sequence that it necessarily spends all 
its searching time doing so. Second, a closer look at their measurements shows that around 30 
ms, they only detected 0.2 fluorescent spots/cell, with a level of dCas9 expression amounting 
to five proteins/cell. Put together, this would mean that only 4% of their dCas9 proteins would 
actually be interacting with DNA for 30 ms (Figure 5.5). Considering that below 5 ms, they 
stated reaching the threshold of freely-diffusing particles, we are bound to wonder about their 
actual fraction of dCas9 proteins interacting with PAM sequences.  





Figure 5.5. Distribution of dCas9-YPet detected spots/cell with varying exposure times. With varying 
exposure times (from 1 ms to 1 s), dCas9-YPet fluorescent spots were counted, either in the presence of a 
gRNA (blue), or in its absence (red). Highlighted are the coordinates of the point corresponding to 30 ms, 
without gRNA. Adapted from Jones, D. L. et al. Kinetics of dCas9 target search in Escherichia coli. Science 
(80-. ). 9, 1420–1424 (2017)79. 
 
Finally, we can compare both assays. Their technique is based on a collection of snapshots 
leading to the detection of immobile particles and further inference of protein behaviour. Ours 
relies on the direct observation of the complete range of behaviours the protein can adopt, in 
real time and in four different conditions. In other words, they infer whereas we visualize. 
In conclusion, although we accept that dCas9 may take 30 ms to probe a PAM sequence, we 
do not believe there is sufficient evidence to support the theory following which Cas9 searching 













ON and OFF-targets observations 
 
A further observation we make from our model relates to the fractions of ON and OFF-
target interactions the Cas9 protein displayed. As explained in the previous chapter, we were 
unable to differentiate between the two types of interactions, due to technical limitations. 
However, when Cas9 is associated to a gRNA, yet with no target present on the genome, there 
can be no ON-target events. As a result, the corresponding fraction of ‘ON and OFF-target’ 
events actually limits itself to only OFF-target ones, which thus amount to 11% of the total 
number of tracks (Figure 5.6). 
In contrast, the literature reported levels of OFF-target interactions ranging from 105-time less 
than ON-target ones (with gRNAs presenting more than 2 mismatches with the target) to just 
10-time less (in the worst case, with only single mismatches)47. Comparing with our results 
indicating that with 22 targets, there are 18% of ‘ON and OFF-target’ events, we can 
extrapolate and state that even in the eventuality of those 18% being entirely the result of ON-
target interactions, it would barely be twice more than the previously-measured fraction of 
OFF-target ones (11%). Despite the fact that we are comparing two separate datasets (‘no-
target’ and ’22 targets’), and should therefore remain prudent with any further quantification, 
we can still qualitatively remark that we are far from the ’10-time less OFF-target than ON-
target’ report of the literature. 
 
 





Figure 5.6. Quantification of the fractions of slow tracks in different datasets. Fractions of slow tracks 
(with Dapp < 1 µm2/s) detected from cells containing Cas9-HaloTag with either no genomic DNA and no 
gRNA (black), genomic DNA but no gRNA (blue), a gRNA but no genomic target (green) or a gRNA and 
22 genomic target (purple). Comparing the datasets together, we can quantify three main diffusion 
behaviours, indicated in the legend. Note that without target, there can be no ON-target interaction. 
So what are the reasons of this new discrepancy, making us observe much more OFF-target 
interactions that reported in the literature? Let us remember that previous studies were relying 
on DNA modifications (indels) to detect such events, and as we hypothesized earlier in this 
work, those modifications may only represent a fraction of all OFF-target events. Indeed, some 
of those interactions may remain ‘silent’, with the CRISPR complex unwinding the DNA 
without reaching full homology, and thus preventing DNA cleavage. It is thus reasonable to 
assume that those ‘silent’ interactions may be much more frequent than those leading to DNA 
double-stranded breaks. Indeed, we observed a minimum of 1.6-fold less (or 40% less) OFF-
target events, with 22 targets. Normalized to a single target, this number may drop even further 
(~2% less). Finally, we are here estimating the minimum ON/OFF difference; it may be the 








Put together, our results stress the need for a more comprehensive study of OFF-target events, 
for in both contexts of gene editing and antimicrobial alternatives, accurately knowing 
CRISPR-Cas9 entire range of DNA-interactions is paramount. Indeed, previous studies 
reported OFF-target interactions to last for up to 1s in vitro114 which, coupled to other reports 
of Cas9’s ability to affect gene regulation35, could result in unwanted adverse effects; 
disturbing an accurate gene editing, or protecting a pathogenic bacteria to eliminate. 
Fortunately, a number of techniques can limit the levels of unwanted OFF-target events. As a 
brief reminder, High-fidelity Cas9 mutants46, anti-CRISPR proteins49 and double-nickases 
techniques47 are being developed. In parallel, improving our OFF-target detection methods is 
also extremely important, with ChIP-seq experiments50, deep sequencing protocols51 and in-
silico predictions115. 
Alternative analysis methods 
 
As shown above, the current analysis methods used in this study, namely the extraction 
of Mean Square Displacement (MSD) and apparent Diffusion Coefficient (Dapp) present the 
main advantage of having been extensively described and used in the literature, thus facilitating 
comparisons with our results. However, those methods also present caveats such as the 
averaging of data (through the computation of MSD) and consequent loss of potentially 
significant information. 
As an alternative, other analytical methods can be found such as the use of Radius of Gyration 
(described in Materials and Methods chapter) or the extraction of Single-Displacement. The 
latter is a particularly interesting example as it does not require any averaging and instead relies 
on the displacements undertaken by the protein, one frame after the next. A distribution of 
those displacements can then be obtained, with significantly more data points than for MSDs. 
To illustrate this example, we computed the Single-Displacement distributions of our Cas9-
HaloTag proteins in Figure 5.7, which offers a striking view of the diffusion shift operated by 
the protein in its four different conditions. In addition, the number of displacements resulting 
in the lacO22 distribution reaches 194,000 datapoints, compared with the 3,200 Dapp points 
computed from the same sample. 




Coupled to a simulation of Brownian motion, this amount of data could both be supportive 
(allowing the testing of additional hypotheses) and informative (through further data extraction, 
distribution fitting and inference). 
 
Figure 5.7. Distribution of Single-Displacement extracted from Cas9-HaloTag proteins. Movies 
describing cells containing the Cas9-HaloTag protein and either of the following constructs were observed: 
the lacO22-sgRNA and the lacO22 array on the genome (22 targets, purple); the lacO22-sgRNA without 
target on the genome (no target, green); the protein without any sgRNA (no gRNA, blue); and finally, no 














In our lab, we now aim to build on our new expertise to expand our set of observations. 
Indeed, a good place to start would be to build a third array of lacO repeats, in order to validate 
our theory following which three different number of targets would reveal their respective 
fractions of ON and OFF-target events, on the assumption that their ON-target fraction linearly 
increases with the number of targets. This time, we would then be able to differentiate between 
the two fractions and quantify their respective presence in the population of tracks. We would 
finally know how much of each Cas9 displays, and which one is more frequent. 
Additionally, further analyses would prove particularly useful to extract more information from 
the data we already obtained. As such, we could implement the fitting methods already 
illustrated by Uphoff and colleagues71,112 applied to DNA repair proteins, which allowed the 
quantification of various behaviours. Along the same line, they also showed how such methods 
could be used to sort protein trajectories according to their diffusion behaviour, and 
subsequently identify their most frequent locations in an E.coli cell. Another direction would 
be to compare our Diffusion Coefficient analysis method with different ones, relying more on 
particle trajectories and less on statistical averaging, as illustrated with the Single-
Displacement method. 
Also, we greatly wish to apply our experiments to the catalytically-dead Cas9 mutant (dCas9), 
which was extensively studied in the literature. Given dCas9’s ability to bind DNA for longer 
than its wild-type counterpart, we should be able to increase our fraction of slow tracks, thus 
increasing our detection sensitivity. Accordingly, the potential discrepancy between the two 
would be a direct measure of both proteins residence times (on the DNA). Additionally, such 
an endeavour would not only confront our expertise with that of other groups, but would also 
shed more light on the differences between mammalian and bacterial protein diffusion, in the 
context of chromatin structures. Finally, comparing both our Cas9 and dCas9 results would 
address new questions relating to the phenotypic activity of the protein, more specifically in 










In this work, we showed how fantastic a tool CRISPR-Cas9 was, and how it 
revolutionized both the way we do research and the way we apply it. Indeed, countless 
laboratories across the world now routinely use its genetic capabilities, which have pervaded 
our society in an attempt to improve every biological process; crop yields, biofuels, 
therapeutics, anti-mosquitoes, antimicrobials. I have to say, the future is exciting. 
However, like every formidable tool, it has its limitations. Beyond potential ethical 
questionings, there are current technical shortcomings. We presented how CRISPR-Cas9 
ability to cleave DNA is as powerful as it is accurate, and how a lack of control could be 
detrimental – if not dramatic. We described the range of behaviours CRISPR-Cas9 can adopt, 
and how despite its specific ON-target interactions with DNA, there were also non-specific 
OFF-target events. Those non-specific events are difficult to predict, difficult to detect and thus 
easy to underestimate. 
In this study, we aimed to go beyond the current detection methods of OFF-target events which 
have focused on DNA modification. Instead, we decided to directly look at the protein and 
infer from its motion the type of behaviour it would adopt, specific or not. To do so, we 
developed a single-molecule microscopy assay designed to track Cas9 displacement in time 
and in various conditions; with-and-without genomic DNA, with-and-without gRNA and with-
and-without target recognised by the gRNA. Put together, we successfully showed that we 
could track Cas9 but also build a first approximation of its fractions of respective behaviours. 
This resulted in the finding that the protein was predominantly diffusing in the cytoplasm, 
searching for its target. Additionally, we speculated that the fraction of OFF-target interaction 
was comparable to that of ON-target ones, if not larger. Finally, we showed how both fractions 
were highly dependent on the type of gRNA, characterized by its target sequence and thus 
genomic homologies. 
Strikingly, those observations were in contradiction with previous studies, which claimed that 
(i) Cas9 spent most of its time interacting with DNA (PAM sequences) and (ii) with far less 
OFF-target events. We confronted those interpretations with (i) our direct observations of 
freely diffusing Cas9, and suggested that (ii) most of the OFF-target interactions detected in 
previous studies were only a fraction of a larger ensemble, invisible to past detection techniques 
and largely underestimated.  




In conclusion, we end this work by encouraging further studies on the quantification, as well 
as on the identification of the potential roles of those ‘silent’ OFF-target events, which could 
well be interfering with DNA maintenance mechanisms (replication, regulation, repair). 
Finally, thank you for the time you have spared reading this material, and I hope you enjoyed 
















Table 1. Plasmids. 
Plasmid Genotype Source 
pXZ02 pOSIP-CT, araC pBAD-Cas9  
pXZ03 pBAD33, araC pBAD-Cas9 Gift from SJR 
pXZ05 pUA66, sgRNA-prtA Gift from SJR 
pXZ06 pOSIP-KH, PsfiA::gfp Gift from SJR 
pXZ08 pKD46, pE-FLP Addgene83 
pXZ10 pOSIP-KT Addgene83 
pXZ11 pOSIP-CT Addgene83 
pXZ13 pOSIP-KL, leaky pTet-Cas9 Gift from DB 
pXZ15 pOSIP-KL, tight pTet-Cas9 Gift from DB 
pXZ17 pOSIP-KL, leaky pTet-Cas9-HaloTag  
pXZ19 pOSIP-KL, tight pTet-Cas9-HaloTag  
pXZ20 pOSIP-CT, araC pBAD-Cas9-HaloTag  
pXZ23 pUA66: gRNA(empty) Gift from SJR 
pXZ24 pTOF(∆recA) Gift from VA 
pXZ32 crRNA (lacZ1) Gift from DB 
pXZ33 crRNA (lacZ2)  Gift from DB 
pXZ36 pUC, lacO6 Built with EGF 
pXZ37 pUC, lacO14 Built with EGF 
pXZ38 pUC, lacO22 Built with EGF 
pXZ39 pUC, lacO30 Built with EGF 
pXZ40 pOSIP-KO, lacO6  
pXZ42 pOSIP-KO, lacO22  
pXZ44 pUA66, sgRNA-lacOA (array)  
pXZ45 pUA66, sgRNA-lacO (genome)  
pXZ46 pBAD-HaloTag Gift from HT 
SJR: Sebastian Jaramillo-Riveri 
DB: David Bikard 
VA: Vincent Amarh 
EGF: Edinburgh Genome Foundry 












For each plasmid, the backbone was either extracted with restriction enzymes (digestion), or amplified 
by PCR. They were then associated via Gibson Assembly with one or several fragments, themselves 
either coming from gBlocks or from PCR amplicons. In the table below are indicated the plasmids, their 
contents, their backbones, the templates from which the PCR were realised, with their respective 
amplification primers. Note that for pXZ40 and pXZ42, simple restriction-ligation was performed. For 
pXZ44 and pXZ45, whole-plasmid amplification was used instead, with the sgRNA target sequence 
introduced on the amplification primers. 
Table 2. Description of templates for plasmid construction. 
Plasmid Content Backbone (digest) Fragments Amplification Primers Checking Primers 
pXZ02 pOSIP-CT, 
araC pBAD-Cas9 
pXZ11 pXZ03 (PCR) pOSIP-CT: oXZ14, oXZ24 










pXZ15 (SacI, NarI) gBlock gXZ01 - oXZ15, oXZ16 
pXZ20 pOSIP-CT, araC 
pBAD-Cas9-
HaloTag 
pXZ02 (PmlI, NarI) gBlock gXZ01, 
pXZ02 
pXZ02: oXZ29, oXZ30 oXZ27, oXZ28 
pXZ40 pOSIP-KO, lacO6 pOSIP-KO (BamHI, 
NarI) 
pXZ36 (BamHI, NarI) - oXZ136, oXZ137 
pXZ42 pOSIP-KO, lacO22 pOSIP-KO (BamHI, 
NarI) 
pXZ38 (BamHI, NarI) - oXZ136, oXZ137 
pXZ44 pUA66, sgRNA-
lacOA (array) 
pXZ05 - oXZ150, oXZ151 oXZ149, oXZ152 
pXZ45 pUA66, sgRNA-
lacO (genome) 

















Table 3. E.coli strains. 
Strain Genotype Plasmid Source/Comment 
MG1655  F- lambda- ilvG- rfb-50 rph-1  E. coli K-12 
BW27783 Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, Δ(araH-araF)570(::FRT), 
ΔaraEp-532::FRT, φPcp8araE535, rph-1, Δ(rhaD-rhaB)568, hsdR514 
 105  
XZ12 BW27783 pXZ03 Gift from SJR 
XZ13 BW27783 pXZ05 Gift from SJR 
XZ14 BW27783 pXZ03, pXZ05  




XZ20 BW27783, HK022::PsfiA-mGFP   
XZ30 DH5a pir pXZ02  
XZ31 DH5a pir  Gift from MEK 
XZ33 E811 pXZ11  
XZ35 DH5a pir pXZ13 Gift from DB 
XZ37 DH5a pir pXZ15 Gift from DB 
XZ50 MG1655, HK022::PsfiA-mGFP, Lambda::(leaky)pTet-Cas9   
XZ54 MG1655, HK022::PsfiA-mGFP, Lambda::(tight)pTet-Cas9   
XZ58 DH5a pir pXZ17  
XZ62 DH5a pir pXZ19  
XZ74 MG1655, Lambda::(leaky)pTet-Cas9   
XZ78 MG1655, Lambda::(tight)pTet-Cas9   
XZ82 MG1655, HK022::PsfiA-mGFP, Lambda::(leaky)pTet-Cas9-HaloTag   
XZ86 MG1655, HK022::PsfiA-mGFP, Lambda::(tight)pTet-Cas9-HaloTag   
XZ90 MG1655, Lambda::(leaky)pTet-Cas9-HaloTag   
XZ94 MG1655, Lambda::(tight)pTet-Cas9-HaloTag   
XZ99 MG1655, HK022::PsfiA-mGFP, Lambda::(tight)pTet-Cas9 pXZ05 gRNA(ptrA) 
XZ106 MG1655, Lambda::(tight)pTet-Cas9 pXZ05 gRNA(ptrA) 
XZ110 MG1655, HK022::PsfiA-mGFP, Lambda::(tight)pTet-Cas9-HaloTag pXZ05 gRNA(ptrA) 
XZ114 MG1655, Lambda::(tight)pTet-Cas9-HaloTag pXZ05 gRNA(ptrA) 
XZ117 BW27783, P21::pBAD-Cas9   
XZ119 MG1655, P21::pBAD-Cas9, HK022::PsfiA-mGFP   
XZ121 BW27783, P21::pBAD-Cas9 pXZ05 gRNA(ptrA) 
XZ122 MG1655, P21::pBAD-Cas9, HK022::PsfiA-mGFP pXZ05 gRNA(ptrA) 
XZ124 DH5a pir pXZ20  
XZ125 DH5a pir pXZ20, pXZ05 gRNA(ptrA) 
XZ128 BW27783, P21::pBAD-Cas9-HaloTag   
XZ130 MG1655, P21::pBAD-Cas9-HaloTag, HK022::PsfiA-mGFP   
XZ136 BW27783, P21::pBAD-Cas9-HaloTag pXZ05 gRNA(ptrA) 





Strain Genotype Plasmid Source/Comment 
XZ145 BW27783, P21::pBAD-Cas9-HaloTag, HK022::PsfiA-mGFP   
XZ148 BW27783, P21::pBAD-Cas9, HK022::PsfiA-mGFP pXZ05 gRNA(ptrA) 
XZ149 BW27783, P21::pBAD-Cas9-HaloTag, HK022::PsfiA-mGFP pXZ05 gRNA(ptrA) 
XZ151 MG1655 pXZ32 crRNA(lacZ1) 
XZ152 MG1655 pXZ33 crRNA(lacZ2) 
XZ157 BW27783 pXZ23 gRNA(empty) 
XZ158 BW27783, P21::pBAD-Cas9-HaloTag, HK022::PsfiA-mGFP pXZ23 gRNA(empty) 
XZ159 XL1-blue pXZ24 Gift from VA 
XZ161 BW27783, P21::pBAD-Cas9-HaloTag, HK022::PsfiA-mGFP, ΔrecA   
XZ162 BW27783, P21::pBAD-Cas9-HaloTag, HK022::PsfiA-mGFP, ΔrecA pXZ23 gRNA(empty) 
XZ163 BW27783, P21::pBAD-Cas9-HaloTag, HK022::PsfiA-mGFP, ΔrecA pXZ05 gRNA(ptrA) 
XZ165 BW27783 pXZ46 pBAD-HaloTag 
XZ179 BW27783, P21::pBAD-Cas9, HK022::PsfiA-mGFP pXZ32 crRNA(lacZ1) 
XZ180 BW27783, P21::pBAD-Cas9, HK022::PsfiA-mGFP ;        unstable pXZ33 crRNA(lacZ2) 
XZ187 BW27783, P21::pBAD-Cas9, HK022::PsfiA-mGFP pXZ23 gRNA(empty) 
XZ189 DH5a pir pXZ36  
XZ190 DH5a pir pXZ37  
XZ191 DH5a pir pXZ38  
XZ192 DH5a pir pXZ39  
XZ195 DH5a pir pXZ40  
XZ197 DH5a pir pXZ42  
XZ199 DH5a pir pXZ45  
XZ200 DH5a pir pXZ44  
XZ210 BW27783, P21::pBAD-Cas9-HaloTag, HK022::PsfiA-mGFP, 186::lacO6   
XZ211 BW27783, P21::pBAD-Cas9-HaloTag, HK022::PsfiA-mGFP, 186::lacO22   
XZ219 BW27783, P21::pBAD-Cas9-HaloTag, HK022::PsfiA-mGFP, 186::lacO6 pXZ23 gRNA(empty) 
XZ220 BW27783, P21::pBAD-Cas9-HaloTag, HK022::PsfiA-mGFP, 186::lacO6 pXZ05 gRNA(ptrA) 
XZ221 BW27783, P21::pBAD-Cas9-HaloTag, HK022::PsfiA-mGFP, 186::lacO6 pXZ45 gRNA(lacO) 
XZ222 BW27783, P21::pBAD-Cas9-HaloTag, HK022::PsfiA-mGFP, 186::lacO6 pXZ44 gRNA(lacOA) 
XZ226 BW27783, P21::pBAD-Cas9-HaloTag, HK022::PsfiA-mGFP, 186::lacO22 pXZ23 gRNA(empty) 
XZ227 BW27783, P21::pBAD-Cas9-HaloTag, HK022::PsfiA-mGFP, 186::lacO22 pXZ05 gRNA(ptrA) 
XZ228 BW27783, P21::pBAD-Cas9-HaloTag, HK022::PsfiA-mGFP, 186::lacO22 pXZ44 gRNA(lacOA) 
XZ235 BW27783, P21::pBAD-Cas9-HaloTag, HK022::PsfiA-mGFP pXZ44 gRNA(lacOA) 
XZ236 BW27783, P21::pBAD-Cas9-HaloTag, HK022::PsfiA-mGFP pXZ38, pXZ44 gRNA(lacOA) 
XZ237 BW27783, P21::pBAD-Cas9-HaloTag, HK022::PsfiA-mGFP, 186::lacO22 pXZ38, pXZ44 gRNA(lacOA) 
SJR: Sebastian Jaramillo-Riveri  
MEK: Meriem El Karoui 
DB: David Bikard 
VA: Vincent Amarh 






Table 4. Description of strains used in experiments. 
Experiment Strains (XZ#) Thesis paragraph 
Qualitative Cas9 activity 99, 110, 148, 149 3.2.1 
Quantitative Cas9 activity 148, 149, 158, 187 3.2.2 
Cas9-HaloTag signal specificity 158, 187 3.3.3 
Protein counting 149, 158, 187 3.2.4 
HiLo signal specificity 149, 158, 187 3.3.1 
Tracking: HaloTag 165 and BW27783 3.3.2 
Tracking: Cas9-HaloTag 149, 158, 187 3.3.3 
Qualitative CRISPR-lacO activity 149, 158, 210, 219, 220, 221, 222, 
226, 227, 228, 235 
4.2.1, 4.2.2 
Quantitative CRISPR-lacO activity 226, 228 4.2.3 
Tracking: CRISPR-lacO6 187, 219, 222 4.3.1 
Tracking: CRISPR-lacO22 187, 226, 228 4.3.2 
Tracking: no target 187, 226, 235 4.3.3 
Tracking: plasmid targets 187, 226, 235, 236, 237 4.3.4 
Tracking: no genomic DNA 158, 162, 187 4.3.4 
 
Table 5. Primers. 
For primers containing overhangs, the annealing part is shown in bold. oXZ150 and oXZ154 
contain SacI restriction sites, to facilitate downstream screening of plasmid construction. For 
oXZ151-155, red base-pairs (bps) indicate the gRNA target sequences, blue bps the SacI 
added restriction site and the underlined bps the sequence overlapping their paired primer. 
Primer Sequence (5’ → 3’) Comment 
oXZ14 GTCAGCTAGGAGGTGACTAACTGCAGGC
ATGCCTCGAGAT 
Building pXZ02, anneals pOSIP-CT 
oXZ15 TATTCAGTCCTAGTGGTTGC Checking pXZ17, pXZ19, forw. 




Building pXZ02, anneals pXZ03 
oXZ23 GGCGCCATGCATCTCGAGGCATGCCTGC
AGTTAGTCACCTCCTAGCTGACTC 
Building pXZ02, anneals pXZ03 
oXZ24 TAGCCGTCAAGTTGTCATAAATACTGTT
ATCTGGCTTTTA 
Building pXZ02, anneals pOSIP-CT 
oXZ25 GCAGACAAGCCCGTCAGGGCGCGT Checking pXZ02, forw.1 
oXZ26 TGTTACTGCGGCGCATGGAAGCGA Checking pXZ02, rev.1 
oXZ27 AGTCCAGAAGATAACGAACAAAAA Checking pXZ02, pXZ20, forw.2 
oXZ28 TTGTATTGCCAATATACCTTTCCGG Checking pXZ02, pXZ20, rev.2 
oXZ29 GGGCGGCATAAGCCAGAAAATATCG Building pXZ20, anneals pXZ02 





oXZ136 GAATTCGAGCTCGGTACCCG Checking and Seq. pXZ40, pXZ42, forw. 
oXZ137 AATCGCCAGAGAAATCTACG Checking and Seq. pXZ40, pXZ42, forw. 
oXZ138 CTCATACAATCGGAAACACAAT Sequencing pXZ42 
oXZ139 CCTGTAGTACAGCGCTTATG Sequencing pXZ42 
oXZ141 CGCGCCGCTAGATTCAACC Sequencing pXZ40, pXZ42 
oXZ144 GAGCGGATAACAATTCTTGAT Sequencing pXZ42 
oXZ145 TCTCCCGCTTGTCATGCC Sequencing pXZ42 
oXZ148 ACTTCGGACGTCTAAGAAAC Sequencing pXZ40, pXZ42 









Building pXZ44, anneals pXZ05 









Building pXZ45, anneals pXZ05 
 
Table 6. Additional sequences. 
Content Sequence (5’ → 3’) Comment 
gRNA(ptrA) GGTGCGCATCATAAAGTAAG Target sequence 
gRNA(lacO) ATGTTGTGTGGAATTGTGAG Target sequence 
gRNA(lacOA) TCCGCTCACAATTCCACATG Target sequence 
crRNA(lacZ1) TCACTGGCCGTCGTTTTACAACGTCGTGAC Target sequence 
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Table 7. Media composition. 
Generic Media Imaging Media HaloTag fixation  
M9 1X M9 1X Formaldehyde 2.5%  
Glucose 0.2% w/v Glucose 0.2% w/v PBS 1X  
MgSO4 2mM MgSO4 2mM   
CaCl2 0.1mM CaCl2 0.1mM   
MEM Essential 1X LB 10%   
MEM Non-Essential 1X    
 
Table 8. Antibiotic concentrations. 
Antibiotics Concentration 
Kanamycin (Kn)  50 μg/ml 
Chloramphenicol (Cl) 30 μg/ml 
Ampicillin (Am)  100 μg/ml 
Anhydrotetracycline 1µM 
 
Table 9. Single-Molecule Tracking script description 
 
0. Cell cropped manually from single-molecule movie 
1. Segmentation of the cell 
a. Extracts information from each frame of the movie, using read_stacks and SumIm 
developed by A. Lepore; 
b. Computes the intensity threshold used to obtain the binary mask; 
c. Extracts information from the identified cell. 
2. Tracking of the fluorescent molecules within the cell 
a. Runs the frames of the movie through findpeak_timeTOtrack, developed by A. 
Lepore, to identify the fluorescent peaks 
i. Applies a band-pass filter that suppresses pixel noise (bpass, from Crocker 
et al.) 
ii. Identifies peaks from their intensity (pkfnd, from E. R. Dufresne) 
iii. Identifies peaks’ centre position by fitting the peaks to a 2D Gaussian 
(centfind, Eric R. Dufresne) 





c. Restricts them to those within the cell (SelTracks, from A. Lepore) 
3. Tracking data visualisation 
a. Shows tracks overlapping the first frame of the cropped movie 
b. Shows distribution of molecules’ occupancy, on a pixel heat map 
 
4. Mean Square Displacement (MSD) and Diffusion Coefficient (D) computation 
a. MSD and Single Displacement respectively computed with MSDcalculations and 
SDcalculations (A. Lepore) 
b. Visualise MSD as a function of lag-time 
c. D computed and distribution visualised (log scale) 
 
Table 10. Parameters used in the tracking script. 
Parameter Function Value Note 
param.Xtime - 150 objective 
magnification 
param.pixel2micron - 16/param.Xtime converts px in µm 






number of frames 
used to track 
param.nstacks_seg read_stacks 200 number of frames 
used to segment 









param.pnoise bpass 1 noise 
param.psize pkfnd, bpass 4 size group of pixel  
param.pgauss centfind 7 size for gaussian 
fit  
param.maxd track 8 maximum dispersion 
para.mem track 0 memory  
para.good track 2 eliminates very 
short trajectories 
para.quiet track 0 to obtain text output 
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